<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
    <journal-id journal-id-type="iso-abbrev">PeerJ</journal-id>
    <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
    <journal-title-group>
      <journal-title>PeerJ</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2167-8359</issn>
    <publisher>
      <publisher-name>PeerJ Inc.</publisher-name>
      <publisher-loc>San Diego, USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10704995</article-id>
    <article-id pub-id-type="publisher-id">16087</article-id>
    <article-id pub-id-type="doi">10.7717/peerj.16087</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Biochemistry</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Bioinformatics</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Biology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Science</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Data Science</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Dark kinase annotation, mining, and visualization using the Protein Kinase Ontology</article-title>
    </title-group>
    <contrib-group>
      <contrib id="author-1" contrib-type="author">
        <name>
          <surname>Soleymani</surname>
          <given-names>Saber</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
      </contrib>
      <contrib id="author-2" contrib-type="author">
        <name>
          <surname>Gravel</surname>
          <given-names>Nathan</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-3" contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Liang-Chin</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-4" contrib-type="author">
        <name>
          <surname>Yeung</surname>
          <given-names>Wayland</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-5" contrib-type="author">
        <name>
          <surname>Bozorgi</surname>
          <given-names>Elika</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
      </contrib>
      <contrib id="author-6" contrib-type="author">
        <name>
          <surname>Bendzunas</surname>
          <given-names>Nathaniel G.</given-names>
        </name>
        <xref rid="aff-3" ref-type="aff">3</xref>
      </contrib>
      <contrib id="author-7" contrib-type="author" corresp="yes">
        <name>
          <surname>Kochut</surname>
          <given-names>Krzysztof J.</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
        <email>kkochut@uga.edu</email>
      </contrib>
      <contrib id="author-8" contrib-type="author" corresp="yes">
        <name>
          <surname>Kannan</surname>
          <given-names>Natarajan</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
        <xref rid="aff-3" ref-type="aff">3</xref>
        <email>nkannan@uga.edu</email>
      </contrib>
      <aff id="aff-1"><label>1</label><institution>Department of Computer Science, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
      <aff id="aff-2"><label>2</label><institution>Institute of Bioinformatics, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
      <aff id="aff-3"><label>3</label><institution>Department of Biochemistry and Molecular Biology, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Góes-Neto</surname>
          <given-names>Aristóteles</given-names>
        </name>
      </contrib>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>12</month>
      <year iso-8601-date="2023">2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>11</volume>
    <elocation-id>e16087</elocation-id>
    <history>
      <date date-type="received" iso-8601-date="2023-04-05">
        <day>5</day>
        <month>4</month>
        <year iso-8601-date="2023">2023</year>
      </date>
      <date date-type="accepted" iso-8601-date="2023-08-22">
        <day>22</day>
        <month>8</month>
        <year iso-8601-date="2023">2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 Soleymani et al.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Soleymani et al.</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="https://peerj.com/articles/16087"/>
    <abstract>
      <p>The Protein Kinase Ontology (ProKinO) is an integrated knowledge graph that conceptualizes the complex relationships among protein kinase sequence, structure, function, and disease in a human and machine-readable format. In this study, we have significantly expanded ProKinO by incorporating additional data on expression patterns and drug interactions. Furthermore, we have developed a completely new browser from the ground up to render the knowledge graph visible and interactive on the web. We have enriched ProKinO with new classes and relationships that capture information on kinase ligand binding sites, expression patterns, and functional features. These additions extend ProKinO’s capabilities as a discovery tool, enabling it to uncover novel insights about understudied members of the protein kinase family. We next demonstrate the application of ProKinO. Specifically, through graph mining and aggregate SPARQL queries, we identify the p21-activated protein kinase 5 (PAK5) as one of the most frequently mutated dark kinases in human cancers with abnormal expression in multiple cancers, including a previously unappreciated role in acute myeloid leukemia. We have identified recurrent oncogenic mutations in the PAK5 activation loop predicted to alter substrate binding and phosphorylation. Additionally, we have identified common ligand/drug binding residues in PAK family kinases, underscoring ProKinO’s potential application in drug discovery. The updated ontology browser and the addition of a web component, ProtVista, which enables interactive mining of kinase sequence annotations in 3D structures and Alphafold models, provide a valuable resource for the signaling community. The updated ProKinO database is accessible at <uri xlink:href="https://prokino.uga.edu">https://prokino.uga.edu</uri>.</p>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Curation</kwd>
      <kwd>User interface</kwd>
      <kwd>Drug discovery</kwd>
      <kwd>Cell signaling</kwd>
      <kwd>Protein structure</kwd>
      <kwd>Protein function</kwd>
      <kwd>Network biology</kwd>
      <kwd>Cancer genomes</kwd>
    </kwd-group>
    <funding-group>
      <award-group id="fund-1">
        <funding-source>National Institutes of Health</funding-source>
        <award-id>U01CA239106 and R35 GM139656</award-id>
      </award-group>
      <funding-statement>This work was supported by the National Institutes of Health (U01CA239106 and R35 GM139656) to Natarajan Kannan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>The protein kinase gene family with nearly 535 human members (collectively called the human kinome) is a biomedically important gene family associated with many human diseases such as cancer, diabetes, Alzheimer’s disease, Parkinson’s disease, and inflammatory disorders. They make up one-third of all drug-related protein target discoveries in the pharmaceutical industry, with over 50 FDA-approved drugs developed since 2001 (<xref rid="ref-17" ref-type="bibr">Ferguson &amp; Gray, 2018</xref>; <xref rid="ref-79" ref-type="bibr">Zhang, Yang &amp; Gray, 2009</xref>). However, despite decades of research on the protein kinase family, our current knowledge of the kinome is skewed towards a subset of well-studied kinases with nearly one-third of the kinome largely understudied. These understudied kinases, collectively referred to as the “dark” kinome by the Knowledge Management Center (KMC) (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>) within the Illuminating the Druggable Genome (IDG) consortium, constitute both active kinases and inactive pseudokinases, which lack one or more of the active site residues, but perform important scaffolding and regulatory roles in signaling pathways (<xref rid="ref-7" ref-type="bibr">Byrne, Foulkes &amp; Eyers, 2017</xref>; <xref rid="ref-13" ref-type="bibr">Eyers, Keeshan &amp; Kannan, 2017</xref>; <xref rid="ref-14" ref-type="bibr">Eyers &amp; Murphy, 2013</xref>; <xref rid="ref-53" ref-type="bibr">Murphy, Mace &amp; Eyers, 2017</xref>) and are druggable (<xref rid="ref-18" ref-type="bibr">Foulkes et al., 2018</xref>). Incomplete knowledge of the structure, function, and regulation of these understudied kinases and pseudokinases presents a major bottleneck for drug discovery efforts. While multiple initiatives are beginning to generate essential tools and resources to characterize dark kinases, integrative mining of these datasets is necessary to develop new testable hypotheses on dark kinase functions. However, integrative mining of protein kinase data is a challenge because of the diverse and disparate nature of protein kinase data sources and formats. Information on the structural and functional aspects of dark kinases, for example, is scattered in the literature posing unique challenges for researchers interested in formulating routine queries such as “disease mutations mapping to conserved structural and functional regions of the kinome” or “post-translational modifications (PTMs) in the activation loop of dark kinases.” Formulating such aggregate queries requires researchers to go through the often time-consuming and error-prone process of collating information from various data sources through customized computer programs, which results in duplication of efforts across laboratories, and does not scale well with the growing complexity and diversity of protein kinase data. For these reasons, the IDG consortium has developed a unified resource, Pharos, for collating diverse forms of information on druggable proteins, including protein kinases (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>; <xref rid="ref-65" ref-type="bibr">Sheils et al., 2020</xref>, <xref rid="ref-64" ref-type="bibr">2021</xref>). A focused Dark Kinase Knowledgebase has also been developed to make experimental data available on dark kinases to the broader research community (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>; <xref rid="ref-52" ref-type="bibr">Moret et al., 2021</xref>). While these unified resources provide a wide range of valuable information on druggable proteins, they offer limited data analytics capabilities in mining sequence and structural data. They do not conceptualize protein kinases’ detailed structural and functional knowledge in a practical and understandable way for protein kinase researchers. Thus, to accelerate the biochemical characterization of understudied dark kinases, a semantically meaningful and mineable representation of the kinase knowledge base is needed (<xref rid="fig-1" ref-type="fig">Fig. 1</xref>).</p>
    <fig position="float" id="fig-1">
      <object-id pub-id-type="doi">10.7717/peerj.16087/fig-1</object-id>
      <label>Figure 1</label>
      <caption>
        <title>The ProKinO architecture and work-flow.</title>
        <p>(A) A subset of curated data sources used in ontology population. (B) A schematic of the ontology schema with classes (boxes) and relationships (lines) connecting the classes. (C) Applications for ontology browsing and navigation.</p>
      </caption>
      <graphic xlink:href="peerj-11-16087-g001" position="float"/>
    </fig>
    <p>To semantically represent protein kinase data in ways protein kinase researchers use and understand, we previously reported the development of a focused protein kinase ontology, ProKinO (<xref rid="ref-21" ref-type="bibr">Gosal, Kannan &amp; Kochut, 2011</xref>; <xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>; <xref rid="ref-49" ref-type="bibr">McSkimming et al., 2015</xref>), which integrates and conceptualizes diverse forms of protein kinase data in computer- and human-readable format (<xref rid="fig-2" ref-type="fig">Fig. 2</xref>). The ontology is instantiated with curated data from internal and external sources and enables aggregate queries linking diverse forms of data in one place. ProKinO enables the generation of new knowledge regarding kinases and pathways altered in various cancer types, and new testable hypotheses regarding the structural and functional impact of disease mutations (<xref rid="ref-2" ref-type="bibr">Bailey et al., 2015</xref>; <xref rid="ref-9" ref-type="bibr">Cicenas &amp; Cicenas, 2016</xref>; <xref rid="ref-20" ref-type="bibr">Goldberg et al., 2013</xref>; <xref rid="ref-21" ref-type="bibr">Gosal, Kannan &amp; Kochut, 2011</xref>; <xref rid="ref-25" ref-type="bibr">Hu et al., 2015</xref>; <xref rid="ref-42" ref-type="bibr">Liu, Liang &amp; Zhang, 2016</xref>; <xref rid="ref-46" ref-type="bibr">McClendon et al., 2014</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>, <xref rid="ref-48" ref-type="bibr">2014</xref>, <xref rid="ref-49" ref-type="bibr">2015</xref>; <xref rid="ref-50" ref-type="bibr">Meharena et al., 2013</xref>; <xref rid="ref-51" ref-type="bibr">Mohanty et al., 2016</xref>; <xref rid="ref-56" ref-type="bibr">Nguyen et al., 2015</xref>; <xref rid="ref-59" ref-type="bibr">Oruganty &amp; Kannan, 2013</xref>; <xref rid="ref-62" ref-type="bibr">Ruan &amp; Kannan, 2015</xref>; <xref rid="ref-66" ref-type="bibr">Simonetti et al., 2014</xref>; <xref rid="ref-69" ref-type="bibr">Taylor et al., 2015</xref>; <xref rid="ref-44" ref-type="bibr">ManChon et al., 2014</xref>; <xref rid="ref-71" ref-type="bibr">Vazquez et al., 2016</xref>). For example, through iterative ProKinO queries and follow-up experimental studies, we identified oncogenic mutations associated with abnormal protein kinase activation and drug sensitivity (<xref rid="ref-43" ref-type="bibr">Lubner et al., 2017</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>, <xref rid="ref-49" ref-type="bibr">2015</xref>; <xref rid="ref-51" ref-type="bibr">Mohanty et al., 2016</xref>; <xref rid="ref-60" ref-type="bibr">Patani et al., 2016</xref>; <xref rid="ref-62" ref-type="bibr">Ruan &amp; Kannan, 2015</xref>; <xref rid="ref-63" ref-type="bibr">Ruan, Katiyar &amp; Kannan, 2017</xref>). We have also employed federated queries linking ProKinO with other widely used ontologies and resources such as the Protein Ontology (PRO), neXtProt, Reactome, and the Mouse Genome Informatics (MGI) to prioritize understudied dark kinases for functional studies and generate testable hypotheses regarding post-translational modification and cancer mutations (<xref rid="ref-26" ref-type="bibr">Huang et al., 2018</xref>).</p>
    <fig position="float" id="fig-2">
      <object-id pub-id-type="doi">10.7717/peerj.16087/fig-2</object-id>
      <label>Figure 2</label>
      <caption>
        <title>Subset of the updated ProKinO schema with new classes and relationships.</title>
        <p>The full schema can be accessed at <uri xlink:href="http://prokino.uga.edu/">http://prokino.uga.edu/</uri>. New classes are colored in cyan and pre-existing classes are colored in pink. Black arrows indicate new relationships introduced to connect the new classes.</p>
      </caption>
      <graphic xlink:href="peerj-11-16087-g002" position="float"/>
    </fig>
    <p>While our preliminary studies have demonstrated the utility of ProKinO in hypothesis generation and knowledge discovery, to fully realize the impact of ProKinO in drug discovery and dark kinome mining, the ontology and the associated analytics tools need to be further developed to expand its scope and usability. For example, mutations at specific functional regions of the protein kinase domain, such as the gatekeeper and activation segments, are known to impact drug binding efficacies (<xref rid="ref-19" ref-type="bibr">Gajiwala et al., 2009</xref>; <xref rid="ref-77" ref-type="bibr">Yun et al., 2008</xref>). Likewise, kinase mRNA expression profiles strongly correlate with drug response (<xref rid="ref-4" ref-type="bibr">Benhar, Engelberg &amp; Levitzki, 2002</xref>; <xref rid="ref-11" ref-type="bibr">Duncan et al., 2012</xref>; <xref rid="ref-34" ref-type="bibr">Kim, Song &amp; Haura, 2009</xref>; <xref rid="ref-57" ref-type="bibr">Niepel et al., 2017</xref>). Thus, integrative mining of disease mutations with drug sensitivity profiles and expression patterns can provide new hypotheses/data for the development and administration of combinatorial drugs where multiple mutated kinases in distinct pathways can be targeted for drug repurposing (<xref rid="ref-12" ref-type="bibr">Erika et al., 2016</xref>; <xref rid="ref-39" ref-type="bibr">Li &amp; Jones, 2012</xref>), as demonstrated by the repurposing of Gleevec for targeting c-kit kinase in Gastrointestinal tumors (<xref rid="ref-31" ref-type="bibr">Joensuu et al., 2001</xref>). Furthermore, the recent generation of structural models of various dark kinases using AlphaFold (<xref rid="ref-32" ref-type="bibr">Jumper et al., 2021</xref>) provides a new framework for generating new hypotheses by interactive mining and visualization of sequence annotations in the context of 3D models. However, the lack of interactive visualization tools to overlay sequence and functional annotations in 3D structural models presents a bottleneck in the effective use of AlphaFold models for function prediction. To address this and other challenges described above related to dark kinase mining and annotation, we have expanded ProKinO by including kinase expression data, as well as a variety of data related to ligand-motif interaction, and ligand response prediction (<xref rid="ref-27" ref-type="bibr">Huang et al., 2021</xref>). We have also significantly revamped the ProKinO browser through incorporation of new visualization tools for the interactive mining of sequence annotations in the context of experimentally determined 3D structures and AlphaFold models. We demonstrate the application of these new tools in dark kinase annotation and mining using the understudied p21-activated protein kinase 5, as an example. The updated ontology and browser provide a valuable resource for mining, visualizing, and annotating the dark kinome and pseudokinome.</p>
  </sec>
  <sec sec-type="materials|methods">
    <title>Materials and Methods</title>
    <sec>
      <title>Data sources</title>
      <p>The ProKinO ontology includes data obtained from curated internal sources as well as external sources. Information from internal sources include annotations of kinase sequence and structural motifs retrieved from curated multiple sequence alignments. External sources are used for information related to kinase sequence and classification (KinBase &amp; UniProt) (<xref rid="ref-3" ref-type="bibr">Bairoch et al., 2005</xref>; <xref rid="ref-45" ref-type="bibr">Manning et al., 2002</xref>) cancer mutations (COSMIC) (<xref rid="ref-68" ref-type="bibr">Tate et al., 2018</xref>), pathways (Reactome) (<xref rid="ref-10" ref-type="bibr">Croft et al., 2011</xref>) and three dimernsioanl structure (PDB) (<xref rid="ref-6" ref-type="bibr">Berman et al., 2000</xref>). The ontology is populated and updated on a regular basis using protocols described in previous studies (<xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>). Here, we describe further enhancements and additions to ProKinO through integration of data on kinase expression patterns and drug interactions, as described below. In a seperate significant project, we have identified and classified nearly 30,000 pseudokinases spanning over 1,300 organisms (<xref rid="ref-38" ref-type="bibr">Kwon et al., 2019</xref>). The schematic representation of the classification of kinases into groups, families, and subfamilies was already in place (<xref rid="ref-24" ref-type="bibr">Hanks &amp; Hunter, 1995</xref>; <xref rid="ref-45" ref-type="bibr">Manning et al., 2002</xref>). Consequently, the addition of the pseudokinases and their classification was relatively simple. However, it significantly enhanced ProKinO as a comprehensive knowledge graph representing kinase-related data. The definition and nomenclature of several kinome-wide conserved motifs were standardized based on several previously published studies which describe the kinase structural features such as subdomains (<xref rid="ref-24" ref-type="bibr">Hanks &amp; Hunter, 1995</xref>), regulatory spine/shell (<xref rid="ref-50" ref-type="bibr">Meharena et al., 2013</xref>), and catalytic spine (<xref rid="ref-25" ref-type="bibr">Hu et al., 2015</xref>). A subset of redundant or family-specific motifs were removed in the updated ontology and motif information on some of the atypical kinases such as ALPHAK2 is not included as they cannot be reliably aligned with canonical protein kinases. Portions of the text were previously published as a part of a preprint (<xref rid="ref-67" ref-type="bibr">Soleymani et al., 2022</xref>).</p>
    </sec>
    <sec>
      <title>Ligand interactions</title>
      <p>Information on kinase-ligand interactions were retrieved from the Kinase-Ligand Interaction Fingerprints and Structures (KLIFS) database (<xref rid="ref-33" ref-type="bibr">Kanev et al., 2021</xref>). The KLIFS database stores detailed drug-protein kinase interaction information derived from diverse (&gt;2,900) structures of catalytic domains of human and mouse protein kinases deposited in the Protein Data Bank. In addition, KLIFS provides an application programming interface (API) for programmatic access to data related to chemicals and structural chemogenomics (<xref rid="ref-33" ref-type="bibr">Kanev et al., 2021</xref>). However, it lacks information regarding kinase pathways or diseases which prevents the user from investigating the effect of drug-mutant protein binding on downstream pathways or diseases. KLIFS annotations, which report PDB residue positions, were converted to UniProt residue numbering using PDBrenum (<xref rid="ref-15" ref-type="bibr">Faezov &amp; Dunbrack, 2021</xref>), then converted to prototypic Protein Kinase A (PKA) numbering using Multiply Aligned Profiles for Global Alignment of Protein Sequences (MAPGAPS) (<xref rid="ref-54" ref-type="bibr">Neuwald, 2009</xref>). Entries that could not be mapped or did not map to the kinase domain were filtered out.</p>
    </sec>
    <sec>
      <title>Ligand responses</title>
      <p>We have also incorporated information on kinase drug sensitivity profile in the updated ProKinO. In particular, we retrieved drug dose response data for kinase-relevant ligands/drugs from the Genomics of Drug Sensitivity in Cancer (GDSC) (<xref rid="ref-75" ref-type="bibr">Yang et al., 2013</xref>). Kinase-relevant ligands are defined based on our previous study (<xref rid="ref-28" ref-type="bibr">Huang et al., 2020</xref>), which collected 143 small-molecule protein kinase inhibitors from GDSC based on four drug-target databases: DrugBank (<xref rid="ref-74" ref-type="bibr">Wishart et al., 2018</xref>), Therapeutic Target Database (<xref rid="ref-40" ref-type="bibr">Li et al., 2018</xref>), Pharos (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>), and the Library of Integrated Network-Based Cellular Signatures (LINCS) Data Portal (<xref rid="ref-36" ref-type="bibr">Koleti et al., 2018</xref>). GDSC provides the half-maximal inhibitory concentration values (IC50) of these 143 ligands in 988 cancer cell lines.</p>
    </sec>
    <sec>
      <title>Ligand activities</title>
      <p>Ligand activities were retrieved from Pharos, a flagship resource (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>) of the National Institutes of Health (NIH) Illuminating the Druggable Genome (IDG) program that includes data on small molecules, including approved drug data and bioassay data. Based on the protein classification (<xref rid="ref-41" ref-type="bibr">Lin et al., 2017</xref>), the drug targets in Pharos include kinases, ion channels, G-protein coupled receptors (GPCRs), and others. In this phase of the project, we decided to include the data relevant to ligand binding in kinases. Pharos integrates drug-target relationships from several resources, such as ChEMBL (<xref rid="ref-8" ref-type="bibr">Bühlmann &amp; Reymond, 2020</xref>) and DrugCentral (<xref rid="ref-1" ref-type="bibr">Avram et al., 2021</xref>).</p>
    </sec>
    <sec>
      <title>Expression data</title>
      <p>An important part of our recent additions was kinase expression data. Genomic expression data (protein, RNA), as well as transcription factors and epigenomic associations, are among many facets of the data included in Pharos. Furthermore, the GDSC repository contains gene expression data (Affymetrix Human Genome U219 Array), as well. Additionally, COSMIC’s Cell Lines Project includes a significant amount of gene expression data, including kinase expression.</p>
    </sec>
    <sec>
      <title>Dark kinases</title>
      <p>Dark kinases were labeled based on the information from Dark Kinase Knowledgebase (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>).</p>
    </sec>
    <sec>
      <title>Protein kinase knowledge graph: schema and data organization</title>
      <p>The ProKinO ontology consists of classes, sub-classes, class types, relationships, relationship types, and constraints of protein kinase and related data (<xref rid="fig-2" ref-type="fig">Fig. 2</xref>). The hierarchy connects all classes to the root, which is ProKinOEntity. Moreover, the schema defines types and constraints for the relationships. With such explicit and constrained schema, composing queries is more intuitive than conventional relational databases. In particular, to enable integrative mining of dark kinase expression data in the context of kinase sequence and structural features, we have introduced three new classes in ProKinO, the Ligand class (including its name, source, and chemical structure) and the following three related classes: (1) LigandInteraction, placed between the Ligand and (already existing) Motif classes to capture kinase-ligand binding and selectivity at the motif and residue level; (2) LigandActivity, placed between the Ligand and (already existing) Protein classes to represent kinases targeted by ligands (and drugs); and (3) LigandResponse, located between the Ligand and (already existing) Sample classes and representing ligand (and drug) sensitivity in kinases. To capture kinase expression, we added the GeneExpression relationship linking the Protein and Sample classes. The outline of the recently added classes and their relationships in ProKinO is illustrated as a UML class diagram, shown in <xref rid="fig-2" ref-type="fig">Fig. 2</xref>.</p>
    </sec>
    <sec>
      <title>ProKinO population</title>
      <p>The ProKinO knowledge graph is automatically populated from several external and local data sources at regular intervals, as originally described (<xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>), ProKinO schema and the associated knowledge graph population software are routinely updated to incorporate additional sources of data such as pseudokinase and “dark” kinase classification and incorporating information on ligand interactions, ligand responses, ligand activities, kinase expression and associated object and datatype properties. We have been using the Protégé ontology editor for the schema creation and its subsequent modifications. The organization of the schema after these modifications is available at <uri xlink:href="https://prokino.uga.edu/about">https://prokino.uga.edu/about</uri>.</p>
      <p>The population software has been coded in Java and uses the Jena Framework. The population process is performed in several steps to add instances, their properties, and a combination of reading the prepared data from CSV, RDF, XML, and other file formats and accessing many remote data sources using their provided API (for example, Reactome’s REST API). Entity interconnections across data retrieved from different data sources are accomplished using UniProt identifiers, kinase names, and other accession identifiers. We modified the population software to create instances and properties for the newly added classes and relationships.</p>
      <p>More specifically, using the KLIFS API, we retrieved the relevant kinases, ligands, and residue-level interaction data. The data was retrieved and then processed by custom Perl scripts. ProKinO ontology schema was modified, and ligands were included as new data, while interaction data (motifs) were either reconciled with the motifs already present in ProKinO or added as new, if not already there.</p>
      <p>Similarly, the ligand response data was retrieved from GDSC and then processed by custom Perl scripts to create suitable CSV files. Additional ligands were included as new data, while the response data and the relevant samples were either reconciled with the samples already present in ProKinO or added as new, if not already there.</p>
      <p>In order to populate the data on ligand activities, we retrieved from Pharos kinase-relevant ligands, as well as their binding data on targeted kinases, for example, IC50 values. This data was retrieved and then processed by custom Perl scripts to produce the necessary CSV files. Additional ligands, not included in the KLIFS dataset, were included as new data. All kinases targeted by ligands were already present in ProKinO, so they were reused in this step.</p>
      <p>Data on kinase expression was first retrieved from Pharos, COSMIC, and GDSC. As before, the relevant kinases were already present in the ProKinO knowledge graph. The expression data was stored as individuals in the Expression class. Some of the relevant data about samples were already present in ProKinO, as we already had a significant amount of sample data from COSMIC. Additional samples were included as new data.</p>
      <p>We reviewed and updated all the motifs already present in ProKinO. Furthermore, we updated the motif naming in cases where there were differences with the standard motif names.</p>
      <p>Finally, we assembled an up-to-date list of dark kinases (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>) and added a Boolean datatype property, <italic toggle="yes">isDarkKinase</italic>, to identify them among all other kinases in the ProKinO knowledge graph.</p>
    </sec>
  </sec>
  <sec>
    <title>Results/discussion</title>
    <p>The expanded ontology and its knowledge graph provide a wealth of data unifying the information available on both well-studied (light) kinases and understudied (dark) kinases that serve as a unified resource for mining the kinome. The current version of ProKinO (version 65), includes 842 classes, 31 objects and 67 data properties, and over seven million individuals (knowledge graph nodes). ProKinO contains information on 153 dark kinases. A total of 137 dark kinases have information on structural motifs, 148 have disease mutations mapped to the kinase domain, 45 dark kinases have pathway information, and 26 are associated with specific reactions, as defined in Reactome.</p>
    <p>Users can navigate the ontology using the ontology browser by searching for a specific kinase of interest or by performing aggregate SPARQL queries linking multiple forms of data. Currently 35 pre-written queries linking different data types can be executed using the ProKinO browser (<uri xlink:href="http://prokino.uga.edu/queries">http://prokino.uga.edu/queries</uri>). A user can also download the ontology or browse data based on organisms, functional domains, diseases, or kinase domain evolutionary hierarchy. Below, we focus on the application of complex SPARQL queries and the ProtVista visualization tools for the illumination of understudied dark kinases.</p>
    <sec>
      <title>Mutation and expression of understudied PAK5 in human cancers</title>
      <p>One possible way to prioritize dark kinases for functional studies is to ask the question, “which dark kinases are most mutated in human diseases, such as cancers?”. Typically answering this question would require collating and post-processing data from multiple resources such as COSMIC, Pharos, and the Dark Kinase Knowledgebase. However, with the updated Protein Kinase Ontology, these questions can be quickly answered using SPARQL. Having the “<italic toggle="yes">isDarkKinase”</italic> property within the Protein class and the RDF triples connecting the “<italic toggle="yes">Mutation”</italic>, “<italic toggle="yes">Sample</italic>” and “<italic toggle="yes">Sequence”</italic> classes, one can formulate aggregate queries requesting all dark kinases mutated in cancer samples. To avoid biases introduced by the length of protein/gene sequences (longer proteins tend to have more mutations), the query can be modified to normalize mutation counts by sequence length. Executing this modified query (Query 27, available at <uri xlink:href="http://prokino.uga.edu/queries">http://prokino.uga.edu/queries</uri>) displays the rank-ordered list of dark kinases based on mutational density. The top ten dark kinases with the highest mutational density are shown in <xref rid="fig-3" ref-type="fig">Fig. 3A</xref>. Notably, the p21 activated kinase 5 (PAK5) is at the top of the list with a mutational density of 1.917, followed by CRK7 (1.054), PKACG (1.011), PSKH2 (1.01) TSSK1 (1.008), CK1A2 (0.991), ERK4 (0.966), DCLK3 (0.912), PKCT (0.894) and PAK3 (0.859). Having identified PAK5 as the most frequently mutated dark kinase in cancers, one can further query the ontology to explore the role of this kinase in various cancers. With the addition of the new “<italic toggle="yes">GeneExpression</italic>” class in ProKinO and the RDF triples connecting gene expression to the “<italic toggle="yes">Sample”</italic> and “<italic toggle="yes">Protein</italic>” classes (<italic toggle="yes">GeneExpression:InSample: Sample; GeneExpression:hasProtein: Protein</italic>), one can formulate queries for PAK5 expression in different samples (<xref rid="fig-3" ref-type="fig">Fig. 3B</xref>). Rank ordering the samples based on PAK5 expression (Query 33) reveals cancer types such as adenocarcinoma (Zscore: 4,701.5) and hepatocellular carcinoma (Zscore: 2,038.3) that have previously been associated with abnormal PAK5 expression (<xref rid="ref-16" ref-type="bibr">Fang et al., 2014</xref>; <xref rid="ref-23" ref-type="bibr">Han et al., 2018</xref>; <xref rid="ref-29" ref-type="bibr">Huo et al., 2019</xref>; <xref rid="ref-78" ref-type="bibr">Zhang et al., 2017</xref>). However, the role of PAK5 in other cancer types such as acute myeloid leukemia (Zscore: 136.5) is relatively underappreciated (<xref rid="ref-61" ref-type="bibr">Quan et al., 2020</xref>). The identification of new cancer sub-types with dark kinase expression and regulation further exemplifies the use of ProKinO in knowledge discovery.</p>
      <fig position="float" id="fig-3">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-3</object-id>
        <label>Figure 3</label>
        <caption>
          <title>SPARQL query results for Query 27 and 33.</title>
          <p>(A) Output of Query 27 requesting top 10 dark kinases with most mutations in different cancer types. The mutation counts are normalized by sequence length. (B) Output of Query 33 listing samples with abnormal PAK5 expression. The query also lists histology, cancer subtypes, regulation, and Z-score. Only a subset of the query results is shown because of space constraints.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g003" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Mutational hotspots in the activation loop of PAK5</title>
      <p>Because ProKinO encodes a wealth of information on the structural and regulatory properties of multiple kinases, it can be used to generate mechanistic predictions on cancer mutation impact. We demonstrate this for the PAK kinases by asking the question “<italic toggle="yes">where are PAK5 mutations located in the protein kinase domain?</italic>” Using the RDF triples connecting the “<italic toggle="yes">Mutation”</italic>, “<italic toggle="yes">Motif”</italic> and “<italic toggle="yes">Sequence</italic>” classes (“<italic toggle="yes">Mutation: LocatedIn: Motif”; “Mutation:InSequence: Sequence”</italic>), one can formulate a query (Query 28) listing mutations in different structural regions/motifs of the PAK5 kinase domain. Examination of the query results reveals that the C-terminal substrate binding lobe (C-lobe) is more frequently mutated (320 mutations) relative to the N-terminal ATP binding lobe (N-lobe: 173 mutations) (<xref rid="fig-4" ref-type="fig">Fig. 4A</xref>). Within the C-lobe, nearly 78 mutations map to the activation loop, which is known to play a critical role in substrate recognition and activation in a diverse array of kinases (<xref rid="ref-30" ref-type="bibr">Huse &amp; Kuriyan, 2002</xref>; <xref rid="ref-37" ref-type="bibr">Kornev &amp; Taylor, 2015</xref>; <xref rid="ref-58" ref-type="bibr">Oruganty &amp; Kannan, 2012</xref>). Despite the prevalence of activation loop mutations in PAK5, there is currently no information on how these mutations impact PAK5 kinase structure and function. Nonetheless, based on the evolutionary relationships captured in ProKinO (based on the alignment of human kinases to the prototypic protein kinase A), one can formulate queries mapping mutations to specific aligned positions in the shared protein kinase domain. A query listing (wild type) WT type and mutant type residues in the activation loop of PAK5 and the equivalent aligned residue positions in PKA (Query 29) provides additional context for these mutations. For example, two distinct mutations map to residue <inline-formula id="ieqn-1"><alternatives><inline-graphic xlink:href="peerj-11-16087-i001.jpg"/><tex-math id="tex-ieqn-1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{602^{{\rm PAK}5}}$\end{document}</tex-math><mml:math id="mml-ieqn-1" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>602</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> in the activation loop of PAK5 that structurally corresponds to a phosphorylatable residue, <inline-formula id="ieqn-2"><alternatives><inline-graphic xlink:href="peerj-11-16087-i002.jpg"/><tex-math id="tex-ieqn-2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm T}{197^{{\rm PKA}}}$\end{document}</tex-math><mml:math id="mml-ieqn-2" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>197</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, in PKA (<xref rid="ref-76" ref-type="bibr">Yonemoto et al., 1993</xref>). Having this context provides a testable hypothesis that S602 mutations in PAK5 impact kinase phosphorylation and regulation. Likewise, WT residue <inline-formula id="ieqn-3"><alternatives><inline-graphic xlink:href="peerj-11-16087-i003.jpg"/><tex-math id="tex-ieqn-3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{607^{{\rm PAK}5}}$\end{document}</tex-math><mml:math id="mml-ieqn-3" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>607</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> is mutated in four distinct cancer samples and this position is equivalent to PKA residue <inline-formula id="ieqn-4"><alternatives><inline-graphic xlink:href="peerj-11-16087-i004.jpg"/><tex-math id="tex-ieqn-4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{202^{{\rm PKA}}}$\end{document}</tex-math><mml:math id="mml-ieqn-4" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>202</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, which configures the activation loop for substrate recognition (<xref rid="ref-35" ref-type="bibr">Knighton et al., 1991</xref>). Thus, mutation of this critical residue is expected to impact substrate binding and activation loop phosphorylation in PAK5. Additional insights into these mutations can also be obtained by visualizing these residues in the context of the PAK5 AlphaFold models using the ProtVista viewer described below.</p>
      <fig position="float" id="fig-4">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-4</object-id>
        <label>Figure 4</label>
        <caption>
          <title>SPARQL query results for Query 28 and 29.</title>
          <p>(A) Output of Query 28 listing the number of unique cancer-linked mutations at various structural locations of PAK5 kinase. (B) Output of Query 29 listing unique point mutations in the activation loop of PAK5 kinase. The query also lists the equivalent PKA position, disease type, primary site of the tissue sample, equivalent residue for the PKA positioning of PKA, and subtype of the tissue sample. Entries containing only one mutation per position were filtered from the original query. Only a subset of the query results is shown.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g004" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Insights into PAK5 ligand binding sites</title>
      <p>With the conceptualization of new information related to kinase ligands, their mode of action and interaction with specific motifs in the kinase domain, new aggregate queries linking mutated kinases to drug sensitivity profiles, mode of action, and ligand binding sites can be performed using the updated ProKinO. For example, queries such as “<italic toggle="yes">list proteins and drugs or ligands interacting with the protein’s gatekeeper residue (GK.45)</italic>” (Query 31) and “<italic toggle="yes">list ligands targeting the Epidermal Growth Factor Receptor (EGFR) kinase and their mode of action</italic>” (Query 34) can be rapidly performed using the updated ProKinO ontology. We demonstrate the application of these new additions in the context of PAK5 by asking the question “<italic toggle="yes">what are the drugs targeting PAK family (PAK1-6) kinases</italic>?” Query 30 answers this question using the RDF triples connecting the “<italic toggle="yes">Ligand</italic>”, “<italic toggle="yes">Motif</italic>” and “<italic toggle="yes">Protein</italic>” classes (list triples) (<xref rid="fig-5" ref-type="fig">Fig. 5</xref>). Examination of the query results indicates multiple drugs targeting PAK family kinases, including STAUROSPORINE and N2-((1R-2S)-2-AMINOCYCLOHEXYL) that bind to structurally equivalent residues/motifs in the ligand binding pocket of PAK4 and PAK5, respectively. The ligand binding sites, and associated interactions can also be visualized using the ProtVista viewer described below. Additional queries linking dark kinases to drug sensitivities, structural motifs, and pathways are listed on the ProKinO website at <uri xlink:href="https://prokino.uga.edu/queries">https://prokino.uga.edu/queries</uri>.</p>
      <fig position="float" id="fig-5">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-5</object-id>
        <label>Figure 5</label>
        <caption>
          <title>SPARQL query results for Query 30.</title>
          <p>Output of Query 30 listing ligands interactions with each PAK family member (PAK1-6). It also includes motif names and positions of full sequence and PKA positioning. The output of Query 30 was rearranged to highlight the homology of PAK4 and PAK5 motif/ligand interactions and the figure highlights only a subset of the query results. Run SPARQL query for full results.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g005" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Visualization tools for dark kinase annotation and mining</title>
      <p>To provide structural context for cancer mutations and to enable interactive mining of dark kinase sequence annotations in the context of 3D structures and predicted models from AlphaFold (<xref rid="ref-32" ref-type="bibr">Jumper et al., 2021</xref>; <xref rid="ref-70" ref-type="bibr">Tunyasuvunakool et al., 2021</xref>), we developed and incorporated a modified version of the ProtVista viewer in ProKinO. The viewer can be deployed for any protein kinase of interest by navigating to the Structure tab in the protein summary page and selecting either a PDB structure or AlphaFold model of interest. A snapshot of the ProtVista viewer displaying the AlphaFold model of PAK5 kinase is shown in <xref rid="fig-6" ref-type="fig">Fig. 6</xref>. The ProtVista viewer uses an enhanced version of the Mol* viewer and the PDB web component (<xref rid="ref-72" ref-type="bibr">Watkins et al., 2017</xref>) to provide two-way interactive navigation between the 3D structure (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>, top panel) and annotation viewer (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>, bottom panel).</p>
      <fig position="float" id="fig-6">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-6</object-id>
        <label>Figure 6</label>
        <caption>
          <title>ProtVista viewer.</title>
          <p>(A) AlphaFold2 model of PAK5 kinase is shown in the structure viewer (top panel). Sequence viewer with annotations are shown in the bottom panel. (B and C) Zoomed in view of structural interactions associated with S602 and P607 in PAK5 activation loop.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g006" position="float"/>
      </fig>
      <p>The annotation viewer consists of multiple tracks populated dynamically based on data from ProKinO and external sources such as UniProt. In addition, prediction confidence scores for AlphaFold models are displayed in the annotation viewer along with additional annotations such as conserved sequence motifs, subdomains, and structural motifs involved in kinase regulation. The annotation viewer also shows other annotations from external sources such as ligand binding sites and predicted functional sites. Users can hover over the residues on the 3D structure viewer to view the equivalent information on the annotation viewer and vice versa. For example, selecting the “<italic toggle="yes">activation loop</italic>” in the annotation viewer highlights the corresponding structural region in the AlphaFold model of PAK5 (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>). Likewise, the selection of residues in the activation loop (S602 and P607) in the structure viewer highlights the annotations associated with these and interacting residues in the sequence viewer. Such interactive mining is expected to accelerate the functional characterization of dark kinases and provide new insights into disease mutations. For example, visualizing the interactions associated with S602 in the activation loop of PAK5 (<xref rid="fig-6" ref-type="fig">Fig. 6B</xref>) indicates a hydrogen bonding interaction with R567, which is part of the conserved HRD motif (sequence annotation). Because the HRD-Arg is known to play a role in kinase regulation by stabilizing activation loop conformation (<xref rid="ref-30" ref-type="bibr">Huse &amp; Kuriyan, 2002</xref>), it provides additional context for predicting the impact of S602 altering mutations. Likewise, examining the structural and sequence context of P607 interacting residues provides new insights into how the alteration of this residue might impact substrate binding and kinase regulation. Together, these examples highlight the value added by the ProtVista viewer in the visualization and annotation of mutations in dark kinases.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions">
    <title>Conclusions</title>
    <p>This work presents an updated version of the Protein Kinase Otology (ProKinO) for mining and annotating dark kinases. ProKinO was developed following FAIR (Findable, Accessible, Interoperable, and Reusable) principles (<xref rid="ref-73" ref-type="bibr">Wilkinson et al., 2016</xref>) and serves as an integrated knowledge graph for relating and conceptualizing diverse forms of disparate data related to protein kinase sequence, structure, function, regulation, and disease (cancer). We present a new ontology browser for navigating these data and demonstrate the application of aggregate SPARQL queries in uncovering new testable hypotheses regarding understudied kinase members. We also provide several pre-written SPARQL queries that can rapidly retrieve information related to protein kinase mutations, pathways, expression, and ligand binding sites. However, writing new queries requires prior knowledge of the ontology schema and the SPARQL query language, which most bench biologists may not have. To alleviate this challenge, we are currently building a graphical SPARQL query interface, which will intuitively enable query formulation through the navigation of the knowledge graph schema. We are also exploring the application of ProKinO for machine learning-based knowledge discovery and hypotheses generation.</p>
  </sec>
</body>
<back>
  <ack>
    <p>We acknowledge members of the Kannan lab for their valuable comments and suggestions. We additionally acknowledge the various contributions to the databases we utilized made through the efforts of the IDG consortium and numerous investigator-initiated efforts.</p>
  </ack>
  <sec sec-type="additional-information">
    <title>Additional Information and Declarations</title>
    <fn-group content-type="competing-interests">
      <title>Competing Interests</title>
      <fn fn-type="COI-statement" id="conflict-1">
        <p>Natarajan Kannan is an Academic Editor for PeerJ.</p>
      </fn>
    </fn-group>
    <fn-group content-type="author-contributions">
      <title>Author Contributions</title>
      <fn fn-type="con" id="contribution-1">
        <p><xref rid="author-1" ref-type="contrib">Saber Soleymani</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-2">
        <p><xref rid="author-2" ref-type="contrib">Nathan Gravel</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-3">
        <p><xref rid="author-3" ref-type="contrib">Liang-Chin Huang</xref> performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-4">
        <p><xref rid="author-4" ref-type="contrib">Wayland Yeung</xref> analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-5">
        <p><xref rid="author-5" ref-type="contrib">Elika Bozorgi</xref> analyzed the data, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-6">
        <p><xref rid="author-6" ref-type="contrib">Nathaniel G. Bendzunas</xref> analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-7">
        <p><xref rid="author-7" ref-type="contrib">Krzysztof J. Kochut</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-8">
        <p><xref rid="author-8" ref-type="contrib">Natarajan Kannan</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
    </fn-group>
    <fn-group content-type="other">
      <title>Data Availability</title>
      <fn id="addinfo-1">
        <p>The following information was supplied regarding data availability:</p>
        <p>The protein kinase ontology (ProKinO)’s current OWL file and previous versions are available at: <uri xlink:href="https://prokino.uga.edu/downloads.html">https://prokino.uga.edu/downloads.html</uri>.</p>
        <p>Future versions of the ontology also will be placed at the same address.</p>
        <p>The ontology browser is available at <uri xlink:href="https://prokino.uga.edu/browser">https://prokino.uga.edu/browser</uri>. Users can save the results of queries in diagrams or other formats such as CSV.</p>
      </fn>
    </fn-group>
  </sec>
  <ref-list content-type="authoryear">
    <title>References</title>
    <ref id="ref-1">
      <label>Avram et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Avram</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Curpan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Halip</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bora</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Knockel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sirimulla</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>DrugCentral 2021 supports drug discovery and repositioning</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1160</fpage>
        <lpage>D1169</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa997</pub-id>
        <pub-id pub-id-type="pmid">33151287</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-2">
      <label>Bailey et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>McSkimming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Going for broke: targeting the human cancer pseudokinome</article-title>
        <source>Biochemical Journal</source>
        <year iso-8601-date="2015">2015</year>
        <volume>465</volume>
        <issue>2</issue>
        <fpage>195</fpage>
        <lpage>211</lpage>
        <pub-id pub-id-type="doi">10.1042/BJ20141060</pub-id>
        <pub-id pub-id-type="pmid">25559089</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-3">
      <label>Bairoch et al. (2005)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bairoch</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Barker</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Boeckmann</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ferro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Magrane</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The universal protein resource (UniProt)</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2005">2005</year>
        <volume>33</volume>
        <issue>Database issue</issue>
        <fpage>D154</fpage>
        <lpage>D159</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gki070</pub-id>
        <pub-id pub-id-type="pmid">15608167</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-4">
      <label>Benhar, Engelberg &amp; Levitzki (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benhar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Engelberg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Levitzki</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ROS, stress-activated kinases and stress signaling in cancer</article-title>
        <source>EMBO Reports</source>
        <year iso-8601-date="2002">2002</year>
        <volume>3</volume>
        <issue>5</issue>
        <fpage>420</fpage>
        <lpage>425</lpage>
        <pub-id pub-id-type="doi">10.1093/embo-reports/kvf094</pub-id>
        <pub-id pub-id-type="pmid">11991946</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-5">
      <label>Berginski et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berginski</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Moret</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Goldfarb</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>The dark kinase knowledgebase: an online compendium of knowledge and experimental results of understudied kinases</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D529</fpage>
        <lpage>D535</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa853</pub-id>
        <pub-id pub-id-type="pmid">33079988</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-6">
      <label>Berman et al. (2000)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Westbrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gilliland</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Weissig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The protein data bank</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2000">2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-8">
      <label>Bühlmann &amp; Reymond (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bühlmann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reymond</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>ChEMBL-likeness score and database GDBChEMBL</article-title>
        <source>Frontiers in Chemistry</source>
        <year iso-8601-date="2020">2020</year>
        <volume>8</volume>
        <fpage>46</fpage>
        <pub-id pub-id-type="doi">10.3389/fchem.2020.00046</pub-id>
        <pub-id pub-id-type="pmid">32117874</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-7">
      <label>Byrne, Foulkes &amp; Eyers (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Foulkes</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Pseudokinases: update on their functions and evaluation as new drug targets</article-title>
        <source>Future Medicinal Chemistry</source>
        <year iso-8601-date="2017">2017</year>
        <volume>9</volume>
        <issue>2</issue>
        <fpage>245</fpage>
        <lpage>265</lpage>
        <pub-id pub-id-type="doi">10.4155/fmc-2016-0207</pub-id>
        <pub-id pub-id-type="pmid">28097887</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-9">
      <label>Cicenas &amp; Cicenas (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cicenas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cicenas</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Multi-kinase inhibitors, AURKs and cancer</article-title>
        <source>Medical Oncology</source>
        <year iso-8601-date="2016">2016</year>
        <volume>33</volume>
        <issue>5</issue>
        <fpage>43</fpage>
        <pub-id pub-id-type="doi">10.1007/s12032-016-0758-4</pub-id>
        <pub-id pub-id-type="pmid">27038473</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-10">
      <label>Croft et al. (2011)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Croft</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>O’Kelly</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Haw</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gillespie</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Caudy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Garapati</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gopinath</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jassal</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Reactome: a database of reactions, pathways and biological processes</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2011">2011</year>
        <volume>39</volume>
        <issue>Database</issue>
        <fpage>D691</fpage>
        <lpage>D697</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1018</pub-id>
        <pub-id pub-id-type="pmid">21067998</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-11">
      <label>Duncan et al. (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Duncan</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Whittle</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Abell</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Midland</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Zawistowski</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Granger</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Jordan</surname>
            <given-names>NV</given-names>
          </name>
          <name>
            <surname>Darr</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Usary</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuan</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Smalley</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Major</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Hoadley</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sharpless</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Perou</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>WY</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Frye</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Earp</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Graves</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>GL</given-names>
          </name>
        </person-group>
        <article-title>Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer</article-title>
        <source>Cell</source>
        <year iso-8601-date="2012">2012</year>
        <volume>149</volume>
        <issue>2</issue>
        <fpage>307</fpage>
        <lpage>321</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.053</pub-id>
        <pub-id pub-id-type="pmid">22500798</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-12">
      <label>Erika et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Erika</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Federica</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Martina</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Anselmo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Luigi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Marina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Davide</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Eleonora</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Monica</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Silverio</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Old tyrosine kinase inhibitors and newcomers in gastrointestinal cancer treatment</article-title>
        <source>Current Cancer Drug Targets</source>
        <year iso-8601-date="2016">2016</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>185</lpage>
        <pub-id pub-id-type="doi">10.2174/1568009615666150817120712</pub-id>
        <pub-id pub-id-type="pmid">26278713</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-13">
      <label>Eyers, Keeshan &amp; Kannan (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Keeshan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tribbles in the 21st century: the evolving roles of tribbles pseudokinases in biology and disease</article-title>
        <source>Trends in Cell Biology</source>
        <year iso-8601-date="2017">2017</year>
        <volume>27</volume>
        <issue>4</issue>
        <fpage>284</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tcb.2016.11.002</pub-id>
        <pub-id pub-id-type="pmid">27908682</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-14">
      <label>Eyers &amp; Murphy (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Dawn of the dead: protein pseudokinases signal new adventures in cell biology</article-title>
        <source>Biochemical Society Transactions</source>
        <year iso-8601-date="2013">2013</year>
        <volume>41</volume>
        <issue>4</issue>
        <fpage>969</fpage>
        <lpage>974</lpage>
        <pub-id pub-id-type="doi">10.1042/BST20130115</pub-id>
        <pub-id pub-id-type="pmid">23863165</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-15">
      <label>Faezov &amp; Dunbrack (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faezov</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dunbrack</surname>
            <given-names>RL</given-names>
            <suffix>Jr</suffix>
          </name>
        </person-group>
        <article-title>PDBrenum: a webserver and program providing protein data bank files renumbered according to their UniProt sequences</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2021">2021</year>
        <volume>16</volume>
        <issue>7</issue>
        <elocation-id>e0253411</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0253411</pub-id>
        <pub-id pub-id-type="pmid">34228733</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-16">
      <label>Fang et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>ZP</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>XF</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>FB</given-names>
          </name>
        </person-group>
        <article-title>P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma</article-title>
        <source>Acta Pharmacologica Sinica</source>
        <year iso-8601-date="2014">2014</year>
        <volume>35</volume>
        <issue>1</issue>
        <fpage>82</fpage>
        <lpage>88</lpage>
        <pub-id pub-id-type="doi">10.1038/aps.2013.31</pub-id>
        <pub-id pub-id-type="pmid">23685956</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-17">
      <label>Ferguson &amp; Gray (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ferguson</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Kinase inhibitors: the road ahead</article-title>
        <source>Nature Reviews Drug Discovery</source>
        <year iso-8601-date="2018">2018</year>
        <volume>17</volume>
        <issue>5</issue>
        <fpage>353</fpage>
        <lpage>377</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd.2018.21</pub-id>
        <pub-id pub-id-type="pmid">29545548</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-18">
      <label>Foulkes et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Foulkes</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Shrestha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Keeshan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Drewry</surname>
            <given-names>DH</given-names>
          </name>
        </person-group>
        <article-title>Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells</article-title>
        <source>Science Signaling</source>
        <year iso-8601-date="2018">2018</year>
        <volume>11</volume>
        <issue>549</issue>
        <fpage>eaat7951</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aat7951</pub-id>
        <pub-id pub-id-type="pmid">30254057</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-19">
      <label>Gajiwala et al. (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gajiwala</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Christensen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Deshmukh</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Diehl</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>DiNitto</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>English</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Greig</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Y-A</given-names>
          </name>
          <name>
            <surname>Jacques</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2009">2009</year>
        <volume>106</volume>
        <issue>5</issue>
        <fpage>1542</fpage>
        <lpage>1547</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0812413106</pub-id>
        <pub-id pub-id-type="pmid">19164557</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-20">
      <label>Goldberg et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goldberg</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Griggs</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Haas</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Wortman</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Kinannote, a computer program to identify and classify members of the eukaryotic protein kinase superfamily</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2013">2013</year>
        <volume>29</volume>
        <issue>19</issue>
        <fpage>2387</fpage>
        <lpage>2394</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt419</pub-id>
        <pub-id pub-id-type="pmid">23904509</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-21">
      <label>Gosal, Kannan &amp; Kochut (2011)</label>
      <element-citation publication-type="confproc">
        <person-group person-group-type="author">
          <name>
            <surname>Gosal</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a framework for protein kinase ontology</article-title>
        <year iso-8601-date="2011">2011</year>
        <conf-name>Proceedings of the IEEE International Conference on Bioinformatics &amp; Biomedicine, Atlanta, Georgia</conf-name>
        <publisher-loc>Piscataway</publisher-loc>
        <publisher-name>IEEE</publisher-name>
        <fpage>550</fpage>
        <lpage>555</lpage>
      </element-citation>
    </ref>
    <ref id="ref-22">
      <label>Gosal, Kochut &amp; Kannan (2011)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gosal</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: an ontology for integrative analysis of protein kinases in cancer</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2011">2011</year>
        <volume>6</volume>
        <issue>12</issue>
        <elocation-id>e28782</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0028782</pub-id>
        <pub-id pub-id-type="pmid">22194913</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-23">
      <label>Han et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>KF</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>PAK5 overexpression is associated with lung metastasis in osteosarcoma</article-title>
        <source>Oncology Letters</source>
        <year iso-8601-date="2018">2018</year>
        <volume>15</volume>
        <fpage>2202</fpage>
        <lpage>2210</lpage>
        <pub-id pub-id-type="doi">10.3892/ol.2017.7545</pub-id>
        <pub-id pub-id-type="pmid">29434926</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-24">
      <label>Hanks &amp; Hunter (1995)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanks</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</article-title>
        <source>FASEB Journal</source>
        <year iso-8601-date="1995">1995</year>
        <volume>9</volume>
        <fpage>576</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="doi">10.1096/fasebj.9.8.7768349</pub-id>
        <pub-id pub-id-type="pmid">7768349</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-25">
      <label>Hu et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ahuja</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Meharena</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Kinase regulation by hydrophobic spine assembly in cancer</article-title>
        <source>Molecular and Cellular Biology</source>
        <year iso-8601-date="2015">2015</year>
        <volume>35</volume>
        <issue>1</issue>
        <fpage>264</fpage>
        <lpage>276</lpage>
        <pub-id pub-id-type="doi">10.1128/MCB.00943-14</pub-id>
        <pub-id pub-id-type="pmid">25348715</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-26">
      <label>Huang et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Baffi</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Drabkin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>D’Eustachio</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>McSkimming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Arighi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Natale</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gaudet</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Newton</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resources</article-title>
        <source>Scientific Reports</source>
        <year iso-8601-date="2018">2018</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>6518</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-24457-1</pub-id>
        <pub-id pub-id-type="pmid">29695735</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-27">
      <label>Huang et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gravel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Venkat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>KinOrtho: a method for mapping human kinase orthologs across the tree of life and illuminating understudied kinases</article-title>
        <source>BMC Bioinformatics</source>
        <year iso-8601-date="2021">2021</year>
        <volume>22</volume>
        <issue>1</issue>
        <fpage>446</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-021-04358-3</pub-id>
        <pub-id pub-id-type="pmid">34537014</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-28">
      <label>Huang et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Venkat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rasheed</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Quantitative structure-mutation-activity relationship tests (QSMART) model for protein kinase inhibitor response prediction</article-title>
        <source>BMC Bioinformatics</source>
        <year iso-8601-date="2020">2020</year>
        <volume>21</volume>
        <issue>1</issue>
        <fpage>520</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-020-03842-6</pub-id>
        <pub-id pub-id-type="pmid">33183223</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-29">
      <label>Huo et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1</article-title>
        <source>Cell Death and Differentiation</source>
        <year iso-8601-date="2019">2019</year>
        <volume>26</volume>
        <issue>6</issue>
        <fpage>994</fpage>
        <lpage>1006</lpage>
        <pub-id pub-id-type="doi">10.1038/s41418-018-0178-4</pub-id>
        <pub-id pub-id-type="pmid">30082769</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-30">
      <label>Huse &amp; Kuriyan (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huse</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kuriyan</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The conformational plasticity of protein kinases</article-title>
        <source>Cell</source>
        <year iso-8601-date="2002">2002</year>
        <volume>109</volume>
        <issue>3</issue>
        <fpage>275</fpage>
        <lpage>282</lpage>
        <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00741-9</pub-id>
        <pub-id pub-id-type="pmid">12015977</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-31">
      <label>Joensuu et al. (2001)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Joensuu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Sarlomo-Rikala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Andersson</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Tervahartiala</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tuveson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Silberman</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Capdeville</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dimitrijevic</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Druker</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
        </person-group>
        <article-title>Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor</article-title>
        <source>New England Journal of Medicine</source>
        <year iso-8601-date="2001">2001</year>
        <volume>344</volume>
        <issue>14</issue>
        <fpage>1052</fpage>
        <lpage>1056</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJM200104053441404</pub-id>
        <pub-id pub-id-type="pmid">11287975</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-32">
      <label>Jumper et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jumper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pritzel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Figurnov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ronneberger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Tunyasuvunakool</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Žídek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Potapenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bridgland</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kohl</surname>
            <given-names>SAA</given-names>
          </name>
          <name>
            <surname>Ballard</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Romera-Paredes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nikolov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Back</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reiman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zielinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinegger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pacholska</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Berghammer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bodenstein</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Silver</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vinyals</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Senior</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Kavukcuoglu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kohli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hassabis</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>
        <source>Nature</source>
        <year iso-8601-date="2021">2021</year>
        <volume>596</volume>
        <issue>7873</issue>
        <fpage>583</fpage>
        <lpage>589</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
        <pub-id pub-id-type="pmid">34265844</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-33">
      <label>Kanev et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanev</surname>
            <given-names>GK</given-names>
          </name>
          <name>
            <surname>de Graaf</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Westerman</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>de Esch</surname>
            <given-names>IJP</given-names>
          </name>
          <name>
            <surname>Kooistra</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>KLIFS: an overhaul after the first 5 years of supporting kinase research</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D562</fpage>
        <lpage>D569</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa895</pub-id>
        <pub-id pub-id-type="pmid">33084889</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-34">
      <label>Kim, Song &amp; Haura (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Haura</surname>
            <given-names>EB</given-names>
          </name>
        </person-group>
        <article-title>Src kinases as therapeutic targets for cancer</article-title>
        <source>Nature Reviews Clinical Oncology</source>
        <year iso-8601-date="2009">2009</year>
        <volume>6</volume>
        <issue>10</issue>
        <fpage>587</fpage>
        <lpage>595</lpage>
        <pub-id pub-id-type="doi">10.1038/nrclinonc.2009.129</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-35">
      <label>Knighton et al. (1991)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knighton</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Ten Eyck</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Ashford</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Xuong</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Sowadski</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</article-title>
        <source>Science</source>
        <year iso-8601-date="1991">1991</year>
        <volume>253</volume>
        <issue>5018</issue>
        <fpage>407</fpage>
        <lpage>414</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1862342</pub-id>
        <pub-id pub-id-type="pmid">1862342</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-36">
      <label>Koleti et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Terryn</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Stathias</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Forlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>D’Urso</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Torre</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jagodnik</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Mader</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fazel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mahi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pilarczyk</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Shamsaei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Meller</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vasiliauskas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Reichard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Medvedovic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pillai</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Data portal for the library of integrated network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D558</fpage>
        <lpage>D566</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1063</pub-id>
        <pub-id pub-id-type="pmid">29140462</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-37">
      <label>Kornev &amp; Taylor (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Dynamics-driven allostery in protein kinases</article-title>
        <source>Trends in Biochemical Sciences</source>
        <year iso-8601-date="2015">2015</year>
        <volume>40</volume>
        <issue>11</issue>
        <fpage>628</fpage>
        <lpage>647</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tibs.2015.09.002</pub-id>
        <pub-id pub-id-type="pmid">26481499</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-38">
      <label>Kwon et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tracing the origin and evolution of pseudokinases across the tree of life</article-title>
        <source>Science Signaling</source>
        <year iso-8601-date="2019">2019</year>
        <volume>12</volume>
        <issue>578</issue>
        <fpage>289</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aav3810</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-39">
      <label>Li &amp; Jones (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>SJ</given-names>
          </name>
        </person-group>
        <article-title>Drug repositioning for personalized medicine</article-title>
        <source>Genome Medicine</source>
        <year iso-8601-date="2012">2012</year>
        <volume>4</volume>
        <issue>3</issue>
        <fpage>27</fpage>
        <pub-id pub-id-type="doi">10.1186/gm326</pub-id>
        <pub-id pub-id-type="pmid">22494857</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-40">
      <label>Li et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XX</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>YZ</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1121</fpage>
        <lpage>D1127</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1076</pub-id>
        <pub-id pub-id-type="pmid">29140520</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-41">
      <label>Lin et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Küçük-McGinty</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Forlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Stathias</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nabizadeh</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mader</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Visser</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Drug target ontology to classify and integrate drug discovery data</article-title>
        <source>Journal of Biomedical Semantics</source>
        <year iso-8601-date="2017">2017</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>50</fpage>
        <pub-id pub-id-type="doi">10.1186/s13326-017-0161-x</pub-id>
        <pub-id pub-id-type="pmid">29122012</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-42">
      <label>Liu, Liang &amp; Zhang (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>XC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Culturing Schwann cells from neonatal rats by improved enzyme digestion combined with explants-culture method</article-title>
        <source>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</source>
        <year iso-8601-date="2016">2016</year>
        <volume>38</volume>
        <fpage>388</fpage>
        <lpage>392</lpage>
        <pub-id pub-id-type="doi">10.3881/j.issn.1000-503X.2016.04.004</pub-id>
        <pub-id pub-id-type="pmid">27594149</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-43">
      <label>Lubner et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lubner</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Dodge-Kafka</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Cushing’s syndrome mutant PKA(L)(205R) exhibits altered substrate specificity</article-title>
        <source>FEBS Letters</source>
        <year iso-8601-date="2017">2017</year>
        <volume>591</volume>
        <issue>3</issue>
        <fpage>459</fpage>
        <lpage>467</lpage>
        <pub-id pub-id-type="doi">10.1002/1873-3468.12562</pub-id>
        <pub-id pub-id-type="pmid">28100013</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-44">
      <label>ManChon et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>ManChon</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rasheed</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Prediction and prioritization of rare oncogenic mutations in the cancer kinome using novel features and multiple classifiers</article-title>
        <source>PLOS Computational Biology</source>
        <year iso-8601-date="2014">2014</year>
        <volume>10</volume>
        <issue>4</issue>
        <elocation-id>e1003545</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003545</pub-id>
        <pub-id pub-id-type="pmid">24743239</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-45">
      <label>Manning et al. (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Manning</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Whyte</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sudarsanam</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The protein kinase complement of the human genome</article-title>
        <source>Science</source>
        <year iso-8601-date="2002">2002</year>
        <volume>298</volume>
        <issue>5600</issue>
        <fpage>1912</fpage>
        <lpage>1934</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1075762</pub-id>
        <pub-id pub-id-type="pmid">12471243</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-46">
      <label>McClendon et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McClendon</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Gilson</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Dynamic architecture of a protein kinase</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2014">2014</year>
        <volume>111</volume>
        <issue>43</issue>
        <fpage>E4623</fpage>
        <lpage>E4631</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1418402111</pub-id>
        <pub-id pub-id-type="pmid">25319261</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-47">
      <label>McSkimming et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Baffi</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Newton</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>KinView: a visual comparative sequence analysis tool for integrated kinome research</article-title>
        <source>Molecular Biosystems</source>
        <year iso-8601-date="2016">2016</year>
        <volume>12</volume>
        <issue>12</issue>
        <fpage>3651</fpage>
        <lpage>3665</lpage>
        <pub-id pub-id-type="doi">10.1039/C6MB00466K</pub-id>
        <pub-id pub-id-type="pmid">27731453</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-48">
      <label>McSkimming et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a unified resource for mining the cancer kinome</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2014">2014</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>186</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22726</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-49">
      <label>McSkimming et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a unified resource for mining the cancer kinome</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2015">2015</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>186</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22726</pub-id>
        <pub-id pub-id-type="pmid">25382819</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-50">
      <label>Meharena et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meharena</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Keshwani</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nene</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Deciphering the structural basis of eukaryotic protein kinase regulation</article-title>
        <source>PLOS Biology</source>
        <year iso-8601-date="2013">2013</year>
        <volume>11</volume>
        <issue>10</issue>
        <elocation-id>e1001680</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pbio.1001680</pub-id>
        <pub-id pub-id-type="pmid">24143133</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-51">
      <label>Mohanty et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mohanty</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kwon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Hanold</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Hydrophobic core variations provide a structural framework for tyrosine kinase evolution and functional specialization</article-title>
        <source>PLOS Genetics</source>
        <year iso-8601-date="2016">2016</year>
        <volume>12</volume>
        <issue>2</issue>
        <elocation-id>e1005885</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1005885</pub-id>
        <pub-id pub-id-type="pmid">26925779</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-52">
      <label>Moret et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moret</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gyori</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Bachman</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Steppi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hug</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Berginski</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>A resource for exploring the understudied human kinome for research and therapeutic opportunities</article-title>
        <source>BioRxiv</source>
        <year iso-8601-date="2021">2021</year>
        <pub-id pub-id-type="doi">10.1101/2020.04.02.022277</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-53">
      <label>Murphy, Mace &amp; Eyers (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murphy</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Mace</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Live and let die: insights into pseudoenzyme mechanisms from structure</article-title>
        <source>Current Opinion in Structural Biology</source>
        <year iso-8601-date="2017">2017</year>
        <volume>47</volume>
        <fpage>95</fpage>
        <lpage>104</lpage>
        <pub-id pub-id-type="doi">10.1016/j.sbi.2017.07.004</pub-id>
        <pub-id pub-id-type="pmid">28787627</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-54">
      <label>Neuwald (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Neuwald</surname>
            <given-names>AF</given-names>
          </name>
        </person-group>
        <article-title>Rapid detection, classification and accurate alignment of up to a million or more related protein sequences</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2009">2009</year>
        <volume>25</volume>
        <fpage>1869</fpage>
        <lpage>1875</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp342</pub-id>
        <pub-id pub-id-type="pmid">19505947</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-55">
      <label>Nguyen et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gaulton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hersey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Karlsson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mandava</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Overington</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rouillard</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Schurer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sheils</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Simeonov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jadhav</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Pharos: collating protein information to shed light on the druggable genome</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2017">2017</year>
        <volume>45</volume>
        <fpage>D995</fpage>
        <lpage>D1002</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw1072</pub-id>
        <pub-id pub-id-type="pmid">27903890</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-56">
      <label>Nguyen et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Co-conserved MAPK features couple D-domain docking groove to distal allosteric sites via the C-terminal flanking tail</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2015">2015</year>
        <volume>10</volume>
        <issue>3</issue>
        <elocation-id>e0119636</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0119636</pub-id>
        <pub-id pub-id-type="pmid">25799139</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-57">
      <label>Niepel et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niepel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hafner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Paull</surname>
            <given-names>EO</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Golub</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
        </person-group>
        <article-title>Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling</article-title>
        <source>Nature Communications</source>
        <year iso-8601-date="2017">2017</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>1186</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-017-01383-w</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-58">
      <label>Oruganty &amp; Kannan (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Design principles underpinning the regulatory diversity of protein kinases</article-title>
        <source>Philosophical Transactions of the Royal Society B: Biological Sciences</source>
        <year iso-8601-date="2012">2012</year>
        <volume>367</volume>
        <issue>1602</issue>
        <fpage>2529</fpage>
        <lpage>2539</lpage>
        <pub-id pub-id-type="doi">10.1098/rstb.2012.0015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-59">
      <label>Oruganty &amp; Kannan (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year iso-8601-date="2013">2013</year>
        <volume>1834</volume>
        <issue>7</issue>
        <fpage>1322</fpage>
        <lpage>1329</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbapap.2013.02.040</pub-id>
        <pub-id pub-id-type="pmid">23499783</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-60">
      <label>Patani et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Patani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bunney</surname>
            <given-names>TD</given-names>
          </name>
          <name>
            <surname>Thiyagarajan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Norman</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Ogg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Breed</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ashford</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Potterton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Edwards</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Knowles</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Breeze</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Orengo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Phillips</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Katan</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use</article-title>
        <source>Oncotarget</source>
        <year iso-8601-date="2016">2016</year>
        <volume>7</volume>
        <issue>17</issue>
        <fpage>24252</fpage>
        <lpage>24268</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.8132</pub-id>
        <pub-id pub-id-type="pmid">26992226</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-61">
      <label>Quan et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Jiao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Prognostic significance of PAK family kinases in acute myeloid leukemia</article-title>
        <source>Cancer Gene Therapy</source>
        <year iso-8601-date="2020">2020</year>
        <volume>27</volume>
        <issue>1–2</issue>
        <fpage>30</fpage>
        <lpage>37</lpage>
        <pub-id pub-id-type="doi">10.1038/s41417-019-0090-1</pub-id>
        <pub-id pub-id-type="pmid">30890765</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-62">
      <label>Ruan &amp; Kannan (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Mechanistic insights into R776H mediated activation of epidermal growth factor receptor kinase</article-title>
        <source>Biochemistry</source>
        <year iso-8601-date="2015">2015</year>
        <volume>54</volume>
        <issue>27</issue>
        <fpage>4216</fpage>
        <lpage>4225</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.biochem.5b00444</pub-id>
        <pub-id pub-id-type="pmid">26101090</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-63">
      <label>Ruan, Katiyar &amp; Kannan (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Computational and experimental characterization of patient derived mutations reveal an unusual mode of regulatory spine assembly and drug sensitivity in EGFR kinase</article-title>
        <source>Biochemistry</source>
        <year iso-8601-date="2017">2017</year>
        <volume>56</volume>
        <issue>1</issue>
        <fpage>22</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.biochem.6b00572</pub-id>
        <pub-id pub-id-type="pmid">27936599</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-64">
      <label>Sheils et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheils</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Kelleher</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Siramshetty</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Vidović</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Dharkar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mathé</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Simeonov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>TCRD and Pharos 2021: mining the human proteome for disease biology</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1334</fpage>
        <lpage>D1346</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa993</pub-id>
        <pub-id pub-id-type="pmid">33156327</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-65">
      <label>Sheils et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheils</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Siramshetty</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>How to illuminate the druggable genome using Pharos</article-title>
        <source>Current Protocols in Bioinformatics</source>
        <year iso-8601-date="2020">2020</year>
        <volume>69</volume>
        <issue>1</issue>
        <elocation-id>e92</elocation-id>
        <pub-id pub-id-type="doi">10.1002/cpbi.92</pub-id>
        <pub-id pub-id-type="pmid">31898878</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-66">
      <label>Simonetti et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simonetti</surname>
            <given-names>FL</given-names>
          </name>
          <name>
            <surname>Tornador</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nabau-Moreto</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Molina-Vila</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Marino-Buslje</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Kin-Driver: a database of driver mutations in protein kinases</article-title>
        <source>Database</source>
        <year iso-8601-date="2014">2014</year>
        <volume>2014</volume>
        <fpage>bau104</fpage>
        <pub-id pub-id-type="doi">10.1093/database/bau104</pub-id>
        <pub-id pub-id-type="pmid">25414382</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-67">
      <label>Soleymani et al. (2022)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Soleymani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gravel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bozorgi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bendzunas</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Dark kinase annotation, mining and visualization using the protein kinase ontology</article-title>
        <source>BioRxiv</source>
        <year iso-8601-date="2022">2022</year>
        <pub-id pub-id-type="doi">10.1101/2022.02.25.482021</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-68">
      <label>Tate et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tate</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Bamford</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jubb</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Sondka</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Beare</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Bindal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Boutselakis</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cole</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Creatore</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dawson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fish</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Harsha</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hathaway</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jupe</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ponting</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ramshaw</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Rye</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Speedy</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Stefancsik</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>SA</given-names>
          </name>
        </person-group>
        <article-title>COSMIC: the catalogue of somatic mutations in cancer</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D941</fpage>
        <lpage>D947</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-69">
      <label>Taylor et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Integration of signaling in the kinome: architecture and regulation of the alphaC Helix</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year iso-8601-date="2015">2015</year>
        <volume>1854</volume>
        <issue>10</issue>
        <fpage>1567</fpage>
        <lpage>1574</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbapap.2015.04.007</pub-id>
        <pub-id pub-id-type="pmid">25891902</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-70">
      <label>Tunyasuvunakool et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tunyasuvunakool</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zielinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Žídek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bridgland</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Laydon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Velankar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kleywegt</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pritzel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Figurnov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ronneberger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kohl</surname>
            <given-names>SAA</given-names>
          </name>
          <name>
            <surname>Potapenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ballard</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Romera-Paredes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nikolov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Reiman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Senior</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Kavukcuoglu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Birney</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kohli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jumper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hassabis</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Highly accurate protein structure prediction for the human proteome</article-title>
        <source>Nature</source>
        <year iso-8601-date="2021">2021</year>
        <volume>596</volume>
        <issue>7873</issue>
        <fpage>590</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>
        <pub-id pub-id-type="pmid">34293799</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-71">
      <label>Vazquez et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vazquez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pons</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Valencia</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Izarzugaza</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>wKinMut-2: identification and interpretation of pathogenic variants in human protein kinases</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2016">2016</year>
        <volume>37</volume>
        <issue>1</issue>
        <fpage>36</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22914</pub-id>
        <pub-id pub-id-type="pmid">26443060</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-72">
      <label>Watkins et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Watkins</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Pundir</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>MJ</given-names>
          </name>
          <collab>UniProt Consortium</collab>
        </person-group>
        <article-title>ProtVista: visualization of protein sequence annotations</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2017">2017</year>
        <volume>33</volume>
        <fpage>2040</fpage>
        <lpage>2041</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx120</pub-id>
        <pub-id pub-id-type="pmid">28334231</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-73">
      <label>Wilkinson et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilkinson</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Dumontier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aalbersberg</surname>
            <given-names>IJ</given-names>
          </name>
          <name>
            <surname>Appleton</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Axton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baak</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blomberg</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Boiten</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>da Silva Santos</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Bouwman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brookes</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Crosas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dillo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Dumon</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Edmunds</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Evelo</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Finkers</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gonzalez-Beltran</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Groth</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Goble</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Grethe</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Heringa</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>t Hoen</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Hooft</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lusher</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Martone</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Mons</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Packer</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Persson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rocca-Serra</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Roos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van Schaik</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sansone</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Schultes</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sengstag</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Slater</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Strawn</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Swertz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van der Lei</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van Mulligen</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Velterop</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Waagmeester</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wittenburg</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wolstencroft</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mons</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The FAIR guiding principles for scientific data management and stewardship</article-title>
        <source>Scientific Data</source>
        <year iso-8601-date="2016">2016</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>160018</fpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2016.18</pub-id>
        <pub-id pub-id-type="pmid">26978244</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-74">
      <label>Wishart et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wishart</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Feunang</surname>
            <given-names>YD</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Lo</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Marcu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Sajed</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sayeeda</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Assempour</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Iynkkaran</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Maciejewski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gale</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Knox</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
        <pub-id pub-id-type="pmid">29126136</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-75">
      <label>Yang et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Soares</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Greninger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Edelman</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Lightfoot</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bindal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Beare</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>IR</given-names>
          </name>
          <name>
            <surname>Ramaswamy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Futreal</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Haber</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Stratton</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Benes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>McDermott</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Garnett</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2013">2013</year>
        <volume>41</volume>
        <issue>D1</issue>
        <fpage>D955</fpage>
        <lpage>D961</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1111</pub-id>
        <pub-id pub-id-type="pmid">23180760</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-76">
      <label>Yonemoto et al. (1993)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yonemoto</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Garrod</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase</article-title>
        <source>Journal of Biological Chemistry</source>
        <year iso-8601-date="1993">1993</year>
        <volume>268</volume>
        <issue>25</issue>
        <fpage>18626</fpage>
        <lpage>18632</lpage>
        <pub-id pub-id-type="doi">10.1016/S0021-9258(17)46675-0</pub-id>
        <pub-id pub-id-type="pmid">8395513</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-77">
      <label>Yun et al. (2008)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yun</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Mengwasser</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Toms</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Woo</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Greulich</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>K-K</given-names>
          </name>
          <name>
            <surname>Meyerson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eck</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2008">2008</year>
        <volume>105</volume>
        <issue>6</issue>
        <fpage>2070</fpage>
        <lpage>2075</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0709662105</pub-id>
        <pub-id pub-id-type="pmid">18227510</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-78">
      <label>Zhang et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Huo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo</article-title>
        <source>Journal of Experimental &amp; Clinical Cancer Research</source>
        <year iso-8601-date="2017">2017</year>
        <volume>36</volume>
        <issue>1</issue>
        <fpage>146</fpage>
        <pub-id pub-id-type="doi">10.1186/s13046-017-0610-5</pub-id>
        <pub-id pub-id-type="pmid">29041983</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-79">
      <label>Zhang, Yang &amp; Gray (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Targeting cancer with small molecule kinase inhibitors</article-title>
        <source>Nature Reviews Cancer</source>
        <year iso-8601-date="2009">2009</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>28</fpage>
        <lpage>39</lpage>
        <pub-id pub-id-type="doi">10.1038/nrc2559</pub-id>
        <pub-id pub-id-type="pmid">19104514</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
    <journal-id journal-id-type="iso-abbrev">PeerJ</journal-id>
    <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
    <journal-title-group>
      <journal-title>PeerJ</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2167-8359</issn>
    <publisher>
      <publisher-name>PeerJ Inc.</publisher-name>
      <publisher-loc>San Diego, USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10704995</article-id>
    <article-id pub-id-type="publisher-id">16087</article-id>
    <article-id pub-id-type="doi">10.7717/peerj.16087</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Biochemistry</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Bioinformatics</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Biology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Science</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Data Science</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Dark kinase annotation, mining, and visualization using the Protein Kinase Ontology</article-title>
    </title-group>
    <contrib-group>
      <contrib id="author-1" contrib-type="author">
        <name>
          <surname>Soleymani</surname>
          <given-names>Saber</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
      </contrib>
      <contrib id="author-2" contrib-type="author">
        <name>
          <surname>Gravel</surname>
          <given-names>Nathan</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-3" contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Liang-Chin</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-4" contrib-type="author">
        <name>
          <surname>Yeung</surname>
          <given-names>Wayland</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-5" contrib-type="author">
        <name>
          <surname>Bozorgi</surname>
          <given-names>Elika</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
      </contrib>
      <contrib id="author-6" contrib-type="author">
        <name>
          <surname>Bendzunas</surname>
          <given-names>Nathaniel G.</given-names>
        </name>
        <xref rid="aff-3" ref-type="aff">3</xref>
      </contrib>
      <contrib id="author-7" contrib-type="author" corresp="yes">
        <name>
          <surname>Kochut</surname>
          <given-names>Krzysztof J.</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
        <email>kkochut@uga.edu</email>
      </contrib>
      <contrib id="author-8" contrib-type="author" corresp="yes">
        <name>
          <surname>Kannan</surname>
          <given-names>Natarajan</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
        <xref rid="aff-3" ref-type="aff">3</xref>
        <email>nkannan@uga.edu</email>
      </contrib>
      <aff id="aff-1"><label>1</label><institution>Department of Computer Science, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
      <aff id="aff-2"><label>2</label><institution>Institute of Bioinformatics, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
      <aff id="aff-3"><label>3</label><institution>Department of Biochemistry and Molecular Biology, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Góes-Neto</surname>
          <given-names>Aristóteles</given-names>
        </name>
      </contrib>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>12</month>
      <year iso-8601-date="2023">2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>11</volume>
    <elocation-id>e16087</elocation-id>
    <history>
      <date date-type="received" iso-8601-date="2023-04-05">
        <day>5</day>
        <month>4</month>
        <year iso-8601-date="2023">2023</year>
      </date>
      <date date-type="accepted" iso-8601-date="2023-08-22">
        <day>22</day>
        <month>8</month>
        <year iso-8601-date="2023">2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 Soleymani et al.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Soleymani et al.</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="https://peerj.com/articles/16087"/>
    <abstract>
      <p>The Protein Kinase Ontology (ProKinO) is an integrated knowledge graph that conceptualizes the complex relationships among protein kinase sequence, structure, function, and disease in a human and machine-readable format. In this study, we have significantly expanded ProKinO by incorporating additional data on expression patterns and drug interactions. Furthermore, we have developed a completely new browser from the ground up to render the knowledge graph visible and interactive on the web. We have enriched ProKinO with new classes and relationships that capture information on kinase ligand binding sites, expression patterns, and functional features. These additions extend ProKinO’s capabilities as a discovery tool, enabling it to uncover novel insights about understudied members of the protein kinase family. We next demonstrate the application of ProKinO. Specifically, through graph mining and aggregate SPARQL queries, we identify the p21-activated protein kinase 5 (PAK5) as one of the most frequently mutated dark kinases in human cancers with abnormal expression in multiple cancers, including a previously unappreciated role in acute myeloid leukemia. We have identified recurrent oncogenic mutations in the PAK5 activation loop predicted to alter substrate binding and phosphorylation. Additionally, we have identified common ligand/drug binding residues in PAK family kinases, underscoring ProKinO’s potential application in drug discovery. The updated ontology browser and the addition of a web component, ProtVista, which enables interactive mining of kinase sequence annotations in 3D structures and Alphafold models, provide a valuable resource for the signaling community. The updated ProKinO database is accessible at <uri xlink:href="https://prokino.uga.edu">https://prokino.uga.edu</uri>.</p>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Curation</kwd>
      <kwd>User interface</kwd>
      <kwd>Drug discovery</kwd>
      <kwd>Cell signaling</kwd>
      <kwd>Protein structure</kwd>
      <kwd>Protein function</kwd>
      <kwd>Network biology</kwd>
      <kwd>Cancer genomes</kwd>
    </kwd-group>
    <funding-group>
      <award-group id="fund-1">
        <funding-source>National Institutes of Health</funding-source>
        <award-id>U01CA239106 and R35 GM139656</award-id>
      </award-group>
      <funding-statement>This work was supported by the National Institutes of Health (U01CA239106 and R35 GM139656) to Natarajan Kannan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>The protein kinase gene family with nearly 535 human members (collectively called the human kinome) is a biomedically important gene family associated with many human diseases such as cancer, diabetes, Alzheimer’s disease, Parkinson’s disease, and inflammatory disorders. They make up one-third of all drug-related protein target discoveries in the pharmaceutical industry, with over 50 FDA-approved drugs developed since 2001 (<xref rid="ref-17" ref-type="bibr">Ferguson &amp; Gray, 2018</xref>; <xref rid="ref-79" ref-type="bibr">Zhang, Yang &amp; Gray, 2009</xref>). However, despite decades of research on the protein kinase family, our current knowledge of the kinome is skewed towards a subset of well-studied kinases with nearly one-third of the kinome largely understudied. These understudied kinases, collectively referred to as the “dark” kinome by the Knowledge Management Center (KMC) (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>) within the Illuminating the Druggable Genome (IDG) consortium, constitute both active kinases and inactive pseudokinases, which lack one or more of the active site residues, but perform important scaffolding and regulatory roles in signaling pathways (<xref rid="ref-7" ref-type="bibr">Byrne, Foulkes &amp; Eyers, 2017</xref>; <xref rid="ref-13" ref-type="bibr">Eyers, Keeshan &amp; Kannan, 2017</xref>; <xref rid="ref-14" ref-type="bibr">Eyers &amp; Murphy, 2013</xref>; <xref rid="ref-53" ref-type="bibr">Murphy, Mace &amp; Eyers, 2017</xref>) and are druggable (<xref rid="ref-18" ref-type="bibr">Foulkes et al., 2018</xref>). Incomplete knowledge of the structure, function, and regulation of these understudied kinases and pseudokinases presents a major bottleneck for drug discovery efforts. While multiple initiatives are beginning to generate essential tools and resources to characterize dark kinases, integrative mining of these datasets is necessary to develop new testable hypotheses on dark kinase functions. However, integrative mining of protein kinase data is a challenge because of the diverse and disparate nature of protein kinase data sources and formats. Information on the structural and functional aspects of dark kinases, for example, is scattered in the literature posing unique challenges for researchers interested in formulating routine queries such as “disease mutations mapping to conserved structural and functional regions of the kinome” or “post-translational modifications (PTMs) in the activation loop of dark kinases.” Formulating such aggregate queries requires researchers to go through the often time-consuming and error-prone process of collating information from various data sources through customized computer programs, which results in duplication of efforts across laboratories, and does not scale well with the growing complexity and diversity of protein kinase data. For these reasons, the IDG consortium has developed a unified resource, Pharos, for collating diverse forms of information on druggable proteins, including protein kinases (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>; <xref rid="ref-65" ref-type="bibr">Sheils et al., 2020</xref>, <xref rid="ref-64" ref-type="bibr">2021</xref>). A focused Dark Kinase Knowledgebase has also been developed to make experimental data available on dark kinases to the broader research community (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>; <xref rid="ref-52" ref-type="bibr">Moret et al., 2021</xref>). While these unified resources provide a wide range of valuable information on druggable proteins, they offer limited data analytics capabilities in mining sequence and structural data. They do not conceptualize protein kinases’ detailed structural and functional knowledge in a practical and understandable way for protein kinase researchers. Thus, to accelerate the biochemical characterization of understudied dark kinases, a semantically meaningful and mineable representation of the kinase knowledge base is needed (<xref rid="fig-1" ref-type="fig">Fig. 1</xref>).</p>
    <fig position="float" id="fig-1">
      <object-id pub-id-type="doi">10.7717/peerj.16087/fig-1</object-id>
      <label>Figure 1</label>
      <caption>
        <title>The ProKinO architecture and work-flow.</title>
        <p>(A) A subset of curated data sources used in ontology population. (B) A schematic of the ontology schema with classes (boxes) and relationships (lines) connecting the classes. (C) Applications for ontology browsing and navigation.</p>
      </caption>
      <graphic xlink:href="peerj-11-16087-g001" position="float"/>
    </fig>
    <p>To semantically represent protein kinase data in ways protein kinase researchers use and understand, we previously reported the development of a focused protein kinase ontology, ProKinO (<xref rid="ref-21" ref-type="bibr">Gosal, Kannan &amp; Kochut, 2011</xref>; <xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>; <xref rid="ref-49" ref-type="bibr">McSkimming et al., 2015</xref>), which integrates and conceptualizes diverse forms of protein kinase data in computer- and human-readable format (<xref rid="fig-2" ref-type="fig">Fig. 2</xref>). The ontology is instantiated with curated data from internal and external sources and enables aggregate queries linking diverse forms of data in one place. ProKinO enables the generation of new knowledge regarding kinases and pathways altered in various cancer types, and new testable hypotheses regarding the structural and functional impact of disease mutations (<xref rid="ref-2" ref-type="bibr">Bailey et al., 2015</xref>; <xref rid="ref-9" ref-type="bibr">Cicenas &amp; Cicenas, 2016</xref>; <xref rid="ref-20" ref-type="bibr">Goldberg et al., 2013</xref>; <xref rid="ref-21" ref-type="bibr">Gosal, Kannan &amp; Kochut, 2011</xref>; <xref rid="ref-25" ref-type="bibr">Hu et al., 2015</xref>; <xref rid="ref-42" ref-type="bibr">Liu, Liang &amp; Zhang, 2016</xref>; <xref rid="ref-46" ref-type="bibr">McClendon et al., 2014</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>, <xref rid="ref-48" ref-type="bibr">2014</xref>, <xref rid="ref-49" ref-type="bibr">2015</xref>; <xref rid="ref-50" ref-type="bibr">Meharena et al., 2013</xref>; <xref rid="ref-51" ref-type="bibr">Mohanty et al., 2016</xref>; <xref rid="ref-56" ref-type="bibr">Nguyen et al., 2015</xref>; <xref rid="ref-59" ref-type="bibr">Oruganty &amp; Kannan, 2013</xref>; <xref rid="ref-62" ref-type="bibr">Ruan &amp; Kannan, 2015</xref>; <xref rid="ref-66" ref-type="bibr">Simonetti et al., 2014</xref>; <xref rid="ref-69" ref-type="bibr">Taylor et al., 2015</xref>; <xref rid="ref-44" ref-type="bibr">ManChon et al., 2014</xref>; <xref rid="ref-71" ref-type="bibr">Vazquez et al., 2016</xref>). For example, through iterative ProKinO queries and follow-up experimental studies, we identified oncogenic mutations associated with abnormal protein kinase activation and drug sensitivity (<xref rid="ref-43" ref-type="bibr">Lubner et al., 2017</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>, <xref rid="ref-49" ref-type="bibr">2015</xref>; <xref rid="ref-51" ref-type="bibr">Mohanty et al., 2016</xref>; <xref rid="ref-60" ref-type="bibr">Patani et al., 2016</xref>; <xref rid="ref-62" ref-type="bibr">Ruan &amp; Kannan, 2015</xref>; <xref rid="ref-63" ref-type="bibr">Ruan, Katiyar &amp; Kannan, 2017</xref>). We have also employed federated queries linking ProKinO with other widely used ontologies and resources such as the Protein Ontology (PRO), neXtProt, Reactome, and the Mouse Genome Informatics (MGI) to prioritize understudied dark kinases for functional studies and generate testable hypotheses regarding post-translational modification and cancer mutations (<xref rid="ref-26" ref-type="bibr">Huang et al., 2018</xref>).</p>
    <fig position="float" id="fig-2">
      <object-id pub-id-type="doi">10.7717/peerj.16087/fig-2</object-id>
      <label>Figure 2</label>
      <caption>
        <title>Subset of the updated ProKinO schema with new classes and relationships.</title>
        <p>The full schema can be accessed at <uri xlink:href="http://prokino.uga.edu/">http://prokino.uga.edu/</uri>. New classes are colored in cyan and pre-existing classes are colored in pink. Black arrows indicate new relationships introduced to connect the new classes.</p>
      </caption>
      <graphic xlink:href="peerj-11-16087-g002" position="float"/>
    </fig>
    <p>While our preliminary studies have demonstrated the utility of ProKinO in hypothesis generation and knowledge discovery, to fully realize the impact of ProKinO in drug discovery and dark kinome mining, the ontology and the associated analytics tools need to be further developed to expand its scope and usability. For example, mutations at specific functional regions of the protein kinase domain, such as the gatekeeper and activation segments, are known to impact drug binding efficacies (<xref rid="ref-19" ref-type="bibr">Gajiwala et al., 2009</xref>; <xref rid="ref-77" ref-type="bibr">Yun et al., 2008</xref>). Likewise, kinase mRNA expression profiles strongly correlate with drug response (<xref rid="ref-4" ref-type="bibr">Benhar, Engelberg &amp; Levitzki, 2002</xref>; <xref rid="ref-11" ref-type="bibr">Duncan et al., 2012</xref>; <xref rid="ref-34" ref-type="bibr">Kim, Song &amp; Haura, 2009</xref>; <xref rid="ref-57" ref-type="bibr">Niepel et al., 2017</xref>). Thus, integrative mining of disease mutations with drug sensitivity profiles and expression patterns can provide new hypotheses/data for the development and administration of combinatorial drugs where multiple mutated kinases in distinct pathways can be targeted for drug repurposing (<xref rid="ref-12" ref-type="bibr">Erika et al., 2016</xref>; <xref rid="ref-39" ref-type="bibr">Li &amp; Jones, 2012</xref>), as demonstrated by the repurposing of Gleevec for targeting c-kit kinase in Gastrointestinal tumors (<xref rid="ref-31" ref-type="bibr">Joensuu et al., 2001</xref>). Furthermore, the recent generation of structural models of various dark kinases using AlphaFold (<xref rid="ref-32" ref-type="bibr">Jumper et al., 2021</xref>) provides a new framework for generating new hypotheses by interactive mining and visualization of sequence annotations in the context of 3D models. However, the lack of interactive visualization tools to overlay sequence and functional annotations in 3D structural models presents a bottleneck in the effective use of AlphaFold models for function prediction. To address this and other challenges described above related to dark kinase mining and annotation, we have expanded ProKinO by including kinase expression data, as well as a variety of data related to ligand-motif interaction, and ligand response prediction (<xref rid="ref-27" ref-type="bibr">Huang et al., 2021</xref>). We have also significantly revamped the ProKinO browser through incorporation of new visualization tools for the interactive mining of sequence annotations in the context of experimentally determined 3D structures and AlphaFold models. We demonstrate the application of these new tools in dark kinase annotation and mining using the understudied p21-activated protein kinase 5, as an example. The updated ontology and browser provide a valuable resource for mining, visualizing, and annotating the dark kinome and pseudokinome.</p>
  </sec>
  <sec sec-type="materials|methods">
    <title>Materials and Methods</title>
    <sec>
      <title>Data sources</title>
      <p>The ProKinO ontology includes data obtained from curated internal sources as well as external sources. Information from internal sources include annotations of kinase sequence and structural motifs retrieved from curated multiple sequence alignments. External sources are used for information related to kinase sequence and classification (KinBase &amp; UniProt) (<xref rid="ref-3" ref-type="bibr">Bairoch et al., 2005</xref>; <xref rid="ref-45" ref-type="bibr">Manning et al., 2002</xref>) cancer mutations (COSMIC) (<xref rid="ref-68" ref-type="bibr">Tate et al., 2018</xref>), pathways (Reactome) (<xref rid="ref-10" ref-type="bibr">Croft et al., 2011</xref>) and three dimernsioanl structure (PDB) (<xref rid="ref-6" ref-type="bibr">Berman et al., 2000</xref>). The ontology is populated and updated on a regular basis using protocols described in previous studies (<xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>). Here, we describe further enhancements and additions to ProKinO through integration of data on kinase expression patterns and drug interactions, as described below. In a seperate significant project, we have identified and classified nearly 30,000 pseudokinases spanning over 1,300 organisms (<xref rid="ref-38" ref-type="bibr">Kwon et al., 2019</xref>). The schematic representation of the classification of kinases into groups, families, and subfamilies was already in place (<xref rid="ref-24" ref-type="bibr">Hanks &amp; Hunter, 1995</xref>; <xref rid="ref-45" ref-type="bibr">Manning et al., 2002</xref>). Consequently, the addition of the pseudokinases and their classification was relatively simple. However, it significantly enhanced ProKinO as a comprehensive knowledge graph representing kinase-related data. The definition and nomenclature of several kinome-wide conserved motifs were standardized based on several previously published studies which describe the kinase structural features such as subdomains (<xref rid="ref-24" ref-type="bibr">Hanks &amp; Hunter, 1995</xref>), regulatory spine/shell (<xref rid="ref-50" ref-type="bibr">Meharena et al., 2013</xref>), and catalytic spine (<xref rid="ref-25" ref-type="bibr">Hu et al., 2015</xref>). A subset of redundant or family-specific motifs were removed in the updated ontology and motif information on some of the atypical kinases such as ALPHAK2 is not included as they cannot be reliably aligned with canonical protein kinases. Portions of the text were previously published as a part of a preprint (<xref rid="ref-67" ref-type="bibr">Soleymani et al., 2022</xref>).</p>
    </sec>
    <sec>
      <title>Ligand interactions</title>
      <p>Information on kinase-ligand interactions were retrieved from the Kinase-Ligand Interaction Fingerprints and Structures (KLIFS) database (<xref rid="ref-33" ref-type="bibr">Kanev et al., 2021</xref>). The KLIFS database stores detailed drug-protein kinase interaction information derived from diverse (&gt;2,900) structures of catalytic domains of human and mouse protein kinases deposited in the Protein Data Bank. In addition, KLIFS provides an application programming interface (API) for programmatic access to data related to chemicals and structural chemogenomics (<xref rid="ref-33" ref-type="bibr">Kanev et al., 2021</xref>). However, it lacks information regarding kinase pathways or diseases which prevents the user from investigating the effect of drug-mutant protein binding on downstream pathways or diseases. KLIFS annotations, which report PDB residue positions, were converted to UniProt residue numbering using PDBrenum (<xref rid="ref-15" ref-type="bibr">Faezov &amp; Dunbrack, 2021</xref>), then converted to prototypic Protein Kinase A (PKA) numbering using Multiply Aligned Profiles for Global Alignment of Protein Sequences (MAPGAPS) (<xref rid="ref-54" ref-type="bibr">Neuwald, 2009</xref>). Entries that could not be mapped or did not map to the kinase domain were filtered out.</p>
    </sec>
    <sec>
      <title>Ligand responses</title>
      <p>We have also incorporated information on kinase drug sensitivity profile in the updated ProKinO. In particular, we retrieved drug dose response data for kinase-relevant ligands/drugs from the Genomics of Drug Sensitivity in Cancer (GDSC) (<xref rid="ref-75" ref-type="bibr">Yang et al., 2013</xref>). Kinase-relevant ligands are defined based on our previous study (<xref rid="ref-28" ref-type="bibr">Huang et al., 2020</xref>), which collected 143 small-molecule protein kinase inhibitors from GDSC based on four drug-target databases: DrugBank (<xref rid="ref-74" ref-type="bibr">Wishart et al., 2018</xref>), Therapeutic Target Database (<xref rid="ref-40" ref-type="bibr">Li et al., 2018</xref>), Pharos (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>), and the Library of Integrated Network-Based Cellular Signatures (LINCS) Data Portal (<xref rid="ref-36" ref-type="bibr">Koleti et al., 2018</xref>). GDSC provides the half-maximal inhibitory concentration values (IC50) of these 143 ligands in 988 cancer cell lines.</p>
    </sec>
    <sec>
      <title>Ligand activities</title>
      <p>Ligand activities were retrieved from Pharos, a flagship resource (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>) of the National Institutes of Health (NIH) Illuminating the Druggable Genome (IDG) program that includes data on small molecules, including approved drug data and bioassay data. Based on the protein classification (<xref rid="ref-41" ref-type="bibr">Lin et al., 2017</xref>), the drug targets in Pharos include kinases, ion channels, G-protein coupled receptors (GPCRs), and others. In this phase of the project, we decided to include the data relevant to ligand binding in kinases. Pharos integrates drug-target relationships from several resources, such as ChEMBL (<xref rid="ref-8" ref-type="bibr">Bühlmann &amp; Reymond, 2020</xref>) and DrugCentral (<xref rid="ref-1" ref-type="bibr">Avram et al., 2021</xref>).</p>
    </sec>
    <sec>
      <title>Expression data</title>
      <p>An important part of our recent additions was kinase expression data. Genomic expression data (protein, RNA), as well as transcription factors and epigenomic associations, are among many facets of the data included in Pharos. Furthermore, the GDSC repository contains gene expression data (Affymetrix Human Genome U219 Array), as well. Additionally, COSMIC’s Cell Lines Project includes a significant amount of gene expression data, including kinase expression.</p>
    </sec>
    <sec>
      <title>Dark kinases</title>
      <p>Dark kinases were labeled based on the information from Dark Kinase Knowledgebase (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>).</p>
    </sec>
    <sec>
      <title>Protein kinase knowledge graph: schema and data organization</title>
      <p>The ProKinO ontology consists of classes, sub-classes, class types, relationships, relationship types, and constraints of protein kinase and related data (<xref rid="fig-2" ref-type="fig">Fig. 2</xref>). The hierarchy connects all classes to the root, which is ProKinOEntity. Moreover, the schema defines types and constraints for the relationships. With such explicit and constrained schema, composing queries is more intuitive than conventional relational databases. In particular, to enable integrative mining of dark kinase expression data in the context of kinase sequence and structural features, we have introduced three new classes in ProKinO, the Ligand class (including its name, source, and chemical structure) and the following three related classes: (1) LigandInteraction, placed between the Ligand and (already existing) Motif classes to capture kinase-ligand binding and selectivity at the motif and residue level; (2) LigandActivity, placed between the Ligand and (already existing) Protein classes to represent kinases targeted by ligands (and drugs); and (3) LigandResponse, located between the Ligand and (already existing) Sample classes and representing ligand (and drug) sensitivity in kinases. To capture kinase expression, we added the GeneExpression relationship linking the Protein and Sample classes. The outline of the recently added classes and their relationships in ProKinO is illustrated as a UML class diagram, shown in <xref rid="fig-2" ref-type="fig">Fig. 2</xref>.</p>
    </sec>
    <sec>
      <title>ProKinO population</title>
      <p>The ProKinO knowledge graph is automatically populated from several external and local data sources at regular intervals, as originally described (<xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>), ProKinO schema and the associated knowledge graph population software are routinely updated to incorporate additional sources of data such as pseudokinase and “dark” kinase classification and incorporating information on ligand interactions, ligand responses, ligand activities, kinase expression and associated object and datatype properties. We have been using the Protégé ontology editor for the schema creation and its subsequent modifications. The organization of the schema after these modifications is available at <uri xlink:href="https://prokino.uga.edu/about">https://prokino.uga.edu/about</uri>.</p>
      <p>The population software has been coded in Java and uses the Jena Framework. The population process is performed in several steps to add instances, their properties, and a combination of reading the prepared data from CSV, RDF, XML, and other file formats and accessing many remote data sources using their provided API (for example, Reactome’s REST API). Entity interconnections across data retrieved from different data sources are accomplished using UniProt identifiers, kinase names, and other accession identifiers. We modified the population software to create instances and properties for the newly added classes and relationships.</p>
      <p>More specifically, using the KLIFS API, we retrieved the relevant kinases, ligands, and residue-level interaction data. The data was retrieved and then processed by custom Perl scripts. ProKinO ontology schema was modified, and ligands were included as new data, while interaction data (motifs) were either reconciled with the motifs already present in ProKinO or added as new, if not already there.</p>
      <p>Similarly, the ligand response data was retrieved from GDSC and then processed by custom Perl scripts to create suitable CSV files. Additional ligands were included as new data, while the response data and the relevant samples were either reconciled with the samples already present in ProKinO or added as new, if not already there.</p>
      <p>In order to populate the data on ligand activities, we retrieved from Pharos kinase-relevant ligands, as well as their binding data on targeted kinases, for example, IC50 values. This data was retrieved and then processed by custom Perl scripts to produce the necessary CSV files. Additional ligands, not included in the KLIFS dataset, were included as new data. All kinases targeted by ligands were already present in ProKinO, so they were reused in this step.</p>
      <p>Data on kinase expression was first retrieved from Pharos, COSMIC, and GDSC. As before, the relevant kinases were already present in the ProKinO knowledge graph. The expression data was stored as individuals in the Expression class. Some of the relevant data about samples were already present in ProKinO, as we already had a significant amount of sample data from COSMIC. Additional samples were included as new data.</p>
      <p>We reviewed and updated all the motifs already present in ProKinO. Furthermore, we updated the motif naming in cases where there were differences with the standard motif names.</p>
      <p>Finally, we assembled an up-to-date list of dark kinases (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>) and added a Boolean datatype property, <italic toggle="yes">isDarkKinase</italic>, to identify them among all other kinases in the ProKinO knowledge graph.</p>
    </sec>
  </sec>
  <sec>
    <title>Results/discussion</title>
    <p>The expanded ontology and its knowledge graph provide a wealth of data unifying the information available on both well-studied (light) kinases and understudied (dark) kinases that serve as a unified resource for mining the kinome. The current version of ProKinO (version 65), includes 842 classes, 31 objects and 67 data properties, and over seven million individuals (knowledge graph nodes). ProKinO contains information on 153 dark kinases. A total of 137 dark kinases have information on structural motifs, 148 have disease mutations mapped to the kinase domain, 45 dark kinases have pathway information, and 26 are associated with specific reactions, as defined in Reactome.</p>
    <p>Users can navigate the ontology using the ontology browser by searching for a specific kinase of interest or by performing aggregate SPARQL queries linking multiple forms of data. Currently 35 pre-written queries linking different data types can be executed using the ProKinO browser (<uri xlink:href="http://prokino.uga.edu/queries">http://prokino.uga.edu/queries</uri>). A user can also download the ontology or browse data based on organisms, functional domains, diseases, or kinase domain evolutionary hierarchy. Below, we focus on the application of complex SPARQL queries and the ProtVista visualization tools for the illumination of understudied dark kinases.</p>
    <sec>
      <title>Mutation and expression of understudied PAK5 in human cancers</title>
      <p>One possible way to prioritize dark kinases for functional studies is to ask the question, “which dark kinases are most mutated in human diseases, such as cancers?”. Typically answering this question would require collating and post-processing data from multiple resources such as COSMIC, Pharos, and the Dark Kinase Knowledgebase. However, with the updated Protein Kinase Ontology, these questions can be quickly answered using SPARQL. Having the “<italic toggle="yes">isDarkKinase”</italic> property within the Protein class and the RDF triples connecting the “<italic toggle="yes">Mutation”</italic>, “<italic toggle="yes">Sample</italic>” and “<italic toggle="yes">Sequence”</italic> classes, one can formulate aggregate queries requesting all dark kinases mutated in cancer samples. To avoid biases introduced by the length of protein/gene sequences (longer proteins tend to have more mutations), the query can be modified to normalize mutation counts by sequence length. Executing this modified query (Query 27, available at <uri xlink:href="http://prokino.uga.edu/queries">http://prokino.uga.edu/queries</uri>) displays the rank-ordered list of dark kinases based on mutational density. The top ten dark kinases with the highest mutational density are shown in <xref rid="fig-3" ref-type="fig">Fig. 3A</xref>. Notably, the p21 activated kinase 5 (PAK5) is at the top of the list with a mutational density of 1.917, followed by CRK7 (1.054), PKACG (1.011), PSKH2 (1.01) TSSK1 (1.008), CK1A2 (0.991), ERK4 (0.966), DCLK3 (0.912), PKCT (0.894) and PAK3 (0.859). Having identified PAK5 as the most frequently mutated dark kinase in cancers, one can further query the ontology to explore the role of this kinase in various cancers. With the addition of the new “<italic toggle="yes">GeneExpression</italic>” class in ProKinO and the RDF triples connecting gene expression to the “<italic toggle="yes">Sample”</italic> and “<italic toggle="yes">Protein</italic>” classes (<italic toggle="yes">GeneExpression:InSample: Sample; GeneExpression:hasProtein: Protein</italic>), one can formulate queries for PAK5 expression in different samples (<xref rid="fig-3" ref-type="fig">Fig. 3B</xref>). Rank ordering the samples based on PAK5 expression (Query 33) reveals cancer types such as adenocarcinoma (Zscore: 4,701.5) and hepatocellular carcinoma (Zscore: 2,038.3) that have previously been associated with abnormal PAK5 expression (<xref rid="ref-16" ref-type="bibr">Fang et al., 2014</xref>; <xref rid="ref-23" ref-type="bibr">Han et al., 2018</xref>; <xref rid="ref-29" ref-type="bibr">Huo et al., 2019</xref>; <xref rid="ref-78" ref-type="bibr">Zhang et al., 2017</xref>). However, the role of PAK5 in other cancer types such as acute myeloid leukemia (Zscore: 136.5) is relatively underappreciated (<xref rid="ref-61" ref-type="bibr">Quan et al., 2020</xref>). The identification of new cancer sub-types with dark kinase expression and regulation further exemplifies the use of ProKinO in knowledge discovery.</p>
      <fig position="float" id="fig-3">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-3</object-id>
        <label>Figure 3</label>
        <caption>
          <title>SPARQL query results for Query 27 and 33.</title>
          <p>(A) Output of Query 27 requesting top 10 dark kinases with most mutations in different cancer types. The mutation counts are normalized by sequence length. (B) Output of Query 33 listing samples with abnormal PAK5 expression. The query also lists histology, cancer subtypes, regulation, and Z-score. Only a subset of the query results is shown because of space constraints.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g003" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Mutational hotspots in the activation loop of PAK5</title>
      <p>Because ProKinO encodes a wealth of information on the structural and regulatory properties of multiple kinases, it can be used to generate mechanistic predictions on cancer mutation impact. We demonstrate this for the PAK kinases by asking the question “<italic toggle="yes">where are PAK5 mutations located in the protein kinase domain?</italic>” Using the RDF triples connecting the “<italic toggle="yes">Mutation”</italic>, “<italic toggle="yes">Motif”</italic> and “<italic toggle="yes">Sequence</italic>” classes (“<italic toggle="yes">Mutation: LocatedIn: Motif”; “Mutation:InSequence: Sequence”</italic>), one can formulate a query (Query 28) listing mutations in different structural regions/motifs of the PAK5 kinase domain. Examination of the query results reveals that the C-terminal substrate binding lobe (C-lobe) is more frequently mutated (320 mutations) relative to the N-terminal ATP binding lobe (N-lobe: 173 mutations) (<xref rid="fig-4" ref-type="fig">Fig. 4A</xref>). Within the C-lobe, nearly 78 mutations map to the activation loop, which is known to play a critical role in substrate recognition and activation in a diverse array of kinases (<xref rid="ref-30" ref-type="bibr">Huse &amp; Kuriyan, 2002</xref>; <xref rid="ref-37" ref-type="bibr">Kornev &amp; Taylor, 2015</xref>; <xref rid="ref-58" ref-type="bibr">Oruganty &amp; Kannan, 2012</xref>). Despite the prevalence of activation loop mutations in PAK5, there is currently no information on how these mutations impact PAK5 kinase structure and function. Nonetheless, based on the evolutionary relationships captured in ProKinO (based on the alignment of human kinases to the prototypic protein kinase A), one can formulate queries mapping mutations to specific aligned positions in the shared protein kinase domain. A query listing (wild type) WT type and mutant type residues in the activation loop of PAK5 and the equivalent aligned residue positions in PKA (Query 29) provides additional context for these mutations. For example, two distinct mutations map to residue <inline-formula id="ieqn-1"><alternatives><inline-graphic xlink:href="peerj-11-16087-i001.jpg"/><tex-math id="tex-ieqn-1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{602^{{\rm PAK}5}}$\end{document}</tex-math><mml:math id="mml-ieqn-1" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>602</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> in the activation loop of PAK5 that structurally corresponds to a phosphorylatable residue, <inline-formula id="ieqn-2"><alternatives><inline-graphic xlink:href="peerj-11-16087-i002.jpg"/><tex-math id="tex-ieqn-2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm T}{197^{{\rm PKA}}}$\end{document}</tex-math><mml:math id="mml-ieqn-2" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>197</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, in PKA (<xref rid="ref-76" ref-type="bibr">Yonemoto et al., 1993</xref>). Having this context provides a testable hypothesis that S602 mutations in PAK5 impact kinase phosphorylation and regulation. Likewise, WT residue <inline-formula id="ieqn-3"><alternatives><inline-graphic xlink:href="peerj-11-16087-i003.jpg"/><tex-math id="tex-ieqn-3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{607^{{\rm PAK}5}}$\end{document}</tex-math><mml:math id="mml-ieqn-3" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>607</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> is mutated in four distinct cancer samples and this position is equivalent to PKA residue <inline-formula id="ieqn-4"><alternatives><inline-graphic xlink:href="peerj-11-16087-i004.jpg"/><tex-math id="tex-ieqn-4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{202^{{\rm PKA}}}$\end{document}</tex-math><mml:math id="mml-ieqn-4" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>202</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, which configures the activation loop for substrate recognition (<xref rid="ref-35" ref-type="bibr">Knighton et al., 1991</xref>). Thus, mutation of this critical residue is expected to impact substrate binding and activation loop phosphorylation in PAK5. Additional insights into these mutations can also be obtained by visualizing these residues in the context of the PAK5 AlphaFold models using the ProtVista viewer described below.</p>
      <fig position="float" id="fig-4">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-4</object-id>
        <label>Figure 4</label>
        <caption>
          <title>SPARQL query results for Query 28 and 29.</title>
          <p>(A) Output of Query 28 listing the number of unique cancer-linked mutations at various structural locations of PAK5 kinase. (B) Output of Query 29 listing unique point mutations in the activation loop of PAK5 kinase. The query also lists the equivalent PKA position, disease type, primary site of the tissue sample, equivalent residue for the PKA positioning of PKA, and subtype of the tissue sample. Entries containing only one mutation per position were filtered from the original query. Only a subset of the query results is shown.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g004" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Insights into PAK5 ligand binding sites</title>
      <p>With the conceptualization of new information related to kinase ligands, their mode of action and interaction with specific motifs in the kinase domain, new aggregate queries linking mutated kinases to drug sensitivity profiles, mode of action, and ligand binding sites can be performed using the updated ProKinO. For example, queries such as “<italic toggle="yes">list proteins and drugs or ligands interacting with the protein’s gatekeeper residue (GK.45)</italic>” (Query 31) and “<italic toggle="yes">list ligands targeting the Epidermal Growth Factor Receptor (EGFR) kinase and their mode of action</italic>” (Query 34) can be rapidly performed using the updated ProKinO ontology. We demonstrate the application of these new additions in the context of PAK5 by asking the question “<italic toggle="yes">what are the drugs targeting PAK family (PAK1-6) kinases</italic>?” Query 30 answers this question using the RDF triples connecting the “<italic toggle="yes">Ligand</italic>”, “<italic toggle="yes">Motif</italic>” and “<italic toggle="yes">Protein</italic>” classes (list triples) (<xref rid="fig-5" ref-type="fig">Fig. 5</xref>). Examination of the query results indicates multiple drugs targeting PAK family kinases, including STAUROSPORINE and N2-((1R-2S)-2-AMINOCYCLOHEXYL) that bind to structurally equivalent residues/motifs in the ligand binding pocket of PAK4 and PAK5, respectively. The ligand binding sites, and associated interactions can also be visualized using the ProtVista viewer described below. Additional queries linking dark kinases to drug sensitivities, structural motifs, and pathways are listed on the ProKinO website at <uri xlink:href="https://prokino.uga.edu/queries">https://prokino.uga.edu/queries</uri>.</p>
      <fig position="float" id="fig-5">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-5</object-id>
        <label>Figure 5</label>
        <caption>
          <title>SPARQL query results for Query 30.</title>
          <p>Output of Query 30 listing ligands interactions with each PAK family member (PAK1-6). It also includes motif names and positions of full sequence and PKA positioning. The output of Query 30 was rearranged to highlight the homology of PAK4 and PAK5 motif/ligand interactions and the figure highlights only a subset of the query results. Run SPARQL query for full results.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g005" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Visualization tools for dark kinase annotation and mining</title>
      <p>To provide structural context for cancer mutations and to enable interactive mining of dark kinase sequence annotations in the context of 3D structures and predicted models from AlphaFold (<xref rid="ref-32" ref-type="bibr">Jumper et al., 2021</xref>; <xref rid="ref-70" ref-type="bibr">Tunyasuvunakool et al., 2021</xref>), we developed and incorporated a modified version of the ProtVista viewer in ProKinO. The viewer can be deployed for any protein kinase of interest by navigating to the Structure tab in the protein summary page and selecting either a PDB structure or AlphaFold model of interest. A snapshot of the ProtVista viewer displaying the AlphaFold model of PAK5 kinase is shown in <xref rid="fig-6" ref-type="fig">Fig. 6</xref>. The ProtVista viewer uses an enhanced version of the Mol* viewer and the PDB web component (<xref rid="ref-72" ref-type="bibr">Watkins et al., 2017</xref>) to provide two-way interactive navigation between the 3D structure (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>, top panel) and annotation viewer (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>, bottom panel).</p>
      <fig position="float" id="fig-6">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-6</object-id>
        <label>Figure 6</label>
        <caption>
          <title>ProtVista viewer.</title>
          <p>(A) AlphaFold2 model of PAK5 kinase is shown in the structure viewer (top panel). Sequence viewer with annotations are shown in the bottom panel. (B and C) Zoomed in view of structural interactions associated with S602 and P607 in PAK5 activation loop.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g006" position="float"/>
      </fig>
      <p>The annotation viewer consists of multiple tracks populated dynamically based on data from ProKinO and external sources such as UniProt. In addition, prediction confidence scores for AlphaFold models are displayed in the annotation viewer along with additional annotations such as conserved sequence motifs, subdomains, and structural motifs involved in kinase regulation. The annotation viewer also shows other annotations from external sources such as ligand binding sites and predicted functional sites. Users can hover over the residues on the 3D structure viewer to view the equivalent information on the annotation viewer and vice versa. For example, selecting the “<italic toggle="yes">activation loop</italic>” in the annotation viewer highlights the corresponding structural region in the AlphaFold model of PAK5 (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>). Likewise, the selection of residues in the activation loop (S602 and P607) in the structure viewer highlights the annotations associated with these and interacting residues in the sequence viewer. Such interactive mining is expected to accelerate the functional characterization of dark kinases and provide new insights into disease mutations. For example, visualizing the interactions associated with S602 in the activation loop of PAK5 (<xref rid="fig-6" ref-type="fig">Fig. 6B</xref>) indicates a hydrogen bonding interaction with R567, which is part of the conserved HRD motif (sequence annotation). Because the HRD-Arg is known to play a role in kinase regulation by stabilizing activation loop conformation (<xref rid="ref-30" ref-type="bibr">Huse &amp; Kuriyan, 2002</xref>), it provides additional context for predicting the impact of S602 altering mutations. Likewise, examining the structural and sequence context of P607 interacting residues provides new insights into how the alteration of this residue might impact substrate binding and kinase regulation. Together, these examples highlight the value added by the ProtVista viewer in the visualization and annotation of mutations in dark kinases.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions">
    <title>Conclusions</title>
    <p>This work presents an updated version of the Protein Kinase Otology (ProKinO) for mining and annotating dark kinases. ProKinO was developed following FAIR (Findable, Accessible, Interoperable, and Reusable) principles (<xref rid="ref-73" ref-type="bibr">Wilkinson et al., 2016</xref>) and serves as an integrated knowledge graph for relating and conceptualizing diverse forms of disparate data related to protein kinase sequence, structure, function, regulation, and disease (cancer). We present a new ontology browser for navigating these data and demonstrate the application of aggregate SPARQL queries in uncovering new testable hypotheses regarding understudied kinase members. We also provide several pre-written SPARQL queries that can rapidly retrieve information related to protein kinase mutations, pathways, expression, and ligand binding sites. However, writing new queries requires prior knowledge of the ontology schema and the SPARQL query language, which most bench biologists may not have. To alleviate this challenge, we are currently building a graphical SPARQL query interface, which will intuitively enable query formulation through the navigation of the knowledge graph schema. We are also exploring the application of ProKinO for machine learning-based knowledge discovery and hypotheses generation.</p>
  </sec>
</body>
<back>
  <ack>
    <p>We acknowledge members of the Kannan lab for their valuable comments and suggestions. We additionally acknowledge the various contributions to the databases we utilized made through the efforts of the IDG consortium and numerous investigator-initiated efforts.</p>
  </ack>
  <sec sec-type="additional-information">
    <title>Additional Information and Declarations</title>
    <fn-group content-type="competing-interests">
      <title>Competing Interests</title>
      <fn fn-type="COI-statement" id="conflict-1">
        <p>Natarajan Kannan is an Academic Editor for PeerJ.</p>
      </fn>
    </fn-group>
    <fn-group content-type="author-contributions">
      <title>Author Contributions</title>
      <fn fn-type="con" id="contribution-1">
        <p><xref rid="author-1" ref-type="contrib">Saber Soleymani</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-2">
        <p><xref rid="author-2" ref-type="contrib">Nathan Gravel</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-3">
        <p><xref rid="author-3" ref-type="contrib">Liang-Chin Huang</xref> performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-4">
        <p><xref rid="author-4" ref-type="contrib">Wayland Yeung</xref> analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-5">
        <p><xref rid="author-5" ref-type="contrib">Elika Bozorgi</xref> analyzed the data, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-6">
        <p><xref rid="author-6" ref-type="contrib">Nathaniel G. Bendzunas</xref> analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-7">
        <p><xref rid="author-7" ref-type="contrib">Krzysztof J. Kochut</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-8">
        <p><xref rid="author-8" ref-type="contrib">Natarajan Kannan</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
    </fn-group>
    <fn-group content-type="other">
      <title>Data Availability</title>
      <fn id="addinfo-1">
        <p>The following information was supplied regarding data availability:</p>
        <p>The protein kinase ontology (ProKinO)’s current OWL file and previous versions are available at: <uri xlink:href="https://prokino.uga.edu/downloads.html">https://prokino.uga.edu/downloads.html</uri>.</p>
        <p>Future versions of the ontology also will be placed at the same address.</p>
        <p>The ontology browser is available at <uri xlink:href="https://prokino.uga.edu/browser">https://prokino.uga.edu/browser</uri>. Users can save the results of queries in diagrams or other formats such as CSV.</p>
      </fn>
    </fn-group>
  </sec>
  <ref-list content-type="authoryear">
    <title>References</title>
    <ref id="ref-1">
      <label>Avram et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Avram</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Curpan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Halip</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bora</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Knockel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sirimulla</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>DrugCentral 2021 supports drug discovery and repositioning</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1160</fpage>
        <lpage>D1169</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa997</pub-id>
        <pub-id pub-id-type="pmid">33151287</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-2">
      <label>Bailey et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>McSkimming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Going for broke: targeting the human cancer pseudokinome</article-title>
        <source>Biochemical Journal</source>
        <year iso-8601-date="2015">2015</year>
        <volume>465</volume>
        <issue>2</issue>
        <fpage>195</fpage>
        <lpage>211</lpage>
        <pub-id pub-id-type="doi">10.1042/BJ20141060</pub-id>
        <pub-id pub-id-type="pmid">25559089</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-3">
      <label>Bairoch et al. (2005)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bairoch</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Barker</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Boeckmann</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ferro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Magrane</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The universal protein resource (UniProt)</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2005">2005</year>
        <volume>33</volume>
        <issue>Database issue</issue>
        <fpage>D154</fpage>
        <lpage>D159</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gki070</pub-id>
        <pub-id pub-id-type="pmid">15608167</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-4">
      <label>Benhar, Engelberg &amp; Levitzki (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benhar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Engelberg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Levitzki</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ROS, stress-activated kinases and stress signaling in cancer</article-title>
        <source>EMBO Reports</source>
        <year iso-8601-date="2002">2002</year>
        <volume>3</volume>
        <issue>5</issue>
        <fpage>420</fpage>
        <lpage>425</lpage>
        <pub-id pub-id-type="doi">10.1093/embo-reports/kvf094</pub-id>
        <pub-id pub-id-type="pmid">11991946</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-5">
      <label>Berginski et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berginski</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Moret</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Goldfarb</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>The dark kinase knowledgebase: an online compendium of knowledge and experimental results of understudied kinases</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D529</fpage>
        <lpage>D535</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa853</pub-id>
        <pub-id pub-id-type="pmid">33079988</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-6">
      <label>Berman et al. (2000)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Westbrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gilliland</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Weissig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The protein data bank</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2000">2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-8">
      <label>Bühlmann &amp; Reymond (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bühlmann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reymond</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>ChEMBL-likeness score and database GDBChEMBL</article-title>
        <source>Frontiers in Chemistry</source>
        <year iso-8601-date="2020">2020</year>
        <volume>8</volume>
        <fpage>46</fpage>
        <pub-id pub-id-type="doi">10.3389/fchem.2020.00046</pub-id>
        <pub-id pub-id-type="pmid">32117874</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-7">
      <label>Byrne, Foulkes &amp; Eyers (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Foulkes</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Pseudokinases: update on their functions and evaluation as new drug targets</article-title>
        <source>Future Medicinal Chemistry</source>
        <year iso-8601-date="2017">2017</year>
        <volume>9</volume>
        <issue>2</issue>
        <fpage>245</fpage>
        <lpage>265</lpage>
        <pub-id pub-id-type="doi">10.4155/fmc-2016-0207</pub-id>
        <pub-id pub-id-type="pmid">28097887</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-9">
      <label>Cicenas &amp; Cicenas (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cicenas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cicenas</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Multi-kinase inhibitors, AURKs and cancer</article-title>
        <source>Medical Oncology</source>
        <year iso-8601-date="2016">2016</year>
        <volume>33</volume>
        <issue>5</issue>
        <fpage>43</fpage>
        <pub-id pub-id-type="doi">10.1007/s12032-016-0758-4</pub-id>
        <pub-id pub-id-type="pmid">27038473</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-10">
      <label>Croft et al. (2011)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Croft</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>O’Kelly</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Haw</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gillespie</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Caudy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Garapati</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gopinath</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jassal</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Reactome: a database of reactions, pathways and biological processes</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2011">2011</year>
        <volume>39</volume>
        <issue>Database</issue>
        <fpage>D691</fpage>
        <lpage>D697</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1018</pub-id>
        <pub-id pub-id-type="pmid">21067998</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-11">
      <label>Duncan et al. (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Duncan</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Whittle</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Abell</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Midland</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Zawistowski</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Granger</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Jordan</surname>
            <given-names>NV</given-names>
          </name>
          <name>
            <surname>Darr</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Usary</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuan</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Smalley</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Major</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Hoadley</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sharpless</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Perou</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>WY</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Frye</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Earp</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Graves</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>GL</given-names>
          </name>
        </person-group>
        <article-title>Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer</article-title>
        <source>Cell</source>
        <year iso-8601-date="2012">2012</year>
        <volume>149</volume>
        <issue>2</issue>
        <fpage>307</fpage>
        <lpage>321</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.053</pub-id>
        <pub-id pub-id-type="pmid">22500798</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-12">
      <label>Erika et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Erika</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Federica</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Martina</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Anselmo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Luigi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Marina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Davide</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Eleonora</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Monica</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Silverio</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Old tyrosine kinase inhibitors and newcomers in gastrointestinal cancer treatment</article-title>
        <source>Current Cancer Drug Targets</source>
        <year iso-8601-date="2016">2016</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>185</lpage>
        <pub-id pub-id-type="doi">10.2174/1568009615666150817120712</pub-id>
        <pub-id pub-id-type="pmid">26278713</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-13">
      <label>Eyers, Keeshan &amp; Kannan (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Keeshan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tribbles in the 21st century: the evolving roles of tribbles pseudokinases in biology and disease</article-title>
        <source>Trends in Cell Biology</source>
        <year iso-8601-date="2017">2017</year>
        <volume>27</volume>
        <issue>4</issue>
        <fpage>284</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tcb.2016.11.002</pub-id>
        <pub-id pub-id-type="pmid">27908682</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-14">
      <label>Eyers &amp; Murphy (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Dawn of the dead: protein pseudokinases signal new adventures in cell biology</article-title>
        <source>Biochemical Society Transactions</source>
        <year iso-8601-date="2013">2013</year>
        <volume>41</volume>
        <issue>4</issue>
        <fpage>969</fpage>
        <lpage>974</lpage>
        <pub-id pub-id-type="doi">10.1042/BST20130115</pub-id>
        <pub-id pub-id-type="pmid">23863165</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-15">
      <label>Faezov &amp; Dunbrack (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faezov</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dunbrack</surname>
            <given-names>RL</given-names>
            <suffix>Jr</suffix>
          </name>
        </person-group>
        <article-title>PDBrenum: a webserver and program providing protein data bank files renumbered according to their UniProt sequences</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2021">2021</year>
        <volume>16</volume>
        <issue>7</issue>
        <elocation-id>e0253411</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0253411</pub-id>
        <pub-id pub-id-type="pmid">34228733</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-16">
      <label>Fang et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>ZP</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>XF</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>FB</given-names>
          </name>
        </person-group>
        <article-title>P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma</article-title>
        <source>Acta Pharmacologica Sinica</source>
        <year iso-8601-date="2014">2014</year>
        <volume>35</volume>
        <issue>1</issue>
        <fpage>82</fpage>
        <lpage>88</lpage>
        <pub-id pub-id-type="doi">10.1038/aps.2013.31</pub-id>
        <pub-id pub-id-type="pmid">23685956</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-17">
      <label>Ferguson &amp; Gray (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ferguson</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Kinase inhibitors: the road ahead</article-title>
        <source>Nature Reviews Drug Discovery</source>
        <year iso-8601-date="2018">2018</year>
        <volume>17</volume>
        <issue>5</issue>
        <fpage>353</fpage>
        <lpage>377</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd.2018.21</pub-id>
        <pub-id pub-id-type="pmid">29545548</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-18">
      <label>Foulkes et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Foulkes</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Shrestha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Keeshan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Drewry</surname>
            <given-names>DH</given-names>
          </name>
        </person-group>
        <article-title>Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells</article-title>
        <source>Science Signaling</source>
        <year iso-8601-date="2018">2018</year>
        <volume>11</volume>
        <issue>549</issue>
        <fpage>eaat7951</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aat7951</pub-id>
        <pub-id pub-id-type="pmid">30254057</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-19">
      <label>Gajiwala et al. (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gajiwala</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Christensen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Deshmukh</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Diehl</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>DiNitto</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>English</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Greig</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Y-A</given-names>
          </name>
          <name>
            <surname>Jacques</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2009">2009</year>
        <volume>106</volume>
        <issue>5</issue>
        <fpage>1542</fpage>
        <lpage>1547</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0812413106</pub-id>
        <pub-id pub-id-type="pmid">19164557</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-20">
      <label>Goldberg et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goldberg</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Griggs</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Haas</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Wortman</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Kinannote, a computer program to identify and classify members of the eukaryotic protein kinase superfamily</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2013">2013</year>
        <volume>29</volume>
        <issue>19</issue>
        <fpage>2387</fpage>
        <lpage>2394</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt419</pub-id>
        <pub-id pub-id-type="pmid">23904509</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-21">
      <label>Gosal, Kannan &amp; Kochut (2011)</label>
      <element-citation publication-type="confproc">
        <person-group person-group-type="author">
          <name>
            <surname>Gosal</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a framework for protein kinase ontology</article-title>
        <year iso-8601-date="2011">2011</year>
        <conf-name>Proceedings of the IEEE International Conference on Bioinformatics &amp; Biomedicine, Atlanta, Georgia</conf-name>
        <publisher-loc>Piscataway</publisher-loc>
        <publisher-name>IEEE</publisher-name>
        <fpage>550</fpage>
        <lpage>555</lpage>
      </element-citation>
    </ref>
    <ref id="ref-22">
      <label>Gosal, Kochut &amp; Kannan (2011)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gosal</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: an ontology for integrative analysis of protein kinases in cancer</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2011">2011</year>
        <volume>6</volume>
        <issue>12</issue>
        <elocation-id>e28782</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0028782</pub-id>
        <pub-id pub-id-type="pmid">22194913</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-23">
      <label>Han et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>KF</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>PAK5 overexpression is associated with lung metastasis in osteosarcoma</article-title>
        <source>Oncology Letters</source>
        <year iso-8601-date="2018">2018</year>
        <volume>15</volume>
        <fpage>2202</fpage>
        <lpage>2210</lpage>
        <pub-id pub-id-type="doi">10.3892/ol.2017.7545</pub-id>
        <pub-id pub-id-type="pmid">29434926</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-24">
      <label>Hanks &amp; Hunter (1995)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanks</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</article-title>
        <source>FASEB Journal</source>
        <year iso-8601-date="1995">1995</year>
        <volume>9</volume>
        <fpage>576</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="doi">10.1096/fasebj.9.8.7768349</pub-id>
        <pub-id pub-id-type="pmid">7768349</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-25">
      <label>Hu et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ahuja</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Meharena</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Kinase regulation by hydrophobic spine assembly in cancer</article-title>
        <source>Molecular and Cellular Biology</source>
        <year iso-8601-date="2015">2015</year>
        <volume>35</volume>
        <issue>1</issue>
        <fpage>264</fpage>
        <lpage>276</lpage>
        <pub-id pub-id-type="doi">10.1128/MCB.00943-14</pub-id>
        <pub-id pub-id-type="pmid">25348715</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-26">
      <label>Huang et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Baffi</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Drabkin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>D’Eustachio</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>McSkimming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Arighi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Natale</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gaudet</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Newton</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resources</article-title>
        <source>Scientific Reports</source>
        <year iso-8601-date="2018">2018</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>6518</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-24457-1</pub-id>
        <pub-id pub-id-type="pmid">29695735</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-27">
      <label>Huang et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gravel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Venkat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>KinOrtho: a method for mapping human kinase orthologs across the tree of life and illuminating understudied kinases</article-title>
        <source>BMC Bioinformatics</source>
        <year iso-8601-date="2021">2021</year>
        <volume>22</volume>
        <issue>1</issue>
        <fpage>446</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-021-04358-3</pub-id>
        <pub-id pub-id-type="pmid">34537014</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-28">
      <label>Huang et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Venkat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rasheed</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Quantitative structure-mutation-activity relationship tests (QSMART) model for protein kinase inhibitor response prediction</article-title>
        <source>BMC Bioinformatics</source>
        <year iso-8601-date="2020">2020</year>
        <volume>21</volume>
        <issue>1</issue>
        <fpage>520</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-020-03842-6</pub-id>
        <pub-id pub-id-type="pmid">33183223</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-29">
      <label>Huo et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1</article-title>
        <source>Cell Death and Differentiation</source>
        <year iso-8601-date="2019">2019</year>
        <volume>26</volume>
        <issue>6</issue>
        <fpage>994</fpage>
        <lpage>1006</lpage>
        <pub-id pub-id-type="doi">10.1038/s41418-018-0178-4</pub-id>
        <pub-id pub-id-type="pmid">30082769</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-30">
      <label>Huse &amp; Kuriyan (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huse</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kuriyan</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The conformational plasticity of protein kinases</article-title>
        <source>Cell</source>
        <year iso-8601-date="2002">2002</year>
        <volume>109</volume>
        <issue>3</issue>
        <fpage>275</fpage>
        <lpage>282</lpage>
        <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00741-9</pub-id>
        <pub-id pub-id-type="pmid">12015977</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-31">
      <label>Joensuu et al. (2001)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Joensuu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Sarlomo-Rikala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Andersson</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Tervahartiala</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tuveson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Silberman</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Capdeville</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dimitrijevic</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Druker</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
        </person-group>
        <article-title>Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor</article-title>
        <source>New England Journal of Medicine</source>
        <year iso-8601-date="2001">2001</year>
        <volume>344</volume>
        <issue>14</issue>
        <fpage>1052</fpage>
        <lpage>1056</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJM200104053441404</pub-id>
        <pub-id pub-id-type="pmid">11287975</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-32">
      <label>Jumper et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jumper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pritzel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Figurnov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ronneberger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Tunyasuvunakool</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Žídek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Potapenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bridgland</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kohl</surname>
            <given-names>SAA</given-names>
          </name>
          <name>
            <surname>Ballard</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Romera-Paredes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nikolov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Back</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reiman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zielinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinegger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pacholska</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Berghammer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bodenstein</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Silver</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vinyals</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Senior</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Kavukcuoglu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kohli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hassabis</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>
        <source>Nature</source>
        <year iso-8601-date="2021">2021</year>
        <volume>596</volume>
        <issue>7873</issue>
        <fpage>583</fpage>
        <lpage>589</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
        <pub-id pub-id-type="pmid">34265844</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-33">
      <label>Kanev et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanev</surname>
            <given-names>GK</given-names>
          </name>
          <name>
            <surname>de Graaf</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Westerman</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>de Esch</surname>
            <given-names>IJP</given-names>
          </name>
          <name>
            <surname>Kooistra</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>KLIFS: an overhaul after the first 5 years of supporting kinase research</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D562</fpage>
        <lpage>D569</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa895</pub-id>
        <pub-id pub-id-type="pmid">33084889</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-34">
      <label>Kim, Song &amp; Haura (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Haura</surname>
            <given-names>EB</given-names>
          </name>
        </person-group>
        <article-title>Src kinases as therapeutic targets for cancer</article-title>
        <source>Nature Reviews Clinical Oncology</source>
        <year iso-8601-date="2009">2009</year>
        <volume>6</volume>
        <issue>10</issue>
        <fpage>587</fpage>
        <lpage>595</lpage>
        <pub-id pub-id-type="doi">10.1038/nrclinonc.2009.129</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-35">
      <label>Knighton et al. (1991)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knighton</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Ten Eyck</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Ashford</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Xuong</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Sowadski</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</article-title>
        <source>Science</source>
        <year iso-8601-date="1991">1991</year>
        <volume>253</volume>
        <issue>5018</issue>
        <fpage>407</fpage>
        <lpage>414</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1862342</pub-id>
        <pub-id pub-id-type="pmid">1862342</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-36">
      <label>Koleti et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Terryn</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Stathias</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Forlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>D’Urso</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Torre</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jagodnik</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Mader</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fazel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mahi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pilarczyk</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Shamsaei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Meller</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vasiliauskas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Reichard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Medvedovic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pillai</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Data portal for the library of integrated network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D558</fpage>
        <lpage>D566</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1063</pub-id>
        <pub-id pub-id-type="pmid">29140462</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-37">
      <label>Kornev &amp; Taylor (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Dynamics-driven allostery in protein kinases</article-title>
        <source>Trends in Biochemical Sciences</source>
        <year iso-8601-date="2015">2015</year>
        <volume>40</volume>
        <issue>11</issue>
        <fpage>628</fpage>
        <lpage>647</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tibs.2015.09.002</pub-id>
        <pub-id pub-id-type="pmid">26481499</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-38">
      <label>Kwon et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tracing the origin and evolution of pseudokinases across the tree of life</article-title>
        <source>Science Signaling</source>
        <year iso-8601-date="2019">2019</year>
        <volume>12</volume>
        <issue>578</issue>
        <fpage>289</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aav3810</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-39">
      <label>Li &amp; Jones (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>SJ</given-names>
          </name>
        </person-group>
        <article-title>Drug repositioning for personalized medicine</article-title>
        <source>Genome Medicine</source>
        <year iso-8601-date="2012">2012</year>
        <volume>4</volume>
        <issue>3</issue>
        <fpage>27</fpage>
        <pub-id pub-id-type="doi">10.1186/gm326</pub-id>
        <pub-id pub-id-type="pmid">22494857</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-40">
      <label>Li et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XX</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>YZ</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1121</fpage>
        <lpage>D1127</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1076</pub-id>
        <pub-id pub-id-type="pmid">29140520</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-41">
      <label>Lin et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Küçük-McGinty</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Forlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Stathias</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nabizadeh</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mader</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Visser</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Drug target ontology to classify and integrate drug discovery data</article-title>
        <source>Journal of Biomedical Semantics</source>
        <year iso-8601-date="2017">2017</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>50</fpage>
        <pub-id pub-id-type="doi">10.1186/s13326-017-0161-x</pub-id>
        <pub-id pub-id-type="pmid">29122012</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-42">
      <label>Liu, Liang &amp; Zhang (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>XC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Culturing Schwann cells from neonatal rats by improved enzyme digestion combined with explants-culture method</article-title>
        <source>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</source>
        <year iso-8601-date="2016">2016</year>
        <volume>38</volume>
        <fpage>388</fpage>
        <lpage>392</lpage>
        <pub-id pub-id-type="doi">10.3881/j.issn.1000-503X.2016.04.004</pub-id>
        <pub-id pub-id-type="pmid">27594149</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-43">
      <label>Lubner et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lubner</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Dodge-Kafka</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Cushing’s syndrome mutant PKA(L)(205R) exhibits altered substrate specificity</article-title>
        <source>FEBS Letters</source>
        <year iso-8601-date="2017">2017</year>
        <volume>591</volume>
        <issue>3</issue>
        <fpage>459</fpage>
        <lpage>467</lpage>
        <pub-id pub-id-type="doi">10.1002/1873-3468.12562</pub-id>
        <pub-id pub-id-type="pmid">28100013</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-44">
      <label>ManChon et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>ManChon</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rasheed</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Prediction and prioritization of rare oncogenic mutations in the cancer kinome using novel features and multiple classifiers</article-title>
        <source>PLOS Computational Biology</source>
        <year iso-8601-date="2014">2014</year>
        <volume>10</volume>
        <issue>4</issue>
        <elocation-id>e1003545</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003545</pub-id>
        <pub-id pub-id-type="pmid">24743239</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-45">
      <label>Manning et al. (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Manning</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Whyte</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sudarsanam</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The protein kinase complement of the human genome</article-title>
        <source>Science</source>
        <year iso-8601-date="2002">2002</year>
        <volume>298</volume>
        <issue>5600</issue>
        <fpage>1912</fpage>
        <lpage>1934</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1075762</pub-id>
        <pub-id pub-id-type="pmid">12471243</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-46">
      <label>McClendon et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McClendon</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Gilson</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Dynamic architecture of a protein kinase</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2014">2014</year>
        <volume>111</volume>
        <issue>43</issue>
        <fpage>E4623</fpage>
        <lpage>E4631</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1418402111</pub-id>
        <pub-id pub-id-type="pmid">25319261</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-47">
      <label>McSkimming et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Baffi</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Newton</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>KinView: a visual comparative sequence analysis tool for integrated kinome research</article-title>
        <source>Molecular Biosystems</source>
        <year iso-8601-date="2016">2016</year>
        <volume>12</volume>
        <issue>12</issue>
        <fpage>3651</fpage>
        <lpage>3665</lpage>
        <pub-id pub-id-type="doi">10.1039/C6MB00466K</pub-id>
        <pub-id pub-id-type="pmid">27731453</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-48">
      <label>McSkimming et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a unified resource for mining the cancer kinome</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2014">2014</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>186</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22726</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-49">
      <label>McSkimming et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a unified resource for mining the cancer kinome</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2015">2015</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>186</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22726</pub-id>
        <pub-id pub-id-type="pmid">25382819</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-50">
      <label>Meharena et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meharena</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Keshwani</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nene</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Deciphering the structural basis of eukaryotic protein kinase regulation</article-title>
        <source>PLOS Biology</source>
        <year iso-8601-date="2013">2013</year>
        <volume>11</volume>
        <issue>10</issue>
        <elocation-id>e1001680</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pbio.1001680</pub-id>
        <pub-id pub-id-type="pmid">24143133</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-51">
      <label>Mohanty et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mohanty</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kwon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Hanold</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Hydrophobic core variations provide a structural framework for tyrosine kinase evolution and functional specialization</article-title>
        <source>PLOS Genetics</source>
        <year iso-8601-date="2016">2016</year>
        <volume>12</volume>
        <issue>2</issue>
        <elocation-id>e1005885</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1005885</pub-id>
        <pub-id pub-id-type="pmid">26925779</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-52">
      <label>Moret et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moret</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gyori</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Bachman</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Steppi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hug</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Berginski</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>A resource for exploring the understudied human kinome for research and therapeutic opportunities</article-title>
        <source>BioRxiv</source>
        <year iso-8601-date="2021">2021</year>
        <pub-id pub-id-type="doi">10.1101/2020.04.02.022277</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-53">
      <label>Murphy, Mace &amp; Eyers (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murphy</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Mace</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Live and let die: insights into pseudoenzyme mechanisms from structure</article-title>
        <source>Current Opinion in Structural Biology</source>
        <year iso-8601-date="2017">2017</year>
        <volume>47</volume>
        <fpage>95</fpage>
        <lpage>104</lpage>
        <pub-id pub-id-type="doi">10.1016/j.sbi.2017.07.004</pub-id>
        <pub-id pub-id-type="pmid">28787627</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-54">
      <label>Neuwald (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Neuwald</surname>
            <given-names>AF</given-names>
          </name>
        </person-group>
        <article-title>Rapid detection, classification and accurate alignment of up to a million or more related protein sequences</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2009">2009</year>
        <volume>25</volume>
        <fpage>1869</fpage>
        <lpage>1875</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp342</pub-id>
        <pub-id pub-id-type="pmid">19505947</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-55">
      <label>Nguyen et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gaulton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hersey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Karlsson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mandava</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Overington</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rouillard</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Schurer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sheils</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Simeonov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jadhav</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Pharos: collating protein information to shed light on the druggable genome</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2017">2017</year>
        <volume>45</volume>
        <fpage>D995</fpage>
        <lpage>D1002</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw1072</pub-id>
        <pub-id pub-id-type="pmid">27903890</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-56">
      <label>Nguyen et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Co-conserved MAPK features couple D-domain docking groove to distal allosteric sites via the C-terminal flanking tail</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2015">2015</year>
        <volume>10</volume>
        <issue>3</issue>
        <elocation-id>e0119636</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0119636</pub-id>
        <pub-id pub-id-type="pmid">25799139</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-57">
      <label>Niepel et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niepel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hafner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Paull</surname>
            <given-names>EO</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Golub</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
        </person-group>
        <article-title>Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling</article-title>
        <source>Nature Communications</source>
        <year iso-8601-date="2017">2017</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>1186</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-017-01383-w</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-58">
      <label>Oruganty &amp; Kannan (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Design principles underpinning the regulatory diversity of protein kinases</article-title>
        <source>Philosophical Transactions of the Royal Society B: Biological Sciences</source>
        <year iso-8601-date="2012">2012</year>
        <volume>367</volume>
        <issue>1602</issue>
        <fpage>2529</fpage>
        <lpage>2539</lpage>
        <pub-id pub-id-type="doi">10.1098/rstb.2012.0015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-59">
      <label>Oruganty &amp; Kannan (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year iso-8601-date="2013">2013</year>
        <volume>1834</volume>
        <issue>7</issue>
        <fpage>1322</fpage>
        <lpage>1329</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbapap.2013.02.040</pub-id>
        <pub-id pub-id-type="pmid">23499783</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-60">
      <label>Patani et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Patani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bunney</surname>
            <given-names>TD</given-names>
          </name>
          <name>
            <surname>Thiyagarajan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Norman</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Ogg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Breed</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ashford</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Potterton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Edwards</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Knowles</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Breeze</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Orengo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Phillips</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Katan</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use</article-title>
        <source>Oncotarget</source>
        <year iso-8601-date="2016">2016</year>
        <volume>7</volume>
        <issue>17</issue>
        <fpage>24252</fpage>
        <lpage>24268</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.8132</pub-id>
        <pub-id pub-id-type="pmid">26992226</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-61">
      <label>Quan et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Jiao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Prognostic significance of PAK family kinases in acute myeloid leukemia</article-title>
        <source>Cancer Gene Therapy</source>
        <year iso-8601-date="2020">2020</year>
        <volume>27</volume>
        <issue>1–2</issue>
        <fpage>30</fpage>
        <lpage>37</lpage>
        <pub-id pub-id-type="doi">10.1038/s41417-019-0090-1</pub-id>
        <pub-id pub-id-type="pmid">30890765</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-62">
      <label>Ruan &amp; Kannan (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Mechanistic insights into R776H mediated activation of epidermal growth factor receptor kinase</article-title>
        <source>Biochemistry</source>
        <year iso-8601-date="2015">2015</year>
        <volume>54</volume>
        <issue>27</issue>
        <fpage>4216</fpage>
        <lpage>4225</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.biochem.5b00444</pub-id>
        <pub-id pub-id-type="pmid">26101090</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-63">
      <label>Ruan, Katiyar &amp; Kannan (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Computational and experimental characterization of patient derived mutations reveal an unusual mode of regulatory spine assembly and drug sensitivity in EGFR kinase</article-title>
        <source>Biochemistry</source>
        <year iso-8601-date="2017">2017</year>
        <volume>56</volume>
        <issue>1</issue>
        <fpage>22</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.biochem.6b00572</pub-id>
        <pub-id pub-id-type="pmid">27936599</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-64">
      <label>Sheils et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheils</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Kelleher</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Siramshetty</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Vidović</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Dharkar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mathé</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Simeonov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>TCRD and Pharos 2021: mining the human proteome for disease biology</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1334</fpage>
        <lpage>D1346</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa993</pub-id>
        <pub-id pub-id-type="pmid">33156327</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-65">
      <label>Sheils et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheils</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Siramshetty</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>How to illuminate the druggable genome using Pharos</article-title>
        <source>Current Protocols in Bioinformatics</source>
        <year iso-8601-date="2020">2020</year>
        <volume>69</volume>
        <issue>1</issue>
        <elocation-id>e92</elocation-id>
        <pub-id pub-id-type="doi">10.1002/cpbi.92</pub-id>
        <pub-id pub-id-type="pmid">31898878</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-66">
      <label>Simonetti et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simonetti</surname>
            <given-names>FL</given-names>
          </name>
          <name>
            <surname>Tornador</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nabau-Moreto</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Molina-Vila</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Marino-Buslje</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Kin-Driver: a database of driver mutations in protein kinases</article-title>
        <source>Database</source>
        <year iso-8601-date="2014">2014</year>
        <volume>2014</volume>
        <fpage>bau104</fpage>
        <pub-id pub-id-type="doi">10.1093/database/bau104</pub-id>
        <pub-id pub-id-type="pmid">25414382</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-67">
      <label>Soleymani et al. (2022)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Soleymani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gravel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bozorgi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bendzunas</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Dark kinase annotation, mining and visualization using the protein kinase ontology</article-title>
        <source>BioRxiv</source>
        <year iso-8601-date="2022">2022</year>
        <pub-id pub-id-type="doi">10.1101/2022.02.25.482021</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-68">
      <label>Tate et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tate</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Bamford</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jubb</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Sondka</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Beare</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Bindal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Boutselakis</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cole</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Creatore</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dawson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fish</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Harsha</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hathaway</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jupe</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ponting</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ramshaw</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Rye</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Speedy</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Stefancsik</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>SA</given-names>
          </name>
        </person-group>
        <article-title>COSMIC: the catalogue of somatic mutations in cancer</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D941</fpage>
        <lpage>D947</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-69">
      <label>Taylor et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Integration of signaling in the kinome: architecture and regulation of the alphaC Helix</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year iso-8601-date="2015">2015</year>
        <volume>1854</volume>
        <issue>10</issue>
        <fpage>1567</fpage>
        <lpage>1574</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbapap.2015.04.007</pub-id>
        <pub-id pub-id-type="pmid">25891902</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-70">
      <label>Tunyasuvunakool et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tunyasuvunakool</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zielinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Žídek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bridgland</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Laydon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Velankar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kleywegt</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pritzel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Figurnov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ronneberger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kohl</surname>
            <given-names>SAA</given-names>
          </name>
          <name>
            <surname>Potapenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ballard</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Romera-Paredes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nikolov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Reiman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Senior</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Kavukcuoglu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Birney</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kohli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jumper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hassabis</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Highly accurate protein structure prediction for the human proteome</article-title>
        <source>Nature</source>
        <year iso-8601-date="2021">2021</year>
        <volume>596</volume>
        <issue>7873</issue>
        <fpage>590</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>
        <pub-id pub-id-type="pmid">34293799</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-71">
      <label>Vazquez et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vazquez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pons</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Valencia</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Izarzugaza</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>wKinMut-2: identification and interpretation of pathogenic variants in human protein kinases</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2016">2016</year>
        <volume>37</volume>
        <issue>1</issue>
        <fpage>36</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22914</pub-id>
        <pub-id pub-id-type="pmid">26443060</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-72">
      <label>Watkins et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Watkins</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Pundir</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>MJ</given-names>
          </name>
          <collab>UniProt Consortium</collab>
        </person-group>
        <article-title>ProtVista: visualization of protein sequence annotations</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2017">2017</year>
        <volume>33</volume>
        <fpage>2040</fpage>
        <lpage>2041</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx120</pub-id>
        <pub-id pub-id-type="pmid">28334231</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-73">
      <label>Wilkinson et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilkinson</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Dumontier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aalbersberg</surname>
            <given-names>IJ</given-names>
          </name>
          <name>
            <surname>Appleton</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Axton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baak</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blomberg</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Boiten</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>da Silva Santos</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Bouwman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brookes</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Crosas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dillo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Dumon</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Edmunds</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Evelo</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Finkers</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gonzalez-Beltran</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Groth</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Goble</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Grethe</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Heringa</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>t Hoen</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Hooft</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lusher</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Martone</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Mons</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Packer</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Persson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rocca-Serra</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Roos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van Schaik</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sansone</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Schultes</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sengstag</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Slater</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Strawn</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Swertz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van der Lei</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van Mulligen</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Velterop</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Waagmeester</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wittenburg</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wolstencroft</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mons</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The FAIR guiding principles for scientific data management and stewardship</article-title>
        <source>Scientific Data</source>
        <year iso-8601-date="2016">2016</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>160018</fpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2016.18</pub-id>
        <pub-id pub-id-type="pmid">26978244</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-74">
      <label>Wishart et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wishart</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Feunang</surname>
            <given-names>YD</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Lo</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Marcu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Sajed</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sayeeda</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Assempour</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Iynkkaran</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Maciejewski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gale</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Knox</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
        <pub-id pub-id-type="pmid">29126136</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-75">
      <label>Yang et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Soares</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Greninger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Edelman</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Lightfoot</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bindal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Beare</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>IR</given-names>
          </name>
          <name>
            <surname>Ramaswamy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Futreal</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Haber</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Stratton</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Benes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>McDermott</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Garnett</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2013">2013</year>
        <volume>41</volume>
        <issue>D1</issue>
        <fpage>D955</fpage>
        <lpage>D961</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1111</pub-id>
        <pub-id pub-id-type="pmid">23180760</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-76">
      <label>Yonemoto et al. (1993)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yonemoto</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Garrod</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase</article-title>
        <source>Journal of Biological Chemistry</source>
        <year iso-8601-date="1993">1993</year>
        <volume>268</volume>
        <issue>25</issue>
        <fpage>18626</fpage>
        <lpage>18632</lpage>
        <pub-id pub-id-type="doi">10.1016/S0021-9258(17)46675-0</pub-id>
        <pub-id pub-id-type="pmid">8395513</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-77">
      <label>Yun et al. (2008)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yun</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Mengwasser</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Toms</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Woo</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Greulich</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>K-K</given-names>
          </name>
          <name>
            <surname>Meyerson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eck</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2008">2008</year>
        <volume>105</volume>
        <issue>6</issue>
        <fpage>2070</fpage>
        <lpage>2075</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0709662105</pub-id>
        <pub-id pub-id-type="pmid">18227510</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-78">
      <label>Zhang et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Huo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo</article-title>
        <source>Journal of Experimental &amp; Clinical Cancer Research</source>
        <year iso-8601-date="2017">2017</year>
        <volume>36</volume>
        <issue>1</issue>
        <fpage>146</fpage>
        <pub-id pub-id-type="doi">10.1186/s13046-017-0610-5</pub-id>
        <pub-id pub-id-type="pmid">29041983</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-79">
      <label>Zhang, Yang &amp; Gray (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Targeting cancer with small molecule kinase inhibitors</article-title>
        <source>Nature Reviews Cancer</source>
        <year iso-8601-date="2009">2009</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>28</fpage>
        <lpage>39</lpage>
        <pub-id pub-id-type="doi">10.1038/nrc2559</pub-id>
        <pub-id pub-id-type="pmid">19104514</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
    <journal-id journal-id-type="iso-abbrev">PeerJ</journal-id>
    <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
    <journal-title-group>
      <journal-title>PeerJ</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2167-8359</issn>
    <publisher>
      <publisher-name>PeerJ Inc.</publisher-name>
      <publisher-loc>San Diego, USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10704995</article-id>
    <article-id pub-id-type="publisher-id">16087</article-id>
    <article-id pub-id-type="doi">10.7717/peerj.16087</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Biochemistry</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Bioinformatics</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Biology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Science</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Data Science</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Dark kinase annotation, mining, and visualization using the Protein Kinase Ontology</article-title>
    </title-group>
    <contrib-group>
      <contrib id="author-1" contrib-type="author">
        <name>
          <surname>Soleymani</surname>
          <given-names>Saber</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
      </contrib>
      <contrib id="author-2" contrib-type="author">
        <name>
          <surname>Gravel</surname>
          <given-names>Nathan</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-3" contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Liang-Chin</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-4" contrib-type="author">
        <name>
          <surname>Yeung</surname>
          <given-names>Wayland</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
      </contrib>
      <contrib id="author-5" contrib-type="author">
        <name>
          <surname>Bozorgi</surname>
          <given-names>Elika</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
      </contrib>
      <contrib id="author-6" contrib-type="author">
        <name>
          <surname>Bendzunas</surname>
          <given-names>Nathaniel G.</given-names>
        </name>
        <xref rid="aff-3" ref-type="aff">3</xref>
      </contrib>
      <contrib id="author-7" contrib-type="author" corresp="yes">
        <name>
          <surname>Kochut</surname>
          <given-names>Krzysztof J.</given-names>
        </name>
        <xref rid="aff-1" ref-type="aff">1</xref>
        <email>kkochut@uga.edu</email>
      </contrib>
      <contrib id="author-8" contrib-type="author" corresp="yes">
        <name>
          <surname>Kannan</surname>
          <given-names>Natarajan</given-names>
        </name>
        <xref rid="aff-2" ref-type="aff">2</xref>
        <xref rid="aff-3" ref-type="aff">3</xref>
        <email>nkannan@uga.edu</email>
      </contrib>
      <aff id="aff-1"><label>1</label><institution>Department of Computer Science, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
      <aff id="aff-2"><label>2</label><institution>Institute of Bioinformatics, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
      <aff id="aff-3"><label>3</label><institution>Department of Biochemistry and Molecular Biology, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Góes-Neto</surname>
          <given-names>Aristóteles</given-names>
        </name>
      </contrib>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>12</month>
      <year iso-8601-date="2023">2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>11</volume>
    <elocation-id>e16087</elocation-id>
    <history>
      <date date-type="received" iso-8601-date="2023-04-05">
        <day>5</day>
        <month>4</month>
        <year iso-8601-date="2023">2023</year>
      </date>
      <date date-type="accepted" iso-8601-date="2023-08-22">
        <day>22</day>
        <month>8</month>
        <year iso-8601-date="2023">2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 Soleymani et al.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Soleymani et al.</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="https://peerj.com/articles/16087"/>
    <abstract>
      <p>The Protein Kinase Ontology (ProKinO) is an integrated knowledge graph that conceptualizes the complex relationships among protein kinase sequence, structure, function, and disease in a human and machine-readable format. In this study, we have significantly expanded ProKinO by incorporating additional data on expression patterns and drug interactions. Furthermore, we have developed a completely new browser from the ground up to render the knowledge graph visible and interactive on the web. We have enriched ProKinO with new classes and relationships that capture information on kinase ligand binding sites, expression patterns, and functional features. These additions extend ProKinO’s capabilities as a discovery tool, enabling it to uncover novel insights about understudied members of the protein kinase family. We next demonstrate the application of ProKinO. Specifically, through graph mining and aggregate SPARQL queries, we identify the p21-activated protein kinase 5 (PAK5) as one of the most frequently mutated dark kinases in human cancers with abnormal expression in multiple cancers, including a previously unappreciated role in acute myeloid leukemia. We have identified recurrent oncogenic mutations in the PAK5 activation loop predicted to alter substrate binding and phosphorylation. Additionally, we have identified common ligand/drug binding residues in PAK family kinases, underscoring ProKinO’s potential application in drug discovery. The updated ontology browser and the addition of a web component, ProtVista, which enables interactive mining of kinase sequence annotations in 3D structures and Alphafold models, provide a valuable resource for the signaling community. The updated ProKinO database is accessible at <uri xlink:href="https://prokino.uga.edu">https://prokino.uga.edu</uri>.</p>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Curation</kwd>
      <kwd>User interface</kwd>
      <kwd>Drug discovery</kwd>
      <kwd>Cell signaling</kwd>
      <kwd>Protein structure</kwd>
      <kwd>Protein function</kwd>
      <kwd>Network biology</kwd>
      <kwd>Cancer genomes</kwd>
    </kwd-group>
    <funding-group>
      <award-group id="fund-1">
        <funding-source>National Institutes of Health</funding-source>
        <award-id>U01CA239106 and R35 GM139656</award-id>
      </award-group>
      <funding-statement>This work was supported by the National Institutes of Health (U01CA239106 and R35 GM139656) to Natarajan Kannan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>The protein kinase gene family with nearly 535 human members (collectively called the human kinome) is a biomedically important gene family associated with many human diseases such as cancer, diabetes, Alzheimer’s disease, Parkinson’s disease, and inflammatory disorders. They make up one-third of all drug-related protein target discoveries in the pharmaceutical industry, with over 50 FDA-approved drugs developed since 2001 (<xref rid="ref-17" ref-type="bibr">Ferguson &amp; Gray, 2018</xref>; <xref rid="ref-79" ref-type="bibr">Zhang, Yang &amp; Gray, 2009</xref>). However, despite decades of research on the protein kinase family, our current knowledge of the kinome is skewed towards a subset of well-studied kinases with nearly one-third of the kinome largely understudied. These understudied kinases, collectively referred to as the “dark” kinome by the Knowledge Management Center (KMC) (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>) within the Illuminating the Druggable Genome (IDG) consortium, constitute both active kinases and inactive pseudokinases, which lack one or more of the active site residues, but perform important scaffolding and regulatory roles in signaling pathways (<xref rid="ref-7" ref-type="bibr">Byrne, Foulkes &amp; Eyers, 2017</xref>; <xref rid="ref-13" ref-type="bibr">Eyers, Keeshan &amp; Kannan, 2017</xref>; <xref rid="ref-14" ref-type="bibr">Eyers &amp; Murphy, 2013</xref>; <xref rid="ref-53" ref-type="bibr">Murphy, Mace &amp; Eyers, 2017</xref>) and are druggable (<xref rid="ref-18" ref-type="bibr">Foulkes et al., 2018</xref>). Incomplete knowledge of the structure, function, and regulation of these understudied kinases and pseudokinases presents a major bottleneck for drug discovery efforts. While multiple initiatives are beginning to generate essential tools and resources to characterize dark kinases, integrative mining of these datasets is necessary to develop new testable hypotheses on dark kinase functions. However, integrative mining of protein kinase data is a challenge because of the diverse and disparate nature of protein kinase data sources and formats. Information on the structural and functional aspects of dark kinases, for example, is scattered in the literature posing unique challenges for researchers interested in formulating routine queries such as “disease mutations mapping to conserved structural and functional regions of the kinome” or “post-translational modifications (PTMs) in the activation loop of dark kinases.” Formulating such aggregate queries requires researchers to go through the often time-consuming and error-prone process of collating information from various data sources through customized computer programs, which results in duplication of efforts across laboratories, and does not scale well with the growing complexity and diversity of protein kinase data. For these reasons, the IDG consortium has developed a unified resource, Pharos, for collating diverse forms of information on druggable proteins, including protein kinases (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>; <xref rid="ref-65" ref-type="bibr">Sheils et al., 2020</xref>, <xref rid="ref-64" ref-type="bibr">2021</xref>). A focused Dark Kinase Knowledgebase has also been developed to make experimental data available on dark kinases to the broader research community (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>; <xref rid="ref-52" ref-type="bibr">Moret et al., 2021</xref>). While these unified resources provide a wide range of valuable information on druggable proteins, they offer limited data analytics capabilities in mining sequence and structural data. They do not conceptualize protein kinases’ detailed structural and functional knowledge in a practical and understandable way for protein kinase researchers. Thus, to accelerate the biochemical characterization of understudied dark kinases, a semantically meaningful and mineable representation of the kinase knowledge base is needed (<xref rid="fig-1" ref-type="fig">Fig. 1</xref>).</p>
    <fig position="float" id="fig-1">
      <object-id pub-id-type="doi">10.7717/peerj.16087/fig-1</object-id>
      <label>Figure 1</label>
      <caption>
        <title>The ProKinO architecture and work-flow.</title>
        <p>(A) A subset of curated data sources used in ontology population. (B) A schematic of the ontology schema with classes (boxes) and relationships (lines) connecting the classes. (C) Applications for ontology browsing and navigation.</p>
      </caption>
      <graphic xlink:href="peerj-11-16087-g001" position="float"/>
    </fig>
    <p>To semantically represent protein kinase data in ways protein kinase researchers use and understand, we previously reported the development of a focused protein kinase ontology, ProKinO (<xref rid="ref-21" ref-type="bibr">Gosal, Kannan &amp; Kochut, 2011</xref>; <xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>; <xref rid="ref-49" ref-type="bibr">McSkimming et al., 2015</xref>), which integrates and conceptualizes diverse forms of protein kinase data in computer- and human-readable format (<xref rid="fig-2" ref-type="fig">Fig. 2</xref>). The ontology is instantiated with curated data from internal and external sources and enables aggregate queries linking diverse forms of data in one place. ProKinO enables the generation of new knowledge regarding kinases and pathways altered in various cancer types, and new testable hypotheses regarding the structural and functional impact of disease mutations (<xref rid="ref-2" ref-type="bibr">Bailey et al., 2015</xref>; <xref rid="ref-9" ref-type="bibr">Cicenas &amp; Cicenas, 2016</xref>; <xref rid="ref-20" ref-type="bibr">Goldberg et al., 2013</xref>; <xref rid="ref-21" ref-type="bibr">Gosal, Kannan &amp; Kochut, 2011</xref>; <xref rid="ref-25" ref-type="bibr">Hu et al., 2015</xref>; <xref rid="ref-42" ref-type="bibr">Liu, Liang &amp; Zhang, 2016</xref>; <xref rid="ref-46" ref-type="bibr">McClendon et al., 2014</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>, <xref rid="ref-48" ref-type="bibr">2014</xref>, <xref rid="ref-49" ref-type="bibr">2015</xref>; <xref rid="ref-50" ref-type="bibr">Meharena et al., 2013</xref>; <xref rid="ref-51" ref-type="bibr">Mohanty et al., 2016</xref>; <xref rid="ref-56" ref-type="bibr">Nguyen et al., 2015</xref>; <xref rid="ref-59" ref-type="bibr">Oruganty &amp; Kannan, 2013</xref>; <xref rid="ref-62" ref-type="bibr">Ruan &amp; Kannan, 2015</xref>; <xref rid="ref-66" ref-type="bibr">Simonetti et al., 2014</xref>; <xref rid="ref-69" ref-type="bibr">Taylor et al., 2015</xref>; <xref rid="ref-44" ref-type="bibr">ManChon et al., 2014</xref>; <xref rid="ref-71" ref-type="bibr">Vazquez et al., 2016</xref>). For example, through iterative ProKinO queries and follow-up experimental studies, we identified oncogenic mutations associated with abnormal protein kinase activation and drug sensitivity (<xref rid="ref-43" ref-type="bibr">Lubner et al., 2017</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>, <xref rid="ref-49" ref-type="bibr">2015</xref>; <xref rid="ref-51" ref-type="bibr">Mohanty et al., 2016</xref>; <xref rid="ref-60" ref-type="bibr">Patani et al., 2016</xref>; <xref rid="ref-62" ref-type="bibr">Ruan &amp; Kannan, 2015</xref>; <xref rid="ref-63" ref-type="bibr">Ruan, Katiyar &amp; Kannan, 2017</xref>). We have also employed federated queries linking ProKinO with other widely used ontologies and resources such as the Protein Ontology (PRO), neXtProt, Reactome, and the Mouse Genome Informatics (MGI) to prioritize understudied dark kinases for functional studies and generate testable hypotheses regarding post-translational modification and cancer mutations (<xref rid="ref-26" ref-type="bibr">Huang et al., 2018</xref>).</p>
    <fig position="float" id="fig-2">
      <object-id pub-id-type="doi">10.7717/peerj.16087/fig-2</object-id>
      <label>Figure 2</label>
      <caption>
        <title>Subset of the updated ProKinO schema with new classes and relationships.</title>
        <p>The full schema can be accessed at <uri xlink:href="http://prokino.uga.edu/">http://prokino.uga.edu/</uri>. New classes are colored in cyan and pre-existing classes are colored in pink. Black arrows indicate new relationships introduced to connect the new classes.</p>
      </caption>
      <graphic xlink:href="peerj-11-16087-g002" position="float"/>
    </fig>
    <p>While our preliminary studies have demonstrated the utility of ProKinO in hypothesis generation and knowledge discovery, to fully realize the impact of ProKinO in drug discovery and dark kinome mining, the ontology and the associated analytics tools need to be further developed to expand its scope and usability. For example, mutations at specific functional regions of the protein kinase domain, such as the gatekeeper and activation segments, are known to impact drug binding efficacies (<xref rid="ref-19" ref-type="bibr">Gajiwala et al., 2009</xref>; <xref rid="ref-77" ref-type="bibr">Yun et al., 2008</xref>). Likewise, kinase mRNA expression profiles strongly correlate with drug response (<xref rid="ref-4" ref-type="bibr">Benhar, Engelberg &amp; Levitzki, 2002</xref>; <xref rid="ref-11" ref-type="bibr">Duncan et al., 2012</xref>; <xref rid="ref-34" ref-type="bibr">Kim, Song &amp; Haura, 2009</xref>; <xref rid="ref-57" ref-type="bibr">Niepel et al., 2017</xref>). Thus, integrative mining of disease mutations with drug sensitivity profiles and expression patterns can provide new hypotheses/data for the development and administration of combinatorial drugs where multiple mutated kinases in distinct pathways can be targeted for drug repurposing (<xref rid="ref-12" ref-type="bibr">Erika et al., 2016</xref>; <xref rid="ref-39" ref-type="bibr">Li &amp; Jones, 2012</xref>), as demonstrated by the repurposing of Gleevec for targeting c-kit kinase in Gastrointestinal tumors (<xref rid="ref-31" ref-type="bibr">Joensuu et al., 2001</xref>). Furthermore, the recent generation of structural models of various dark kinases using AlphaFold (<xref rid="ref-32" ref-type="bibr">Jumper et al., 2021</xref>) provides a new framework for generating new hypotheses by interactive mining and visualization of sequence annotations in the context of 3D models. However, the lack of interactive visualization tools to overlay sequence and functional annotations in 3D structural models presents a bottleneck in the effective use of AlphaFold models for function prediction. To address this and other challenges described above related to dark kinase mining and annotation, we have expanded ProKinO by including kinase expression data, as well as a variety of data related to ligand-motif interaction, and ligand response prediction (<xref rid="ref-27" ref-type="bibr">Huang et al., 2021</xref>). We have also significantly revamped the ProKinO browser through incorporation of new visualization tools for the interactive mining of sequence annotations in the context of experimentally determined 3D structures and AlphaFold models. We demonstrate the application of these new tools in dark kinase annotation and mining using the understudied p21-activated protein kinase 5, as an example. The updated ontology and browser provide a valuable resource for mining, visualizing, and annotating the dark kinome and pseudokinome.</p>
  </sec>
  <sec sec-type="materials|methods">
    <title>Materials and Methods</title>
    <sec>
      <title>Data sources</title>
      <p>The ProKinO ontology includes data obtained from curated internal sources as well as external sources. Information from internal sources include annotations of kinase sequence and structural motifs retrieved from curated multiple sequence alignments. External sources are used for information related to kinase sequence and classification (KinBase &amp; UniProt) (<xref rid="ref-3" ref-type="bibr">Bairoch et al., 2005</xref>; <xref rid="ref-45" ref-type="bibr">Manning et al., 2002</xref>) cancer mutations (COSMIC) (<xref rid="ref-68" ref-type="bibr">Tate et al., 2018</xref>), pathways (Reactome) (<xref rid="ref-10" ref-type="bibr">Croft et al., 2011</xref>) and three dimernsioanl structure (PDB) (<xref rid="ref-6" ref-type="bibr">Berman et al., 2000</xref>). The ontology is populated and updated on a regular basis using protocols described in previous studies (<xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>; <xref rid="ref-47" ref-type="bibr">McSkimming et al., 2016</xref>). Here, we describe further enhancements and additions to ProKinO through integration of data on kinase expression patterns and drug interactions, as described below. In a seperate significant project, we have identified and classified nearly 30,000 pseudokinases spanning over 1,300 organisms (<xref rid="ref-38" ref-type="bibr">Kwon et al., 2019</xref>). The schematic representation of the classification of kinases into groups, families, and subfamilies was already in place (<xref rid="ref-24" ref-type="bibr">Hanks &amp; Hunter, 1995</xref>; <xref rid="ref-45" ref-type="bibr">Manning et al., 2002</xref>). Consequently, the addition of the pseudokinases and their classification was relatively simple. However, it significantly enhanced ProKinO as a comprehensive knowledge graph representing kinase-related data. The definition and nomenclature of several kinome-wide conserved motifs were standardized based on several previously published studies which describe the kinase structural features such as subdomains (<xref rid="ref-24" ref-type="bibr">Hanks &amp; Hunter, 1995</xref>), regulatory spine/shell (<xref rid="ref-50" ref-type="bibr">Meharena et al., 2013</xref>), and catalytic spine (<xref rid="ref-25" ref-type="bibr">Hu et al., 2015</xref>). A subset of redundant or family-specific motifs were removed in the updated ontology and motif information on some of the atypical kinases such as ALPHAK2 is not included as they cannot be reliably aligned with canonical protein kinases. Portions of the text were previously published as a part of a preprint (<xref rid="ref-67" ref-type="bibr">Soleymani et al., 2022</xref>).</p>
    </sec>
    <sec>
      <title>Ligand interactions</title>
      <p>Information on kinase-ligand interactions were retrieved from the Kinase-Ligand Interaction Fingerprints and Structures (KLIFS) database (<xref rid="ref-33" ref-type="bibr">Kanev et al., 2021</xref>). The KLIFS database stores detailed drug-protein kinase interaction information derived from diverse (&gt;2,900) structures of catalytic domains of human and mouse protein kinases deposited in the Protein Data Bank. In addition, KLIFS provides an application programming interface (API) for programmatic access to data related to chemicals and structural chemogenomics (<xref rid="ref-33" ref-type="bibr">Kanev et al., 2021</xref>). However, it lacks information regarding kinase pathways or diseases which prevents the user from investigating the effect of drug-mutant protein binding on downstream pathways or diseases. KLIFS annotations, which report PDB residue positions, were converted to UniProt residue numbering using PDBrenum (<xref rid="ref-15" ref-type="bibr">Faezov &amp; Dunbrack, 2021</xref>), then converted to prototypic Protein Kinase A (PKA) numbering using Multiply Aligned Profiles for Global Alignment of Protein Sequences (MAPGAPS) (<xref rid="ref-54" ref-type="bibr">Neuwald, 2009</xref>). Entries that could not be mapped or did not map to the kinase domain were filtered out.</p>
    </sec>
    <sec>
      <title>Ligand responses</title>
      <p>We have also incorporated information on kinase drug sensitivity profile in the updated ProKinO. In particular, we retrieved drug dose response data for kinase-relevant ligands/drugs from the Genomics of Drug Sensitivity in Cancer (GDSC) (<xref rid="ref-75" ref-type="bibr">Yang et al., 2013</xref>). Kinase-relevant ligands are defined based on our previous study (<xref rid="ref-28" ref-type="bibr">Huang et al., 2020</xref>), which collected 143 small-molecule protein kinase inhibitors from GDSC based on four drug-target databases: DrugBank (<xref rid="ref-74" ref-type="bibr">Wishart et al., 2018</xref>), Therapeutic Target Database (<xref rid="ref-40" ref-type="bibr">Li et al., 2018</xref>), Pharos (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>), and the Library of Integrated Network-Based Cellular Signatures (LINCS) Data Portal (<xref rid="ref-36" ref-type="bibr">Koleti et al., 2018</xref>). GDSC provides the half-maximal inhibitory concentration values (IC50) of these 143 ligands in 988 cancer cell lines.</p>
    </sec>
    <sec>
      <title>Ligand activities</title>
      <p>Ligand activities were retrieved from Pharos, a flagship resource (<xref rid="ref-55" ref-type="bibr">Nguyen et al., 2017</xref>) of the National Institutes of Health (NIH) Illuminating the Druggable Genome (IDG) program that includes data on small molecules, including approved drug data and bioassay data. Based on the protein classification (<xref rid="ref-41" ref-type="bibr">Lin et al., 2017</xref>), the drug targets in Pharos include kinases, ion channels, G-protein coupled receptors (GPCRs), and others. In this phase of the project, we decided to include the data relevant to ligand binding in kinases. Pharos integrates drug-target relationships from several resources, such as ChEMBL (<xref rid="ref-8" ref-type="bibr">Bühlmann &amp; Reymond, 2020</xref>) and DrugCentral (<xref rid="ref-1" ref-type="bibr">Avram et al., 2021</xref>).</p>
    </sec>
    <sec>
      <title>Expression data</title>
      <p>An important part of our recent additions was kinase expression data. Genomic expression data (protein, RNA), as well as transcription factors and epigenomic associations, are among many facets of the data included in Pharos. Furthermore, the GDSC repository contains gene expression data (Affymetrix Human Genome U219 Array), as well. Additionally, COSMIC’s Cell Lines Project includes a significant amount of gene expression data, including kinase expression.</p>
    </sec>
    <sec>
      <title>Dark kinases</title>
      <p>Dark kinases were labeled based on the information from Dark Kinase Knowledgebase (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>).</p>
    </sec>
    <sec>
      <title>Protein kinase knowledge graph: schema and data organization</title>
      <p>The ProKinO ontology consists of classes, sub-classes, class types, relationships, relationship types, and constraints of protein kinase and related data (<xref rid="fig-2" ref-type="fig">Fig. 2</xref>). The hierarchy connects all classes to the root, which is ProKinOEntity. Moreover, the schema defines types and constraints for the relationships. With such explicit and constrained schema, composing queries is more intuitive than conventional relational databases. In particular, to enable integrative mining of dark kinase expression data in the context of kinase sequence and structural features, we have introduced three new classes in ProKinO, the Ligand class (including its name, source, and chemical structure) and the following three related classes: (1) LigandInteraction, placed between the Ligand and (already existing) Motif classes to capture kinase-ligand binding and selectivity at the motif and residue level; (2) LigandActivity, placed between the Ligand and (already existing) Protein classes to represent kinases targeted by ligands (and drugs); and (3) LigandResponse, located between the Ligand and (already existing) Sample classes and representing ligand (and drug) sensitivity in kinases. To capture kinase expression, we added the GeneExpression relationship linking the Protein and Sample classes. The outline of the recently added classes and their relationships in ProKinO is illustrated as a UML class diagram, shown in <xref rid="fig-2" ref-type="fig">Fig. 2</xref>.</p>
    </sec>
    <sec>
      <title>ProKinO population</title>
      <p>The ProKinO knowledge graph is automatically populated from several external and local data sources at regular intervals, as originally described (<xref rid="ref-22" ref-type="bibr">Gosal, Kochut &amp; Kannan, 2011</xref>), ProKinO schema and the associated knowledge graph population software are routinely updated to incorporate additional sources of data such as pseudokinase and “dark” kinase classification and incorporating information on ligand interactions, ligand responses, ligand activities, kinase expression and associated object and datatype properties. We have been using the Protégé ontology editor for the schema creation and its subsequent modifications. The organization of the schema after these modifications is available at <uri xlink:href="https://prokino.uga.edu/about">https://prokino.uga.edu/about</uri>.</p>
      <p>The population software has been coded in Java and uses the Jena Framework. The population process is performed in several steps to add instances, their properties, and a combination of reading the prepared data from CSV, RDF, XML, and other file formats and accessing many remote data sources using their provided API (for example, Reactome’s REST API). Entity interconnections across data retrieved from different data sources are accomplished using UniProt identifiers, kinase names, and other accession identifiers. We modified the population software to create instances and properties for the newly added classes and relationships.</p>
      <p>More specifically, using the KLIFS API, we retrieved the relevant kinases, ligands, and residue-level interaction data. The data was retrieved and then processed by custom Perl scripts. ProKinO ontology schema was modified, and ligands were included as new data, while interaction data (motifs) were either reconciled with the motifs already present in ProKinO or added as new, if not already there.</p>
      <p>Similarly, the ligand response data was retrieved from GDSC and then processed by custom Perl scripts to create suitable CSV files. Additional ligands were included as new data, while the response data and the relevant samples were either reconciled with the samples already present in ProKinO or added as new, if not already there.</p>
      <p>In order to populate the data on ligand activities, we retrieved from Pharos kinase-relevant ligands, as well as their binding data on targeted kinases, for example, IC50 values. This data was retrieved and then processed by custom Perl scripts to produce the necessary CSV files. Additional ligands, not included in the KLIFS dataset, were included as new data. All kinases targeted by ligands were already present in ProKinO, so they were reused in this step.</p>
      <p>Data on kinase expression was first retrieved from Pharos, COSMIC, and GDSC. As before, the relevant kinases were already present in the ProKinO knowledge graph. The expression data was stored as individuals in the Expression class. Some of the relevant data about samples were already present in ProKinO, as we already had a significant amount of sample data from COSMIC. Additional samples were included as new data.</p>
      <p>We reviewed and updated all the motifs already present in ProKinO. Furthermore, we updated the motif naming in cases where there were differences with the standard motif names.</p>
      <p>Finally, we assembled an up-to-date list of dark kinases (<xref rid="ref-5" ref-type="bibr">Berginski et al., 2021</xref>) and added a Boolean datatype property, <italic toggle="yes">isDarkKinase</italic>, to identify them among all other kinases in the ProKinO knowledge graph.</p>
    </sec>
  </sec>
  <sec>
    <title>Results/discussion</title>
    <p>The expanded ontology and its knowledge graph provide a wealth of data unifying the information available on both well-studied (light) kinases and understudied (dark) kinases that serve as a unified resource for mining the kinome. The current version of ProKinO (version 65), includes 842 classes, 31 objects and 67 data properties, and over seven million individuals (knowledge graph nodes). ProKinO contains information on 153 dark kinases. A total of 137 dark kinases have information on structural motifs, 148 have disease mutations mapped to the kinase domain, 45 dark kinases have pathway information, and 26 are associated with specific reactions, as defined in Reactome.</p>
    <p>Users can navigate the ontology using the ontology browser by searching for a specific kinase of interest or by performing aggregate SPARQL queries linking multiple forms of data. Currently 35 pre-written queries linking different data types can be executed using the ProKinO browser (<uri xlink:href="http://prokino.uga.edu/queries">http://prokino.uga.edu/queries</uri>). A user can also download the ontology or browse data based on organisms, functional domains, diseases, or kinase domain evolutionary hierarchy. Below, we focus on the application of complex SPARQL queries and the ProtVista visualization tools for the illumination of understudied dark kinases.</p>
    <sec>
      <title>Mutation and expression of understudied PAK5 in human cancers</title>
      <p>One possible way to prioritize dark kinases for functional studies is to ask the question, “which dark kinases are most mutated in human diseases, such as cancers?”. Typically answering this question would require collating and post-processing data from multiple resources such as COSMIC, Pharos, and the Dark Kinase Knowledgebase. However, with the updated Protein Kinase Ontology, these questions can be quickly answered using SPARQL. Having the “<italic toggle="yes">isDarkKinase”</italic> property within the Protein class and the RDF triples connecting the “<italic toggle="yes">Mutation”</italic>, “<italic toggle="yes">Sample</italic>” and “<italic toggle="yes">Sequence”</italic> classes, one can formulate aggregate queries requesting all dark kinases mutated in cancer samples. To avoid biases introduced by the length of protein/gene sequences (longer proteins tend to have more mutations), the query can be modified to normalize mutation counts by sequence length. Executing this modified query (Query 27, available at <uri xlink:href="http://prokino.uga.edu/queries">http://prokino.uga.edu/queries</uri>) displays the rank-ordered list of dark kinases based on mutational density. The top ten dark kinases with the highest mutational density are shown in <xref rid="fig-3" ref-type="fig">Fig. 3A</xref>. Notably, the p21 activated kinase 5 (PAK5) is at the top of the list with a mutational density of 1.917, followed by CRK7 (1.054), PKACG (1.011), PSKH2 (1.01) TSSK1 (1.008), CK1A2 (0.991), ERK4 (0.966), DCLK3 (0.912), PKCT (0.894) and PAK3 (0.859). Having identified PAK5 as the most frequently mutated dark kinase in cancers, one can further query the ontology to explore the role of this kinase in various cancers. With the addition of the new “<italic toggle="yes">GeneExpression</italic>” class in ProKinO and the RDF triples connecting gene expression to the “<italic toggle="yes">Sample”</italic> and “<italic toggle="yes">Protein</italic>” classes (<italic toggle="yes">GeneExpression:InSample: Sample; GeneExpression:hasProtein: Protein</italic>), one can formulate queries for PAK5 expression in different samples (<xref rid="fig-3" ref-type="fig">Fig. 3B</xref>). Rank ordering the samples based on PAK5 expression (Query 33) reveals cancer types such as adenocarcinoma (Zscore: 4,701.5) and hepatocellular carcinoma (Zscore: 2,038.3) that have previously been associated with abnormal PAK5 expression (<xref rid="ref-16" ref-type="bibr">Fang et al., 2014</xref>; <xref rid="ref-23" ref-type="bibr">Han et al., 2018</xref>; <xref rid="ref-29" ref-type="bibr">Huo et al., 2019</xref>; <xref rid="ref-78" ref-type="bibr">Zhang et al., 2017</xref>). However, the role of PAK5 in other cancer types such as acute myeloid leukemia (Zscore: 136.5) is relatively underappreciated (<xref rid="ref-61" ref-type="bibr">Quan et al., 2020</xref>). The identification of new cancer sub-types with dark kinase expression and regulation further exemplifies the use of ProKinO in knowledge discovery.</p>
      <fig position="float" id="fig-3">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-3</object-id>
        <label>Figure 3</label>
        <caption>
          <title>SPARQL query results for Query 27 and 33.</title>
          <p>(A) Output of Query 27 requesting top 10 dark kinases with most mutations in different cancer types. The mutation counts are normalized by sequence length. (B) Output of Query 33 listing samples with abnormal PAK5 expression. The query also lists histology, cancer subtypes, regulation, and Z-score. Only a subset of the query results is shown because of space constraints.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g003" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Mutational hotspots in the activation loop of PAK5</title>
      <p>Because ProKinO encodes a wealth of information on the structural and regulatory properties of multiple kinases, it can be used to generate mechanistic predictions on cancer mutation impact. We demonstrate this for the PAK kinases by asking the question “<italic toggle="yes">where are PAK5 mutations located in the protein kinase domain?</italic>” Using the RDF triples connecting the “<italic toggle="yes">Mutation”</italic>, “<italic toggle="yes">Motif”</italic> and “<italic toggle="yes">Sequence</italic>” classes (“<italic toggle="yes">Mutation: LocatedIn: Motif”; “Mutation:InSequence: Sequence”</italic>), one can formulate a query (Query 28) listing mutations in different structural regions/motifs of the PAK5 kinase domain. Examination of the query results reveals that the C-terminal substrate binding lobe (C-lobe) is more frequently mutated (320 mutations) relative to the N-terminal ATP binding lobe (N-lobe: 173 mutations) (<xref rid="fig-4" ref-type="fig">Fig. 4A</xref>). Within the C-lobe, nearly 78 mutations map to the activation loop, which is known to play a critical role in substrate recognition and activation in a diverse array of kinases (<xref rid="ref-30" ref-type="bibr">Huse &amp; Kuriyan, 2002</xref>; <xref rid="ref-37" ref-type="bibr">Kornev &amp; Taylor, 2015</xref>; <xref rid="ref-58" ref-type="bibr">Oruganty &amp; Kannan, 2012</xref>). Despite the prevalence of activation loop mutations in PAK5, there is currently no information on how these mutations impact PAK5 kinase structure and function. Nonetheless, based on the evolutionary relationships captured in ProKinO (based on the alignment of human kinases to the prototypic protein kinase A), one can formulate queries mapping mutations to specific aligned positions in the shared protein kinase domain. A query listing (wild type) WT type and mutant type residues in the activation loop of PAK5 and the equivalent aligned residue positions in PKA (Query 29) provides additional context for these mutations. For example, two distinct mutations map to residue <inline-formula id="ieqn-1"><alternatives><inline-graphic xlink:href="peerj-11-16087-i001.jpg"/><tex-math id="tex-ieqn-1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{602^{{\rm PAK}5}}$\end{document}</tex-math><mml:math id="mml-ieqn-1" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>602</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> in the activation loop of PAK5 that structurally corresponds to a phosphorylatable residue, <inline-formula id="ieqn-2"><alternatives><inline-graphic xlink:href="peerj-11-16087-i002.jpg"/><tex-math id="tex-ieqn-2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm T}{197^{{\rm PKA}}}$\end{document}</tex-math><mml:math id="mml-ieqn-2" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>197</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, in PKA (<xref rid="ref-76" ref-type="bibr">Yonemoto et al., 1993</xref>). Having this context provides a testable hypothesis that S602 mutations in PAK5 impact kinase phosphorylation and regulation. Likewise, WT residue <inline-formula id="ieqn-3"><alternatives><inline-graphic xlink:href="peerj-11-16087-i003.jpg"/><tex-math id="tex-ieqn-3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{607^{{\rm PAK}5}}$\end{document}</tex-math><mml:math id="mml-ieqn-3" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>607</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> is mutated in four distinct cancer samples and this position is equivalent to PKA residue <inline-formula id="ieqn-4"><alternatives><inline-graphic xlink:href="peerj-11-16087-i004.jpg"/><tex-math id="tex-ieqn-4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\rm P}{202^{{\rm PKA}}}$\end{document}</tex-math><mml:math id="mml-ieqn-4" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mn>202</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, which configures the activation loop for substrate recognition (<xref rid="ref-35" ref-type="bibr">Knighton et al., 1991</xref>). Thus, mutation of this critical residue is expected to impact substrate binding and activation loop phosphorylation in PAK5. Additional insights into these mutations can also be obtained by visualizing these residues in the context of the PAK5 AlphaFold models using the ProtVista viewer described below.</p>
      <fig position="float" id="fig-4">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-4</object-id>
        <label>Figure 4</label>
        <caption>
          <title>SPARQL query results for Query 28 and 29.</title>
          <p>(A) Output of Query 28 listing the number of unique cancer-linked mutations at various structural locations of PAK5 kinase. (B) Output of Query 29 listing unique point mutations in the activation loop of PAK5 kinase. The query also lists the equivalent PKA position, disease type, primary site of the tissue sample, equivalent residue for the PKA positioning of PKA, and subtype of the tissue sample. Entries containing only one mutation per position were filtered from the original query. Only a subset of the query results is shown.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g004" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Insights into PAK5 ligand binding sites</title>
      <p>With the conceptualization of new information related to kinase ligands, their mode of action and interaction with specific motifs in the kinase domain, new aggregate queries linking mutated kinases to drug sensitivity profiles, mode of action, and ligand binding sites can be performed using the updated ProKinO. For example, queries such as “<italic toggle="yes">list proteins and drugs or ligands interacting with the protein’s gatekeeper residue (GK.45)</italic>” (Query 31) and “<italic toggle="yes">list ligands targeting the Epidermal Growth Factor Receptor (EGFR) kinase and their mode of action</italic>” (Query 34) can be rapidly performed using the updated ProKinO ontology. We demonstrate the application of these new additions in the context of PAK5 by asking the question “<italic toggle="yes">what are the drugs targeting PAK family (PAK1-6) kinases</italic>?” Query 30 answers this question using the RDF triples connecting the “<italic toggle="yes">Ligand</italic>”, “<italic toggle="yes">Motif</italic>” and “<italic toggle="yes">Protein</italic>” classes (list triples) (<xref rid="fig-5" ref-type="fig">Fig. 5</xref>). Examination of the query results indicates multiple drugs targeting PAK family kinases, including STAUROSPORINE and N2-((1R-2S)-2-AMINOCYCLOHEXYL) that bind to structurally equivalent residues/motifs in the ligand binding pocket of PAK4 and PAK5, respectively. The ligand binding sites, and associated interactions can also be visualized using the ProtVista viewer described below. Additional queries linking dark kinases to drug sensitivities, structural motifs, and pathways are listed on the ProKinO website at <uri xlink:href="https://prokino.uga.edu/queries">https://prokino.uga.edu/queries</uri>.</p>
      <fig position="float" id="fig-5">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-5</object-id>
        <label>Figure 5</label>
        <caption>
          <title>SPARQL query results for Query 30.</title>
          <p>Output of Query 30 listing ligands interactions with each PAK family member (PAK1-6). It also includes motif names and positions of full sequence and PKA positioning. The output of Query 30 was rearranged to highlight the homology of PAK4 and PAK5 motif/ligand interactions and the figure highlights only a subset of the query results. Run SPARQL query for full results.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g005" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>Visualization tools for dark kinase annotation and mining</title>
      <p>To provide structural context for cancer mutations and to enable interactive mining of dark kinase sequence annotations in the context of 3D structures and predicted models from AlphaFold (<xref rid="ref-32" ref-type="bibr">Jumper et al., 2021</xref>; <xref rid="ref-70" ref-type="bibr">Tunyasuvunakool et al., 2021</xref>), we developed and incorporated a modified version of the ProtVista viewer in ProKinO. The viewer can be deployed for any protein kinase of interest by navigating to the Structure tab in the protein summary page and selecting either a PDB structure or AlphaFold model of interest. A snapshot of the ProtVista viewer displaying the AlphaFold model of PAK5 kinase is shown in <xref rid="fig-6" ref-type="fig">Fig. 6</xref>. The ProtVista viewer uses an enhanced version of the Mol* viewer and the PDB web component (<xref rid="ref-72" ref-type="bibr">Watkins et al., 2017</xref>) to provide two-way interactive navigation between the 3D structure (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>, top panel) and annotation viewer (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>, bottom panel).</p>
      <fig position="float" id="fig-6">
        <object-id pub-id-type="doi">10.7717/peerj.16087/fig-6</object-id>
        <label>Figure 6</label>
        <caption>
          <title>ProtVista viewer.</title>
          <p>(A) AlphaFold2 model of PAK5 kinase is shown in the structure viewer (top panel). Sequence viewer with annotations are shown in the bottom panel. (B and C) Zoomed in view of structural interactions associated with S602 and P607 in PAK5 activation loop.</p>
        </caption>
        <graphic xlink:href="peerj-11-16087-g006" position="float"/>
      </fig>
      <p>The annotation viewer consists of multiple tracks populated dynamically based on data from ProKinO and external sources such as UniProt. In addition, prediction confidence scores for AlphaFold models are displayed in the annotation viewer along with additional annotations such as conserved sequence motifs, subdomains, and structural motifs involved in kinase regulation. The annotation viewer also shows other annotations from external sources such as ligand binding sites and predicted functional sites. Users can hover over the residues on the 3D structure viewer to view the equivalent information on the annotation viewer and vice versa. For example, selecting the “<italic toggle="yes">activation loop</italic>” in the annotation viewer highlights the corresponding structural region in the AlphaFold model of PAK5 (<xref rid="fig-6" ref-type="fig">Fig. 6A</xref>). Likewise, the selection of residues in the activation loop (S602 and P607) in the structure viewer highlights the annotations associated with these and interacting residues in the sequence viewer. Such interactive mining is expected to accelerate the functional characterization of dark kinases and provide new insights into disease mutations. For example, visualizing the interactions associated with S602 in the activation loop of PAK5 (<xref rid="fig-6" ref-type="fig">Fig. 6B</xref>) indicates a hydrogen bonding interaction with R567, which is part of the conserved HRD motif (sequence annotation). Because the HRD-Arg is known to play a role in kinase regulation by stabilizing activation loop conformation (<xref rid="ref-30" ref-type="bibr">Huse &amp; Kuriyan, 2002</xref>), it provides additional context for predicting the impact of S602 altering mutations. Likewise, examining the structural and sequence context of P607 interacting residues provides new insights into how the alteration of this residue might impact substrate binding and kinase regulation. Together, these examples highlight the value added by the ProtVista viewer in the visualization and annotation of mutations in dark kinases.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions">
    <title>Conclusions</title>
    <p>This work presents an updated version of the Protein Kinase Otology (ProKinO) for mining and annotating dark kinases. ProKinO was developed following FAIR (Findable, Accessible, Interoperable, and Reusable) principles (<xref rid="ref-73" ref-type="bibr">Wilkinson et al., 2016</xref>) and serves as an integrated knowledge graph for relating and conceptualizing diverse forms of disparate data related to protein kinase sequence, structure, function, regulation, and disease (cancer). We present a new ontology browser for navigating these data and demonstrate the application of aggregate SPARQL queries in uncovering new testable hypotheses regarding understudied kinase members. We also provide several pre-written SPARQL queries that can rapidly retrieve information related to protein kinase mutations, pathways, expression, and ligand binding sites. However, writing new queries requires prior knowledge of the ontology schema and the SPARQL query language, which most bench biologists may not have. To alleviate this challenge, we are currently building a graphical SPARQL query interface, which will intuitively enable query formulation through the navigation of the knowledge graph schema. We are also exploring the application of ProKinO for machine learning-based knowledge discovery and hypotheses generation.</p>
  </sec>
</body>
<back>
  <ack>
    <p>We acknowledge members of the Kannan lab for their valuable comments and suggestions. We additionally acknowledge the various contributions to the databases we utilized made through the efforts of the IDG consortium and numerous investigator-initiated efforts.</p>
  </ack>
  <sec sec-type="additional-information">
    <title>Additional Information and Declarations</title>
    <fn-group content-type="competing-interests">
      <title>Competing Interests</title>
      <fn fn-type="COI-statement" id="conflict-1">
        <p>Natarajan Kannan is an Academic Editor for PeerJ.</p>
      </fn>
    </fn-group>
    <fn-group content-type="author-contributions">
      <title>Author Contributions</title>
      <fn fn-type="con" id="contribution-1">
        <p><xref rid="author-1" ref-type="contrib">Saber Soleymani</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-2">
        <p><xref rid="author-2" ref-type="contrib">Nathan Gravel</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-3">
        <p><xref rid="author-3" ref-type="contrib">Liang-Chin Huang</xref> performed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-4">
        <p><xref rid="author-4" ref-type="contrib">Wayland Yeung</xref> analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-5">
        <p><xref rid="author-5" ref-type="contrib">Elika Bozorgi</xref> analyzed the data, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-6">
        <p><xref rid="author-6" ref-type="contrib">Nathaniel G. Bendzunas</xref> analyzed the data, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-7">
        <p><xref rid="author-7" ref-type="contrib">Krzysztof J. Kochut</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, updated the browser and ontology, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-8">
        <p><xref rid="author-8" ref-type="contrib">Natarajan Kannan</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p>
      </fn>
    </fn-group>
    <fn-group content-type="other">
      <title>Data Availability</title>
      <fn id="addinfo-1">
        <p>The following information was supplied regarding data availability:</p>
        <p>The protein kinase ontology (ProKinO)’s current OWL file and previous versions are available at: <uri xlink:href="https://prokino.uga.edu/downloads.html">https://prokino.uga.edu/downloads.html</uri>.</p>
        <p>Future versions of the ontology also will be placed at the same address.</p>
        <p>The ontology browser is available at <uri xlink:href="https://prokino.uga.edu/browser">https://prokino.uga.edu/browser</uri>. Users can save the results of queries in diagrams or other formats such as CSV.</p>
      </fn>
    </fn-group>
  </sec>
  <ref-list content-type="authoryear">
    <title>References</title>
    <ref id="ref-1">
      <label>Avram et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Avram</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Curpan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Halip</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bora</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Knockel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sirimulla</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>DrugCentral 2021 supports drug discovery and repositioning</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1160</fpage>
        <lpage>D1169</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa997</pub-id>
        <pub-id pub-id-type="pmid">33151287</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-2">
      <label>Bailey et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>McSkimming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Going for broke: targeting the human cancer pseudokinome</article-title>
        <source>Biochemical Journal</source>
        <year iso-8601-date="2015">2015</year>
        <volume>465</volume>
        <issue>2</issue>
        <fpage>195</fpage>
        <lpage>211</lpage>
        <pub-id pub-id-type="doi">10.1042/BJ20141060</pub-id>
        <pub-id pub-id-type="pmid">25559089</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-3">
      <label>Bairoch et al. (2005)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bairoch</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Barker</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Boeckmann</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ferro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Magrane</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The universal protein resource (UniProt)</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2005">2005</year>
        <volume>33</volume>
        <issue>Database issue</issue>
        <fpage>D154</fpage>
        <lpage>D159</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gki070</pub-id>
        <pub-id pub-id-type="pmid">15608167</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-4">
      <label>Benhar, Engelberg &amp; Levitzki (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benhar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Engelberg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Levitzki</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ROS, stress-activated kinases and stress signaling in cancer</article-title>
        <source>EMBO Reports</source>
        <year iso-8601-date="2002">2002</year>
        <volume>3</volume>
        <issue>5</issue>
        <fpage>420</fpage>
        <lpage>425</lpage>
        <pub-id pub-id-type="doi">10.1093/embo-reports/kvf094</pub-id>
        <pub-id pub-id-type="pmid">11991946</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-5">
      <label>Berginski et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berginski</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Moret</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Goldfarb</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>The dark kinase knowledgebase: an online compendium of knowledge and experimental results of understudied kinases</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D529</fpage>
        <lpage>D535</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa853</pub-id>
        <pub-id pub-id-type="pmid">33079988</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-6">
      <label>Berman et al. (2000)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Westbrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gilliland</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Weissig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The protein data bank</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2000">2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-8">
      <label>Bühlmann &amp; Reymond (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bühlmann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reymond</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>ChEMBL-likeness score and database GDBChEMBL</article-title>
        <source>Frontiers in Chemistry</source>
        <year iso-8601-date="2020">2020</year>
        <volume>8</volume>
        <fpage>46</fpage>
        <pub-id pub-id-type="doi">10.3389/fchem.2020.00046</pub-id>
        <pub-id pub-id-type="pmid">32117874</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-7">
      <label>Byrne, Foulkes &amp; Eyers (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Foulkes</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Pseudokinases: update on their functions and evaluation as new drug targets</article-title>
        <source>Future Medicinal Chemistry</source>
        <year iso-8601-date="2017">2017</year>
        <volume>9</volume>
        <issue>2</issue>
        <fpage>245</fpage>
        <lpage>265</lpage>
        <pub-id pub-id-type="doi">10.4155/fmc-2016-0207</pub-id>
        <pub-id pub-id-type="pmid">28097887</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-9">
      <label>Cicenas &amp; Cicenas (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cicenas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cicenas</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Multi-kinase inhibitors, AURKs and cancer</article-title>
        <source>Medical Oncology</source>
        <year iso-8601-date="2016">2016</year>
        <volume>33</volume>
        <issue>5</issue>
        <fpage>43</fpage>
        <pub-id pub-id-type="doi">10.1007/s12032-016-0758-4</pub-id>
        <pub-id pub-id-type="pmid">27038473</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-10">
      <label>Croft et al. (2011)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Croft</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>O’Kelly</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Haw</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gillespie</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Caudy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Garapati</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gopinath</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jassal</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Reactome: a database of reactions, pathways and biological processes</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2011">2011</year>
        <volume>39</volume>
        <issue>Database</issue>
        <fpage>D691</fpage>
        <lpage>D697</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1018</pub-id>
        <pub-id pub-id-type="pmid">21067998</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-11">
      <label>Duncan et al. (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Duncan</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Whittle</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Abell</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Midland</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Zawistowski</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Granger</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Jordan</surname>
            <given-names>NV</given-names>
          </name>
          <name>
            <surname>Darr</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Usary</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuan</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Smalley</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Major</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Hoadley</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sharpless</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Perou</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>WY</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Frye</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Earp</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Graves</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>GL</given-names>
          </name>
        </person-group>
        <article-title>Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer</article-title>
        <source>Cell</source>
        <year iso-8601-date="2012">2012</year>
        <volume>149</volume>
        <issue>2</issue>
        <fpage>307</fpage>
        <lpage>321</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.053</pub-id>
        <pub-id pub-id-type="pmid">22500798</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-12">
      <label>Erika et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Erika</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Federica</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Martina</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Anselmo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Luigi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Marina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Davide</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Eleonora</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Monica</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Silverio</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Old tyrosine kinase inhibitors and newcomers in gastrointestinal cancer treatment</article-title>
        <source>Current Cancer Drug Targets</source>
        <year iso-8601-date="2016">2016</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>185</lpage>
        <pub-id pub-id-type="doi">10.2174/1568009615666150817120712</pub-id>
        <pub-id pub-id-type="pmid">26278713</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-13">
      <label>Eyers, Keeshan &amp; Kannan (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Keeshan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tribbles in the 21st century: the evolving roles of tribbles pseudokinases in biology and disease</article-title>
        <source>Trends in Cell Biology</source>
        <year iso-8601-date="2017">2017</year>
        <volume>27</volume>
        <issue>4</issue>
        <fpage>284</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tcb.2016.11.002</pub-id>
        <pub-id pub-id-type="pmid">27908682</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-14">
      <label>Eyers &amp; Murphy (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Dawn of the dead: protein pseudokinases signal new adventures in cell biology</article-title>
        <source>Biochemical Society Transactions</source>
        <year iso-8601-date="2013">2013</year>
        <volume>41</volume>
        <issue>4</issue>
        <fpage>969</fpage>
        <lpage>974</lpage>
        <pub-id pub-id-type="doi">10.1042/BST20130115</pub-id>
        <pub-id pub-id-type="pmid">23863165</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-15">
      <label>Faezov &amp; Dunbrack (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faezov</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dunbrack</surname>
            <given-names>RL</given-names>
            <suffix>Jr</suffix>
          </name>
        </person-group>
        <article-title>PDBrenum: a webserver and program providing protein data bank files renumbered according to their UniProt sequences</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2021">2021</year>
        <volume>16</volume>
        <issue>7</issue>
        <elocation-id>e0253411</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0253411</pub-id>
        <pub-id pub-id-type="pmid">34228733</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-16">
      <label>Fang et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>ZP</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>XF</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>FB</given-names>
          </name>
        </person-group>
        <article-title>P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma</article-title>
        <source>Acta Pharmacologica Sinica</source>
        <year iso-8601-date="2014">2014</year>
        <volume>35</volume>
        <issue>1</issue>
        <fpage>82</fpage>
        <lpage>88</lpage>
        <pub-id pub-id-type="doi">10.1038/aps.2013.31</pub-id>
        <pub-id pub-id-type="pmid">23685956</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-17">
      <label>Ferguson &amp; Gray (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ferguson</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Kinase inhibitors: the road ahead</article-title>
        <source>Nature Reviews Drug Discovery</source>
        <year iso-8601-date="2018">2018</year>
        <volume>17</volume>
        <issue>5</issue>
        <fpage>353</fpage>
        <lpage>377</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd.2018.21</pub-id>
        <pub-id pub-id-type="pmid">29545548</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-18">
      <label>Foulkes et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Foulkes</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Shrestha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Keeshan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Drewry</surname>
            <given-names>DH</given-names>
          </name>
        </person-group>
        <article-title>Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells</article-title>
        <source>Science Signaling</source>
        <year iso-8601-date="2018">2018</year>
        <volume>11</volume>
        <issue>549</issue>
        <fpage>eaat7951</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aat7951</pub-id>
        <pub-id pub-id-type="pmid">30254057</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-19">
      <label>Gajiwala et al. (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gajiwala</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Christensen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Deshmukh</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Diehl</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>DiNitto</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>English</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Greig</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Y-A</given-names>
          </name>
          <name>
            <surname>Jacques</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2009">2009</year>
        <volume>106</volume>
        <issue>5</issue>
        <fpage>1542</fpage>
        <lpage>1547</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0812413106</pub-id>
        <pub-id pub-id-type="pmid">19164557</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-20">
      <label>Goldberg et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goldberg</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Griggs</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Haas</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Wortman</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Kinannote, a computer program to identify and classify members of the eukaryotic protein kinase superfamily</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2013">2013</year>
        <volume>29</volume>
        <issue>19</issue>
        <fpage>2387</fpage>
        <lpage>2394</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt419</pub-id>
        <pub-id pub-id-type="pmid">23904509</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-21">
      <label>Gosal, Kannan &amp; Kochut (2011)</label>
      <element-citation publication-type="confproc">
        <person-group person-group-type="author">
          <name>
            <surname>Gosal</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a framework for protein kinase ontology</article-title>
        <year iso-8601-date="2011">2011</year>
        <conf-name>Proceedings of the IEEE International Conference on Bioinformatics &amp; Biomedicine, Atlanta, Georgia</conf-name>
        <publisher-loc>Piscataway</publisher-loc>
        <publisher-name>IEEE</publisher-name>
        <fpage>550</fpage>
        <lpage>555</lpage>
      </element-citation>
    </ref>
    <ref id="ref-22">
      <label>Gosal, Kochut &amp; Kannan (2011)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gosal</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: an ontology for integrative analysis of protein kinases in cancer</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2011">2011</year>
        <volume>6</volume>
        <issue>12</issue>
        <elocation-id>e28782</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0028782</pub-id>
        <pub-id pub-id-type="pmid">22194913</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-23">
      <label>Han et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>KF</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>PAK5 overexpression is associated with lung metastasis in osteosarcoma</article-title>
        <source>Oncology Letters</source>
        <year iso-8601-date="2018">2018</year>
        <volume>15</volume>
        <fpage>2202</fpage>
        <lpage>2210</lpage>
        <pub-id pub-id-type="doi">10.3892/ol.2017.7545</pub-id>
        <pub-id pub-id-type="pmid">29434926</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-24">
      <label>Hanks &amp; Hunter (1995)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanks</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</article-title>
        <source>FASEB Journal</source>
        <year iso-8601-date="1995">1995</year>
        <volume>9</volume>
        <fpage>576</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="doi">10.1096/fasebj.9.8.7768349</pub-id>
        <pub-id pub-id-type="pmid">7768349</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-25">
      <label>Hu et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ahuja</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Meharena</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Kinase regulation by hydrophobic spine assembly in cancer</article-title>
        <source>Molecular and Cellular Biology</source>
        <year iso-8601-date="2015">2015</year>
        <volume>35</volume>
        <issue>1</issue>
        <fpage>264</fpage>
        <lpage>276</lpage>
        <pub-id pub-id-type="doi">10.1128/MCB.00943-14</pub-id>
        <pub-id pub-id-type="pmid">25348715</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-26">
      <label>Huang et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Baffi</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Drabkin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>D’Eustachio</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>McSkimming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Arighi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Natale</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gaudet</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Newton</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resources</article-title>
        <source>Scientific Reports</source>
        <year iso-8601-date="2018">2018</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>6518</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-24457-1</pub-id>
        <pub-id pub-id-type="pmid">29695735</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-27">
      <label>Huang et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gravel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Venkat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>KinOrtho: a method for mapping human kinase orthologs across the tree of life and illuminating understudied kinases</article-title>
        <source>BMC Bioinformatics</source>
        <year iso-8601-date="2021">2021</year>
        <volume>22</volume>
        <issue>1</issue>
        <fpage>446</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-021-04358-3</pub-id>
        <pub-id pub-id-type="pmid">34537014</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-28">
      <label>Huang et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Venkat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rasheed</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Quantitative structure-mutation-activity relationship tests (QSMART) model for protein kinase inhibitor response prediction</article-title>
        <source>BMC Bioinformatics</source>
        <year iso-8601-date="2020">2020</year>
        <volume>21</volume>
        <issue>1</issue>
        <fpage>520</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-020-03842-6</pub-id>
        <pub-id pub-id-type="pmid">33183223</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-29">
      <label>Huo et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1</article-title>
        <source>Cell Death and Differentiation</source>
        <year iso-8601-date="2019">2019</year>
        <volume>26</volume>
        <issue>6</issue>
        <fpage>994</fpage>
        <lpage>1006</lpage>
        <pub-id pub-id-type="doi">10.1038/s41418-018-0178-4</pub-id>
        <pub-id pub-id-type="pmid">30082769</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-30">
      <label>Huse &amp; Kuriyan (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huse</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kuriyan</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The conformational plasticity of protein kinases</article-title>
        <source>Cell</source>
        <year iso-8601-date="2002">2002</year>
        <volume>109</volume>
        <issue>3</issue>
        <fpage>275</fpage>
        <lpage>282</lpage>
        <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00741-9</pub-id>
        <pub-id pub-id-type="pmid">12015977</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-31">
      <label>Joensuu et al. (2001)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Joensuu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Sarlomo-Rikala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Andersson</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Tervahartiala</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tuveson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Silberman</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Capdeville</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dimitrijevic</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Druker</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
        </person-group>
        <article-title>Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor</article-title>
        <source>New England Journal of Medicine</source>
        <year iso-8601-date="2001">2001</year>
        <volume>344</volume>
        <issue>14</issue>
        <fpage>1052</fpage>
        <lpage>1056</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJM200104053441404</pub-id>
        <pub-id pub-id-type="pmid">11287975</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-32">
      <label>Jumper et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jumper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pritzel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Figurnov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ronneberger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Tunyasuvunakool</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Žídek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Potapenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bridgland</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kohl</surname>
            <given-names>SAA</given-names>
          </name>
          <name>
            <surname>Ballard</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Romera-Paredes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nikolov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Back</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reiman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zielinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinegger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pacholska</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Berghammer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bodenstein</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Silver</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vinyals</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Senior</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Kavukcuoglu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kohli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hassabis</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>
        <source>Nature</source>
        <year iso-8601-date="2021">2021</year>
        <volume>596</volume>
        <issue>7873</issue>
        <fpage>583</fpage>
        <lpage>589</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
        <pub-id pub-id-type="pmid">34265844</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-33">
      <label>Kanev et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanev</surname>
            <given-names>GK</given-names>
          </name>
          <name>
            <surname>de Graaf</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Westerman</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>de Esch</surname>
            <given-names>IJP</given-names>
          </name>
          <name>
            <surname>Kooistra</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>KLIFS: an overhaul after the first 5 years of supporting kinase research</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D562</fpage>
        <lpage>D569</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa895</pub-id>
        <pub-id pub-id-type="pmid">33084889</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-34">
      <label>Kim, Song &amp; Haura (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Haura</surname>
            <given-names>EB</given-names>
          </name>
        </person-group>
        <article-title>Src kinases as therapeutic targets for cancer</article-title>
        <source>Nature Reviews Clinical Oncology</source>
        <year iso-8601-date="2009">2009</year>
        <volume>6</volume>
        <issue>10</issue>
        <fpage>587</fpage>
        <lpage>595</lpage>
        <pub-id pub-id-type="doi">10.1038/nrclinonc.2009.129</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-35">
      <label>Knighton et al. (1991)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knighton</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Ten Eyck</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Ashford</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Xuong</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Sowadski</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</article-title>
        <source>Science</source>
        <year iso-8601-date="1991">1991</year>
        <volume>253</volume>
        <issue>5018</issue>
        <fpage>407</fpage>
        <lpage>414</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1862342</pub-id>
        <pub-id pub-id-type="pmid">1862342</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-36">
      <label>Koleti et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Terryn</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Stathias</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Forlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>D’Urso</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Torre</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jagodnik</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Mader</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fazel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mahi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pilarczyk</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Shamsaei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Meller</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vasiliauskas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Reichard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Medvedovic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pillai</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Data portal for the library of integrated network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D558</fpage>
        <lpage>D566</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1063</pub-id>
        <pub-id pub-id-type="pmid">29140462</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-37">
      <label>Kornev &amp; Taylor (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Dynamics-driven allostery in protein kinases</article-title>
        <source>Trends in Biochemical Sciences</source>
        <year iso-8601-date="2015">2015</year>
        <volume>40</volume>
        <issue>11</issue>
        <fpage>628</fpage>
        <lpage>647</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tibs.2015.09.002</pub-id>
        <pub-id pub-id-type="pmid">26481499</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-38">
      <label>Kwon et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tracing the origin and evolution of pseudokinases across the tree of life</article-title>
        <source>Science Signaling</source>
        <year iso-8601-date="2019">2019</year>
        <volume>12</volume>
        <issue>578</issue>
        <fpage>289</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aav3810</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-39">
      <label>Li &amp; Jones (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>SJ</given-names>
          </name>
        </person-group>
        <article-title>Drug repositioning for personalized medicine</article-title>
        <source>Genome Medicine</source>
        <year iso-8601-date="2012">2012</year>
        <volume>4</volume>
        <issue>3</issue>
        <fpage>27</fpage>
        <pub-id pub-id-type="doi">10.1186/gm326</pub-id>
        <pub-id pub-id-type="pmid">22494857</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-40">
      <label>Li et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XX</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>YZ</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1121</fpage>
        <lpage>D1127</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1076</pub-id>
        <pub-id pub-id-type="pmid">29140520</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-41">
      <label>Lin et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Küçük-McGinty</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Forlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Stathias</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nabizadeh</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mader</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Visser</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Drug target ontology to classify and integrate drug discovery data</article-title>
        <source>Journal of Biomedical Semantics</source>
        <year iso-8601-date="2017">2017</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>50</fpage>
        <pub-id pub-id-type="doi">10.1186/s13326-017-0161-x</pub-id>
        <pub-id pub-id-type="pmid">29122012</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-42">
      <label>Liu, Liang &amp; Zhang (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>XC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Culturing Schwann cells from neonatal rats by improved enzyme digestion combined with explants-culture method</article-title>
        <source>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</source>
        <year iso-8601-date="2016">2016</year>
        <volume>38</volume>
        <fpage>388</fpage>
        <lpage>392</lpage>
        <pub-id pub-id-type="doi">10.3881/j.issn.1000-503X.2016.04.004</pub-id>
        <pub-id pub-id-type="pmid">27594149</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-43">
      <label>Lubner et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lubner</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Dodge-Kafka</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Cushing’s syndrome mutant PKA(L)(205R) exhibits altered substrate specificity</article-title>
        <source>FEBS Letters</source>
        <year iso-8601-date="2017">2017</year>
        <volume>591</volume>
        <issue>3</issue>
        <fpage>459</fpage>
        <lpage>467</lpage>
        <pub-id pub-id-type="doi">10.1002/1873-3468.12562</pub-id>
        <pub-id pub-id-type="pmid">28100013</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-44">
      <label>ManChon et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>ManChon</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rasheed</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Prediction and prioritization of rare oncogenic mutations in the cancer kinome using novel features and multiple classifiers</article-title>
        <source>PLOS Computational Biology</source>
        <year iso-8601-date="2014">2014</year>
        <volume>10</volume>
        <issue>4</issue>
        <elocation-id>e1003545</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003545</pub-id>
        <pub-id pub-id-type="pmid">24743239</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-45">
      <label>Manning et al. (2002)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Manning</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Whyte</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sudarsanam</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The protein kinase complement of the human genome</article-title>
        <source>Science</source>
        <year iso-8601-date="2002">2002</year>
        <volume>298</volume>
        <issue>5600</issue>
        <fpage>1912</fpage>
        <lpage>1934</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1075762</pub-id>
        <pub-id pub-id-type="pmid">12471243</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-46">
      <label>McClendon et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McClendon</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Gilson</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Dynamic architecture of a protein kinase</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2014">2014</year>
        <volume>111</volume>
        <issue>43</issue>
        <fpage>E4623</fpage>
        <lpage>E4631</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1418402111</pub-id>
        <pub-id pub-id-type="pmid">25319261</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-47">
      <label>McSkimming et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Baffi</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Newton</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>KinView: a visual comparative sequence analysis tool for integrated kinome research</article-title>
        <source>Molecular Biosystems</source>
        <year iso-8601-date="2016">2016</year>
        <volume>12</volume>
        <issue>12</issue>
        <fpage>3651</fpage>
        <lpage>3665</lpage>
        <pub-id pub-id-type="doi">10.1039/C6MB00466K</pub-id>
        <pub-id pub-id-type="pmid">27731453</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-48">
      <label>McSkimming et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a unified resource for mining the cancer kinome</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2014">2014</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>186</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22726</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-49">
      <label>McSkimming et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McSkimming</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Dastgheib</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Talevich</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ProKinO: a unified resource for mining the cancer kinome</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2015">2015</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>175</fpage>
        <lpage>186</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22726</pub-id>
        <pub-id pub-id-type="pmid">25382819</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-50">
      <label>Meharena et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meharena</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Keshwani</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nene</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Deciphering the structural basis of eukaryotic protein kinase regulation</article-title>
        <source>PLOS Biology</source>
        <year iso-8601-date="2013">2013</year>
        <volume>11</volume>
        <issue>10</issue>
        <elocation-id>e1001680</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pbio.1001680</pub-id>
        <pub-id pub-id-type="pmid">24143133</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-51">
      <label>Mohanty et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mohanty</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kwon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Ferries</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Hanold</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Hydrophobic core variations provide a structural framework for tyrosine kinase evolution and functional specialization</article-title>
        <source>PLOS Genetics</source>
        <year iso-8601-date="2016">2016</year>
        <volume>12</volume>
        <issue>2</issue>
        <elocation-id>e1005885</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1005885</pub-id>
        <pub-id pub-id-type="pmid">26925779</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-52">
      <label>Moret et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moret</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gyori</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Bachman</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Steppi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hug</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Taujale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Berginski</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Gomez</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>A resource for exploring the understudied human kinome for research and therapeutic opportunities</article-title>
        <source>BioRxiv</source>
        <year iso-8601-date="2021">2021</year>
        <pub-id pub-id-type="doi">10.1101/2020.04.02.022277</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-53">
      <label>Murphy, Mace &amp; Eyers (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murphy</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Mace</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Eyers</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Live and let die: insights into pseudoenzyme mechanisms from structure</article-title>
        <source>Current Opinion in Structural Biology</source>
        <year iso-8601-date="2017">2017</year>
        <volume>47</volume>
        <fpage>95</fpage>
        <lpage>104</lpage>
        <pub-id pub-id-type="doi">10.1016/j.sbi.2017.07.004</pub-id>
        <pub-id pub-id-type="pmid">28787627</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-54">
      <label>Neuwald (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Neuwald</surname>
            <given-names>AF</given-names>
          </name>
        </person-group>
        <article-title>Rapid detection, classification and accurate alignment of up to a million or more related protein sequences</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2009">2009</year>
        <volume>25</volume>
        <fpage>1869</fpage>
        <lpage>1875</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp342</pub-id>
        <pub-id pub-id-type="pmid">19505947</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-55">
      <label>Nguyen et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gaulton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hersey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Karlsson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mandava</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Overington</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rouillard</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Schurer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sheils</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Simeonov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ursu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Vidovic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jadhav</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Pharos: collating protein information to shed light on the druggable genome</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2017">2017</year>
        <volume>45</volume>
        <fpage>D995</fpage>
        <lpage>D1002</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw1072</pub-id>
        <pub-id pub-id-type="pmid">27903890</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-56">
      <label>Nguyen et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Co-conserved MAPK features couple D-domain docking groove to distal allosteric sites via the C-terminal flanking tail</article-title>
        <source>PLOS ONE</source>
        <year iso-8601-date="2015">2015</year>
        <volume>10</volume>
        <issue>3</issue>
        <elocation-id>e0119636</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0119636</pub-id>
        <pub-id pub-id-type="pmid">25799139</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-57">
      <label>Niepel et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niepel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hafner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Paull</surname>
            <given-names>EO</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Golub</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ma’ayan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sorger</surname>
            <given-names>PK</given-names>
          </name>
        </person-group>
        <article-title>Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling</article-title>
        <source>Nature Communications</source>
        <year iso-8601-date="2017">2017</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>1186</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-017-01383-w</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-58">
      <label>Oruganty &amp; Kannan (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Design principles underpinning the regulatory diversity of protein kinases</article-title>
        <source>Philosophical Transactions of the Royal Society B: Biological Sciences</source>
        <year iso-8601-date="2012">2012</year>
        <volume>367</volume>
        <issue>1602</issue>
        <fpage>2529</fpage>
        <lpage>2539</lpage>
        <pub-id pub-id-type="doi">10.1098/rstb.2012.0015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-59">
      <label>Oruganty &amp; Kannan (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oruganty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year iso-8601-date="2013">2013</year>
        <volume>1834</volume>
        <issue>7</issue>
        <fpage>1322</fpage>
        <lpage>1329</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbapap.2013.02.040</pub-id>
        <pub-id pub-id-type="pmid">23499783</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-60">
      <label>Patani et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Patani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bunney</surname>
            <given-names>TD</given-names>
          </name>
          <name>
            <surname>Thiyagarajan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Norman</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Ogg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Breed</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ashford</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Potterton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Edwards</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Knowles</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Breeze</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Orengo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Phillips</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Katan</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use</article-title>
        <source>Oncotarget</source>
        <year iso-8601-date="2016">2016</year>
        <volume>7</volume>
        <issue>17</issue>
        <fpage>24252</fpage>
        <lpage>24268</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.8132</pub-id>
        <pub-id pub-id-type="pmid">26992226</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-61">
      <label>Quan et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Jiao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Prognostic significance of PAK family kinases in acute myeloid leukemia</article-title>
        <source>Cancer Gene Therapy</source>
        <year iso-8601-date="2020">2020</year>
        <volume>27</volume>
        <issue>1–2</issue>
        <fpage>30</fpage>
        <lpage>37</lpage>
        <pub-id pub-id-type="doi">10.1038/s41417-019-0090-1</pub-id>
        <pub-id pub-id-type="pmid">30890765</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-62">
      <label>Ruan &amp; Kannan (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Mechanistic insights into R776H mediated activation of epidermal growth factor receptor kinase</article-title>
        <source>Biochemistry</source>
        <year iso-8601-date="2015">2015</year>
        <volume>54</volume>
        <issue>27</issue>
        <fpage>4216</fpage>
        <lpage>4225</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.biochem.5b00444</pub-id>
        <pub-id pub-id-type="pmid">26101090</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-63">
      <label>Ruan, Katiyar &amp; Kannan (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Computational and experimental characterization of patient derived mutations reveal an unusual mode of regulatory spine assembly and drug sensitivity in EGFR kinase</article-title>
        <source>Biochemistry</source>
        <year iso-8601-date="2017">2017</year>
        <volume>56</volume>
        <issue>1</issue>
        <fpage>22</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.biochem.6b00572</pub-id>
        <pub-id pub-id-type="pmid">27936599</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-64">
      <label>Sheils et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheils</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Kelleher</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Siramshetty</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Vidović</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Koleti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schürer</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Dharkar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mathé</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Simeonov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>TCRD and Pharos 2021: mining the human proteome for disease biology</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2021">2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1334</fpage>
        <lpage>D1346</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa993</pub-id>
        <pub-id pub-id-type="pmid">33156327</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-65">
      <label>Sheils et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheils</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mathias</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Siramshetty</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Bocci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bologa</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Southall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>How to illuminate the druggable genome using Pharos</article-title>
        <source>Current Protocols in Bioinformatics</source>
        <year iso-8601-date="2020">2020</year>
        <volume>69</volume>
        <issue>1</issue>
        <elocation-id>e92</elocation-id>
        <pub-id pub-id-type="doi">10.1002/cpbi.92</pub-id>
        <pub-id pub-id-type="pmid">31898878</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-66">
      <label>Simonetti et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simonetti</surname>
            <given-names>FL</given-names>
          </name>
          <name>
            <surname>Tornador</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nabau-Moreto</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Molina-Vila</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Marino-Buslje</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Kin-Driver: a database of driver mutations in protein kinases</article-title>
        <source>Database</source>
        <year iso-8601-date="2014">2014</year>
        <volume>2014</volume>
        <fpage>bau104</fpage>
        <pub-id pub-id-type="doi">10.1093/database/bau104</pub-id>
        <pub-id pub-id-type="pmid">25414382</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-67">
      <label>Soleymani et al. (2022)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Soleymani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gravel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bozorgi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bendzunas</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Kochut</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Dark kinase annotation, mining and visualization using the protein kinase ontology</article-title>
        <source>BioRxiv</source>
        <year iso-8601-date="2022">2022</year>
        <pub-id pub-id-type="doi">10.1101/2022.02.25.482021</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-68">
      <label>Tate et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tate</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Bamford</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jubb</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Sondka</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Beare</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Bindal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Boutselakis</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cole</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Creatore</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dawson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fish</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Harsha</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hathaway</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jupe</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ponting</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ramshaw</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Rye</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Speedy</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Stefancsik</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>SA</given-names>
          </name>
        </person-group>
        <article-title>COSMIC: the catalogue of somatic mutations in cancer</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D941</fpage>
        <lpage>D947</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-69">
      <label>Taylor et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kornev</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Integration of signaling in the kinome: architecture and regulation of the alphaC Helix</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year iso-8601-date="2015">2015</year>
        <volume>1854</volume>
        <issue>10</issue>
        <fpage>1567</fpage>
        <lpage>1574</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbapap.2015.04.007</pub-id>
        <pub-id pub-id-type="pmid">25891902</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-70">
      <label>Tunyasuvunakool et al. (2021)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tunyasuvunakool</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zielinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Žídek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bridgland</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Laydon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Velankar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kleywegt</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pritzel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Figurnov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ronneberger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Bates</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kohl</surname>
            <given-names>SAA</given-names>
          </name>
          <name>
            <surname>Potapenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ballard</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Romera-Paredes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nikolov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Reiman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Senior</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Kavukcuoglu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Birney</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kohli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jumper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hassabis</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Highly accurate protein structure prediction for the human proteome</article-title>
        <source>Nature</source>
        <year iso-8601-date="2021">2021</year>
        <volume>596</volume>
        <issue>7873</issue>
        <fpage>590</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>
        <pub-id pub-id-type="pmid">34293799</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-71">
      <label>Vazquez et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vazquez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pons</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Valencia</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Izarzugaza</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>wKinMut-2: identification and interpretation of pathogenic variants in human protein kinases</article-title>
        <source>Human Mutation</source>
        <year iso-8601-date="2016">2016</year>
        <volume>37</volume>
        <issue>1</issue>
        <fpage>36</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22914</pub-id>
        <pub-id pub-id-type="pmid">26443060</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-72">
      <label>Watkins et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Watkins</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Pundir</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>MJ</given-names>
          </name>
          <collab>UniProt Consortium</collab>
        </person-group>
        <article-title>ProtVista: visualization of protein sequence annotations</article-title>
        <source>Bioinformatics</source>
        <year iso-8601-date="2017">2017</year>
        <volume>33</volume>
        <fpage>2040</fpage>
        <lpage>2041</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx120</pub-id>
        <pub-id pub-id-type="pmid">28334231</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-73">
      <label>Wilkinson et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilkinson</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Dumontier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aalbersberg</surname>
            <given-names>IJ</given-names>
          </name>
          <name>
            <surname>Appleton</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Axton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baak</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blomberg</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Boiten</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>da Silva Santos</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Bouwman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brookes</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Crosas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dillo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Dumon</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Edmunds</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Evelo</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Finkers</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gonzalez-Beltran</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Groth</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Goble</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Grethe</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Heringa</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>t Hoen</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Hooft</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lusher</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Martone</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Mons</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Packer</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Persson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rocca-Serra</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Roos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van Schaik</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sansone</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Schultes</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sengstag</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Slater</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Strawn</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Swertz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van der Lei</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van Mulligen</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Velterop</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Waagmeester</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wittenburg</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wolstencroft</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mons</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The FAIR guiding principles for scientific data management and stewardship</article-title>
        <source>Scientific Data</source>
        <year iso-8601-date="2016">2016</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>160018</fpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2016.18</pub-id>
        <pub-id pub-id-type="pmid">26978244</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-74">
      <label>Wishart et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wishart</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Feunang</surname>
            <given-names>YD</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Lo</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Marcu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Sajed</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sayeeda</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Assempour</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Iynkkaran</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Maciejewski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gale</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Knox</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2018">2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
        <pub-id pub-id-type="pmid">29126136</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-75">
      <label>Yang et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Soares</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Greninger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Edelman</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Lightfoot</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bindal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Beare</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>IR</given-names>
          </name>
          <name>
            <surname>Ramaswamy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Futreal</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Haber</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Stratton</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Benes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>McDermott</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Garnett</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</article-title>
        <source>Nucleic Acids Research</source>
        <year iso-8601-date="2013">2013</year>
        <volume>41</volume>
        <issue>D1</issue>
        <fpage>D955</fpage>
        <lpage>D961</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1111</pub-id>
        <pub-id pub-id-type="pmid">23180760</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-76">
      <label>Yonemoto et al. (1993)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yonemoto</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Garrod</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase</article-title>
        <source>Journal of Biological Chemistry</source>
        <year iso-8601-date="1993">1993</year>
        <volume>268</volume>
        <issue>25</issue>
        <fpage>18626</fpage>
        <lpage>18632</lpage>
        <pub-id pub-id-type="doi">10.1016/S0021-9258(17)46675-0</pub-id>
        <pub-id pub-id-type="pmid">8395513</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-77">
      <label>Yun et al. (2008)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yun</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Mengwasser</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Toms</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Woo</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Greulich</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>K-K</given-names>
          </name>
          <name>
            <surname>Meyerson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eck</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year iso-8601-date="2008">2008</year>
        <volume>105</volume>
        <issue>6</issue>
        <fpage>2070</fpage>
        <lpage>2075</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0709662105</pub-id>
        <pub-id pub-id-type="pmid">18227510</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-78">
      <label>Zhang et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Huo</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo</article-title>
        <source>Journal of Experimental &amp; Clinical Cancer Research</source>
        <year iso-8601-date="2017">2017</year>
        <volume>36</volume>
        <issue>1</issue>
        <fpage>146</fpage>
        <pub-id pub-id-type="doi">10.1186/s13046-017-0610-5</pub-id>
        <pub-id pub-id-type="pmid">29041983</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-79">
      <label>Zhang, Yang &amp; Gray (2009)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>NS</given-names>
          </name>
        </person-group>
        <article-title>Targeting cancer with small molecule kinase inhibitors</article-title>
        <source>Nature Reviews Cancer</source>
        <year iso-8601-date="2009">2009</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>28</fpage>
        <lpage>39</lpage>
        <pub-id pub-id-type="doi">10.1038/nrc2559</pub-id>
        <pub-id pub-id-type="pmid">19104514</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
